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The synthesis and design of biocompatible nanoparticles for targeted drug delivery and 
bioimaging requires knowledge of both their potential toxicity and their transport. For both 
practical and ethical reasons, evaluating exposure via cell studies is a logical precursor to in 
vivo tests. As a step towards clinical trials, this work extensively investigated the toxicity of 
gold nanoparticles (Au NPs) and carbon dot (CD) nanoparticles as a prelude to their in vivo 
application, focusing specifically on ocular cells. As a further step, it also evaluated their 
whole-body transport in mice. The research pursued two approaches in assessing the toxicity 
of engineered nanoparticles and the suitability of their use in targeted delivery and 
bioimaging applications: (1) In vitro (using retinal pigment epithelial, corneal, and lens 
epithelial cells (2) In vivo (mouse whole body studies).  
Part. 1.  In the in vitro assessments of Part 1, the biocompatibilities of spherical, rod, and 
cubic shaped Au NPs were compared for different exposure concentrations. Spherical Au 
NPs were evaluated in particular detail, and a possible toxicity mechanism was proposed, 
based on the findings of a colorimetric assay, electrical impedance measurements, and 
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confocal imaging analysis. The assay measured the activity of succinate hydrogenase, a 
mitochondrial enzyme, while electrical impedance spectroscopy quantified the strength of 
cell-cell and cell-substrate attachment, a proxy of viability. Finally, confocal imaging analysis 
verified that the NPs were internalized and confirmed the degree of their toxicity. 
Collectively, the data indicated that surface area concentration was the critical toxicity 
parameter. Subsequently, to create biocompatible Au NPs, a unique end-thiolation of 
hyaluronic acid was adapted to create homogenously coated Au NPs. The end-thiolated 
hyaluronate (HS-HA) coating not only improved the biocompatibility of the Au NPs but also 
enhanced the internalization rate of the larger Au NPs, which could not enter the cells 
otherwise.  
The first part of this research also studied the synthesis of biocompatible deep red-emissive 
CDs for bioimaging applications. For this purpose, a central-composite design response 
surface methodology (CCD-RSM) was utilized. A scalable isolation-free microwave 
pyrolysis method for synthesizing deep red-emissive nitrogen-doped carbon dots (nCDs) 
from citric acid and ethylenediamine was successfully developed and optimized. The 
formation of C‒N and the presence of pyrrolic N content proved to be keys to creating red-
emissive nCDs. Confocal images demonstrated that the nanoparticles could enter healthy 
corneal, retinal, and lens epithelial ocular cells, as well as cancerous Chinese Hamster Ovary 
cells.  
Part 2.  Building on the results of in-vitro testing of the engineered Au NPs and nCDs, in Part 
2 we developed protocols for injecting both types of NPs in-vivo. Prior to any intravenous or 
intravitreal injections, a preliminary study tested the ability of Au NPs to cross the tight 
junctions between retinal pigment epithelial cells. Transwell® permeable supports were used 
to simulate the blood-retinal barrier (BRB). The results showed that 20 nm Au NPs 
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successfully crossed the permeable supports covered with confluent retinal pigment epithelial 
cells. Based on this finding, both intravitreal and intravenous injections of nascent and HS-
HA coated Au NPs were tested. The intravitreal injections caused retinal detachment, very 
probably due to the mechanical intrusion of the injection needle and the volume, albeit small, 
of the injected NPs. Far more significant and encouraging, intravenously injected coated and 
uncoated NPs successfully crossed the BRB. As a result of the intravenous injections, it was 
observed that both coated and uncoated Au NPs were able to cross the blood-retinal barrier. 
As expected, the numbers of HS-HA-coated Au NPs were significantly higher in specific 
parts of the retina that contain more CD44 expressing cells, which have cell surface receptors 
for internalizing HA. Finally, based on the confocal imaging analysis, the NP concentration 
in each retinal layer was quantified as a function of time, post-injection. The NPs reached the 
retina in less than 5 minutes and reached a maximum concentration within approximately 20 
minutes. Due to the enhanced retention and permeability effect of NPs, 8.5% of the uncoated 
and 12.1% of the HA-coated NPs that reach the retina remained after 24 hours. 
Next, nCDs with and without the HA coating were injected subcutaneously into post-mortem 
mouse and porcine eye globes. Ex-vivo porcine eye images showed that intravitreally injected 
nCDs had effectively diffused through the vitreous to the cornea, and post-mortem whole-
body mouse images also demonstrated that the nCDs are suitable for bioimaging, excitable in 
the NIR region with the sensitivity of 15%. 
Cumulatively, our observations indicate that HA coated NPs could potentially deliver other 
payloads such as DNAs, mRNAs, proteins, siRNAs, and drugs into the cells which 
overexpress CD44 receptors, for example, cancerous and inflammatory cells, thus providing a 
platform for targeted treatment and imaging of many severe vision-threatening diseases and 
degenerative conditions.  
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Chapter 1: Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
The results of this chapter have been partially compiled in Karakoçak, B. B., Biswas, P., and 
Ravi N. (2018). Applications of Gold Nanoparticles in Ophthalmology. Prog. Retin. Eye Res. 
In preparation.  
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1.1 Background and Motivation 
During the past three decades, nanomaterials have received tremendous attention for their 
distinctive mechanic, thermal, acoustic, magnetic, electrical, and optical characteristics. At 
nanometer scale, materials have a high surface area to mass ratio, which gives them novel 
properties that differ markedly from the same properties exhibited at bulk scale. Worldwide, 
the nanotechnology sector has achieved a multi-billion US$ market (Markets 2018). 
According to a recent study, from 2014 to 2019 the global market for nanoparticles in the 
pharmaceutical and biotechnology sectors is expected to increase from $30 to 80 billion by 
2019, with a compound annual growth rate of 22.0% (J. 2014). The annual production of 
engineered nanoparticles is in the millions of tons, valued at over $15 billion/year (Li et al. 
2016).  
Recent advances in the synthesis and biomolecular functionalization of engineered 
nanoparticles have dramatically expanded their current and potential biomedical applications, 
including their use as nanoprobes (Leduc et al. 2013) and nanosensors (Swierczewska et al. 
2012). Engineered nanoparticles now play significant roles in bioimaging (Koide et al. 1986, 
McKechnie et al. 1986, Grant et al. 1996, Ruiz-Ederra et al. 2005, Chang 2012), photothermal 
therapy (Ryu et al. 2012), gene therapy (Shestopalov et al. 2002, Raju et al. 2011), targeted 
drug delivery, and tissue engineering (Karthikeyan et al. 2010, Parveen et al. 2012, Kompella 
et al. 2013, Naha et al. 2015).  
Specific engineered nanoparticle types are prominent in biomedical applications. Gold 
nanoparticles (Au NPs) in particular have attractive intrinsic properties, such as high chemical 
stability (Gao et al. 2012), convenient surface functionalization (Adokoh et al. 2014), unique 
surface plasmon properties (Diebold and Calonge 2010, Parveen et al. 2012) and anti-
angiogenic properties (Arvizo et al. 2010, Jo et al. 2014).  
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The synthesis of Au NPs is well studied, with established protocols for creating different 
shapes and sizes (Turkevich et al. 1951, Kimling et al. 2006, Grzelczak et al. 2008, Tyagi et 
al. 2016). However, their toxic potential is debated, and the toxicity mechanism is still an 
enigma (Goodman et al. 2004, Alkilany and Murphy 2010, Albanese and Chan 2011, Choi et 
al. 2012, Fraga et al. 2014).  
As another example, carbon dots (CDs), measuring less than 5 nm in diameter, are the subject 
of several recent studies in bioimaging (Luo et al. 2013, Berezin 2014, Cherukula et al. 2016, 
Gan et al. 2016).They are particularly interesting for their wavelength dependent 
excitation/emission behavior (Jiang et al. 2015, Ding et al. 2016), long fluorescence lifetime 
(Dong et al. 2015), good photostability (Zhang et al. 2015), and relatively high 
biocompatibility (Tao et al. 2012). With these unique properties, CDs have demonstrated 
promise for bioimaging applications.(Hola et al. 2014, Choi et al. 2016, Zhang et al. 2016). 
Especially for bioimaging applications, high quantum yield and near-infrared excitability are 
key properties for CDs to be worthy of exploring. Up to date, numerous synthesis methods 
have been developed for synthesis of CDs such as laser ablation, pyrolysis, electrochemical 
oxidation, hydrothermal reactions, and microwave treatment (Zhu et al. 2009, Zhu et al. 2013, 
Wang et al. 2014, Wang and Hu 2014, Ding et al. 2016). However, the lack of a facile 
synthesis method to create red-emissive CDs with high quantum yield has limited their 
widespread biomedical application.   
1.1.1 Ophthalmic uses of engineered nanoparticles: Opportunities and 
roadblocks  
The eye, considered the most complex organ (Fig. 1.1) after the brain, is the window to the 
colors of life. The retina is an extension of the central nervous system (CNS) because the 
axons of the retinal ganglion cells originate from the optic nerve. Thus, the eye is also 
considered to be a part of the central nervous system (London et al. 2013). Eye transplantation 
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has not been achieved yet due to the complexity of the optic nerve, which has more than 1.2 
million nerve fibers (Sanchez et al. 1986, Sivak et al. 2016). Therefore, curing eye diseases is 
crucial as the eye is the most important sensory organ and has a direct effect on the quality of 
life.  
 
Figure 1.1 The structure of the “Eye”.  
Copyright 2018, Bedia Begüm Karakoçak and Naci Köksal 
Nanoparticles can serve as a platform both for ocular drug delivery and for imaging. Since the 
1985 study of Wood et al. showing the intrinsic capacity of NPs to adhere to the ocular 
surface and interact with the epithelium, nanotechnological agents to treat eye problems have 
been sought. NPs can deliver ocular drugs to specific target sites and promise to revolutionize 
the therapy for many eye diseases (Barar et al. 2008, Diebold and Calonge 2010, Jo et al. 
2011, Gonzalez et al. 2013). Numerous reports to date strongly suggest that ocular medicine 
will benefit greatly from the use of nanotechnology (Diebold et al. 2007, Cai et al. 2008, 
Conley and Naash 2010, Fischer et al. 2011, Jin Hyoung et al. 2011). 
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In treating the eye, intravenous delivery of nanoparticles is challenged by the first pass losses 
through the liver and kidneys, and the presence of the blood-retinal barrier. When agents are 
administered topically, the ocular surface epithelium and tear film, labeled in Fig. 1.2, form 
external barriers (Barar et al. 2008, Boisselier and Astruc 2009, Choonara et al. 2010, Cunha-
Vaz et al. 2011, Honda et al. 2013, Barua and Mitragotri 2014). Due to these barriers, 
intraocular injections are currently the most common route of administration (Abu El-Asrar 
and Al-Mezaine 2010, Choonara et al. 2010, Bochot and Fattal 2012, Christoforidis et al. 
2012). Topical application remains as an optional route for delivering drugs (Del Amo and 
Urtti 2008, Chen et al. 2011, Chantalat et al. 2012, Butler et al. 2013, Cho et al. 2015).  
 
Figure 1.2 Structural features of the eye. Many barriers impede delivery to the retina. Selected agents, such as NPs 
loaded with drugs cannot be efficiently delivered to the retina by topical administration, for example, by using eye 
drops, because of tear drainage and choroidal blood flow. Systemically administered large NPs enter the retina 
with great difficulty because of the strict blood-aqueous barrier and the inner and outer blood-retinal barriers. 
Copyright 2018, Bedia Begüm Karakoçak and Naci Köksal. 
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Direct drug administration using either of these two routes can fail to achieve a therapeutic 
dose, or the dose may not be bioavailable (Avitabile et al. 2001, Duvvuri et al. 2003, Barar et 
al. 2008, Diebold and Calonge 2010, Gaudana et al. 2010, Kompella et al. 2010). Untargeted 
delivery of drugs may have side effects, and repeated uncomfortable treatments are not well 
tolerated by patients.  In short, achieving therapeutic drug levels with currently preferred 
administration routes is difficult. In this regard, the high surface area to volume ratio of 
nanoparticles is of special interest, particularly where the desired therapeutic drug levels can 
be achieved without repeated untargeted injections (Diebold et al. 2007, Diebold and Calonge 
2010, Kompella et al. 2010, Kompella et al. 2013, Zhou et al. 2013, Azharuddin et al. 2014). 
Moreover, for topical administration, nanoparticles may provide improved topical passage of 
large and poorly water-soluble molecules (Poon et al. 2001, Atluri and Mitra 2003, Xiong et 
al. 2008, Shah et al. 2011).  
If the current delivery barriers could be surmounted, ocular disorders such as age-related 
macular degeneration, glaucoma, and retinal ischemia be potentially treated (Gaudana et al. 
2009, Conley and Naash 2010, Fischer et al. 2011, Gonzalez et al. 2013). Conventionally 
developed drugs elicit a limited response due to rapid removal from the eye by local 
circulation and eventual systemic absorption. For example, dipivalylepinephrine, flurbiprofen, 
and timolol have systemic circulation losses of 65%, 74%, and 80%, respectively (Weisse et 
al. 1995). As a result, these drugs, although FDA approved, mostly fail to effectively treat the 
target disease (Saettone 2002). Engineering nanoparticles to overcome the current barriers and 
increase the delivered drug dose can truly promote the effectiveness of curative treatments 
and potentially introduce alternative treatments for most eye diseases (Jo et al. 2013, Luo et 
al. 2013, Zhou et al. 2013). Finally, NPs offer the possibility of targeted and controlled drug 
release, especially for poorly water-soluble drugs, that defeats the ocular barriers and 
effectively reaches the target. In addition to improving the delivery of poorly water-soluble 
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drugs, inherently biocompatible nanoparticle systems can potentially reduce toxicity 
compared to the free drug (Diebold and Calonge 2010).  
1.1.2 Engineering nanoparticles to reduce their toxicity, overcome ocular 
drug delivery barriers, and facilitate imaging  
To make full use of nanoparticles, a thorough understanding of their toxic potential is crucial. 
Classical approaches to predict the toxicity of nanoparticles take into account the level of 
nanoparticle exposure (mass and number concentration), as well as their size, shape, and 
coating (Pan et al. 2007, Johnston et al. 2010, Tarantola et al. 2011, Moghadam et al. 2012, 
Sabella et al. 2014). It has also been shown that nanoparticle toxicity is dependent on the cell 
type (Coulter et al. 2012, Manshian et al. 2015, Schlinkert et al. 2015). Among these toxicity 
factors, the incipient nanoparticle exposure concentration, especially given the traditional 
concentration metrics for assessing toxicity, remains problematic due to the complex 
interactions of nanoparticles with their environment (Biswas and Wu 2005, Suttiponparnit et 
al. 2011).  
Au NPs have been widely explored in medicine as delivery agents for biopharmaceuticals 
(Kim et al. 2011, Kumar et al. 2015). Although Au NPs are usually more biocompatible than 
other metal or metal oxide nanoparticles, their positively charged surface disrupts the 
negatively charged cell membrane, and their labile surface electrons are involved in reactions 
that typically produce reactive oxygen species (ROS), causing cytotoxicity (Moghadam et al. 
2012). Moreover, plasma proteins can spontaneously adsorb to nascent Au NPs, affecting the 
surface properties of the particles and influencing their interaction with cells (Nel et al. 2009). 
As a result, surface modification has been pursued as an essentially ideal way to prevent 
protein adsorption (Larson et al. 2012) and nonspecific delivery of Au NPs (Rana et al. 2012), 
to decrease their opsonization by the immune system (Papasani et al. 2012), and finally to  
mitigate their toxicity.  
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Ocular imaging is critical in diagnosing, treating, and monitoring the progress of many eye 
diseases (Nadler et al. 2012). Fluorescence-based methods such as indocyanine green (ICG) 
angiography remain the gold standard for detecting abnormalities of the choroid vasculature 
in healthy and diseased eyes. Optical coherence tomography (OCT), typically employing a 
near-infrared wavelength, is a well-established optical imaging technique.  It is non-invasive, 
non-destructive, and capable of providing micron-scale axial resolution via low-coherence 
interferometry (Laviers and Zambarakji 2014). The relatively long wavelength light 
penetrates deep into scattering tissue and media. OCT is used in such fields as dermatology, 
cardiology, otolaryngology, ophthalmology, and oncology to acquire cross-sectional images 
of dermal lesions, cardiac vessels, and the retina. In OCT, imaging agents which fluoresce 
with a high quantum yield at near infrared wavelengths are desired. Carbon-based 
nanoparticles have been considered as bioimaging agents (Yanai et al. 2012, Saghiri et al. 
2015, Saghiri et al. 2015); however, most show intense emission only in the blue-green region 
following excitation with ultraviolet or blue light which has a relatively shallow penetration 
depth (Bourlinos et al. 2008, Peng and Travas-Sejdic 2009, Wang et al. 2010, Bourlinos et al. 
2012, Zhu et al. 2013, Yang et al. 2015, Qu et al. 2017). A technique to create highly efficient 
red-emissive carbon dots would significantly extend the reach of ophthalmic imaging. Finally, 
for ocular imaging applications, targeted delivery may also be desirable depending on the 
disease to be treated, in other words, the type of cells of interest.  
Hyaluronic Acid as a Biocompatible Surface Coating for Targeted Delivery of NPs 
Many coating conjugates, ranging from synthetic ligands to natural biomolecules have been 
used to improve the stability of particles and the efficiency of their delivery to specific cells or 
tissues (Manson et al. 2011, Lowe et al. 2015, Yilmaz et al. 2016, Lin et al. 2017). Examples 
include polyethylene glycol, polycarboxybetaine, poly(hydroxy functional acrylates), poly(2-
oxazoline)s, poly(vinylpyrrolidone), and poly(glycerol).   However, these coating conjugates 
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suffer from unspecific protein binding and are not specific to cell types, thus making them 
unsuitable for targeted drug delivery. In this study, we chose hyaluronic acid (HA) as a 
coating material, because it can prevent adsorption of proteins on the surfaces of biomaterials 
(Hans and Lowman 2002) and has an antifouling effect that arises from its hydrophilic and 
polyanionic characteristics (Lee et al. 2008, Santhanam et al. 2015). HA also scavenges free 
radicals and chelates pro-oxidant metals (Glucksam-Galnoy et al. 2012). It exhibits many 
desirable physiological properties:  For example, it can be either anti-inflammatory or pro-
inflammatory, depending on its molecular weight. 
HA plays an essential physiological role as a ligand for several cell-surface receptors. Its 
interaction with cluster of differentiation 44 (CD44), a transmembrane receptor (Jaggupilli 
and Elkord 2012), is the most well studied. It is present on, for example, the lymphatic vessel 
endothelial HA receptor (LYVE-1) (Chen et al. 2005), the receptor for hyaluronate-mediated 
motility (RHAMM) (Nedvetzki et al. 2005), and the HA receptor for endocytosis (HARE) 
(Pandey and Weigel 2014). Proliferating cells, certain types of epithelial and particularly 
cancer cells, express CD44 receptors; therefore, HA-conjugated NPs can be selectively 
delivered to these cells while ensuring that the NPs are biocompatible with the target cell.  
Low molecular weight HA (~2500 Da) was shown to disrupt endothelial cell barriers (Lennon 
et al. 2014). It was also demonstrated that HA aided NPs in passing the BRB transcellularly, 
via CD44-receptor-mediated endocytosis (Santiago-Tirado et al. 2017), as well as by 
increasing the permeability of tight paracellular junctions (Kirschner et al. 2010). Because the 
internalization is based only on the HA coating and not its payload, the HA coating is 
expected to act as a Trojan horse for delivering NPs into ocular cells without causing 
additional toxicity. 
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1.2  Dissertation Outline 
This dissertation has two main objectives: 
1) To evaluate in vitro toxicity and create biocompatible-engineered gold nanoparticles and 
red-emissive carbon dots for targeted delivery and bioimaging applications, respectively.  
2) To investigate Au NPs’ and CDs’ effectiveness as delivery and bioimaging agents in-vivo. 
Each of the five chapters of the dissertation is self-contained, with an introduction, 
experimental section, results, discussion, and conclusions.  Chapters 2 and 3 describe 
respectively the systematic toxicity assessment of Au NPs and how to overcome this 
drawback with an end-thiolated hyaluronate coating. These studies identified the potential 
toxicity of Au NPs with ocular tissue, while offering a representative metric for their toxicity 
assessment and providing a way to use of Au NPs as delivery agents in ophthalmology. In 
Chapter 4, we optimize an isolation-free method for synthesizing red-emissive CDs (red-CDs 
with deep red to NIR fluorescence) as bioimaging agents. This work highlights the use a 
powerful statistical tool, central-composite design response surface methodology, in 
constructing experiments which involve multiple parameters. The tool successfully identified 
the critical parameters in the creation of red emissive CDs. Next, in Chapter 5, we create HA-
conjugated CDs and evaluate their internalization rate as well as their biocompatibility with 
ocular cells. Finally, Chapter 6 investigates the fate and transport of Au NPs in the eye, in 
vivo, following intravitreal and intravenous injections. It also demonstrates the effectiveness 
of CDs as bioimaging agents in ex-vivo porcine eye globes and a post mortem mouse model.  
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Abstract 
Gold nanoparticles (Au NPs) have been tested as targeted delivery agents because of their 
high chemical stability and surface plasmon properties. Here, we investigated the 
biocompatibility of Au spheres (5-, 10-, 20-, 30-, 50-. and 100-nm), cubes (50-nm), and rods 
(10×90nm) on a retinal pigment epithelial (ARPE-19) cell line. The lethal dose for killing 
50% of the cells (LD50) was evaluated using an MTT (3-[4, 5 dimethyl-thiazoly-2-yl] 2-5 
diphenyl tetrazolium bromide) assay. At and above LD50, based on mass concentrations, the 
confluent cell layer began to detach, as shown by real-time measurements of electric 
impedance. We found that the biocompatibility of spheres improved with increasing 
nanoparticle size. The Au rods were less biocompatible than 10-nm spheres.  Confocal 
microscopy showed that cubic (50-nm) and spherical NPs (50- and 100-nm) neither had 
cytotoxic effects nor entered cells. Lethal doses for internalized spherical NPs, which were 
toxic, were recalculated based on surface area (LD50,A) concentrations.  Indeed, when 
biocompatibility was expressed as the surface area concentration of NPs, the curve was 
independent of size. The LD50,A of Au nanospheres was 23 cm
2/ml. Our findings demonstrate 
that the sole modulation of the surface area would make it possible to use Au NPs for 
therapeutic purposes.   
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2.1 Introduction 
Materials at the nanometer scale have a large surface area to mass ratio, which gives them 
novel properties that differ markedly from those of other material properties with 
corresponding bulk sizes. Recent advances in the synthesis and biomolecular functionalization 
of engineered nanoparticles have led to a dramatic expansion of their potential biomedical 
applications, including their use as nanoprobes (Leduc et al. 2013), nanosensors 
(Swierczewska et al. 2012) and in bioimaging (Ruiz-Ederra et al. 2005, Peng et al. 2006), 
photothermal therapy (Ryu et al. 2012), gene therapy (Shestopalov et al. 2002, Raju et al. 
2011), targeted drug delivery, and tissue engineering (Parveen et al. 2012, Kompella et al. 
2013, Austin et al. 2015, Naha et al. 2015). Specifically, gold nanoparticles (Au NPs) are 
being used because of their intrinsic characteristics, such as high chemical stability, suitable 
surface functionalization, and unique surface plasmon properties (Diebold and Calonge 2010, 
Parveen et al. 2012).  
Researchers have attempted nanoparticle-mediated drug and gene delivery to tissues of the 
eye, including the retina, to treat major eye diseases such as age-related macular degeneration 
and diabetes-related retinopathy (Jin Hyoung et al. 2011, Li et al. 2012, Ngwa et al. 2012, 
Ngwa et al. 2012, Joris et al. 2013). Moreover, intravitreal injection of Au NPs has been 
investigated for retinal imaging and inhibition of angiogenesis to prevent macular 
degeneration (Jeong Hun et al. 2009, Farjo and Ma 2010). Au NPs have been shown to be 
promising agents for enhanced delivery of anti-VEGF antibody or other antiangiogenic agents 
to specific sites in the eye (Hayashi et al. 2009, Jeong Hun et al. 2009, Diebold and Calonge 
2010). Currently, intravitreal and topical routes are most commonly used (Hayashi et al. 
2009). 
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The use of intravitreal injection of nanoparticles depends on the safety of the particles 
(Biswas and Wu 2005, Diebold and Calonge 2010, Kompella et al. 2013). Therefore, safety 
concerns necessitate a better understanding of the potential toxicity hazards of novel 
materials. One method of measuring toxicity is to examine cellular viability (Abe and Saito 
1999) by determining the lethal dose concentration (LD50), the dose required to kill 50% of 
the cells. Lethal doses of selected nanoparticles will provide guidance as to safe levels of use 
for nanomedicine applications.  
In this chapter, we report on the in-vitro biocompatibility of Au NPs with spontaneously 
arising retinal pigment epithelial (ARPE-19) cells. This cell line is an acceptable alternative to 
repeated isolation and standardization of primary RPE cells (Dunn et al., 1996; Pfeffer and 
Philp, 2014), provided that its detailed physicochemical characterization is closely similar to 
that of primary cells for toxicity evaluation. Although important research has been done on 
Au NPs (Bakri et al., 2008b, a; Cho et al., 2011; Pan et al., 2007b; Soderstjerna et al., 2014) 
on various cell lines, no studies have correlated the size, shape, and surface area of the 
administered Au NPs while reporting biocompatibility with the RPE cells. In the present 
study, we provided a comprehensive picture of physico-chemical characteristics of NPs and 
correlated these characteristics to their biocompatibility because it is crucial to predict the 
response of the targeted retinal cells to the Au NP exposure.  
The effect of Au NP shape (spherical, cubic, and rod; size 5-100 nm), and concentration (up 
to 5 mg/ml) on toxicity was assessed by MTT (3-[4, 5 dimethyl-thiazoly-2-yl] 2-5 diphenyl 
tetrazolium bromide) assay. In our study, the exposure period was a minimum of 72 h, which 
is long enough for gold nanoparticles to reach the cells (Bejjani et al. 2005, Cohen et al. 2014) 
for biocompatibility assessment. To better understand the effect of Au NP on cell toxicity, the 
electrical impedance of the cells was monitored continuously for 96 h.  Furthermore, the 
presence or absence of NPs inside the cell was verified using plasmonic imaging by confocal 
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microscopy. The correlation was developed for LD50 of Au NPs regarding the mass and 
surface area concentration to toxicity. A mechanistic description of NP toxicity interactions 
with ARPE-19 cells is presented, along with a simple universal toxicity curve that may apply 
to all cell types.  
2.2 Materials and Methods 
The experimental setup for particle generation and measurement (Figure 2.1), methods for 
data inversion, and the experimental plan are described as follows.  
2.2.1 Synthesis of gold nanoparticles 
Au nanoparticles shaped as spheres, cubes, or rods at sizes from 5 to 100 nm were synthesized 
using a seed-mediated approach (Jana et al. 2001, Wu et al. 2010). Details are provided in the 
supplementary information. 
2.2.2 Characterization of nanoparticles and exposure to ARPE-19 cell line 
Synthesized NPs were characterized by their size, shape, and agglomeration state by 
transmission electron microscopy (TEM). To confirm the size and the morphology of the Au 
NPs, micrographs were taken using an FEI Spirit TEM (Hillsboro, OR, USA) operated at 120 
kV. The hydrodynamic diameter and zeta potential of NPs in solution before and after their 
exposure to cell culture medium was measured using dynamic light scattering (DLS). Batch 
mode measurements were done using a Malvern Zetasizer Nano ZS (Malvern Instruments, 
Westborough MA). Quantitative determination of gold (Au) concentrations in stock solutions 
and aliquots before confocal imaging was done with an inductively coupled plasma 
spectrophotometer, ICP-MS (Elan DRC II, Perkin Elmer, Norwalk, CT).  
2.2.3 Biocompatibility assessment of the Au NPs with the ARPE-19 cell line 
Since animal cell culture is sensitive to microbial contamination, Au NP solutions were 
checked for microbial growth before cell exposure. Tests for bacterial and fungal 
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contamination, respectively, were performed on nutrient agar and potato dextrose agar plates 
both at room temperature and 37°C. 
In a flat-bottom, 96-well plates, 150 μL volumes (1.2 × 104 cells per well) of cells were 
incubated (37°C, 5% CO2) until confluent (supplementary information, Fig. S1), then exposed 
to different concentrations of NPs.  Physically characterized particles were dispersed in cell 
culture medium containing Dulbecco’s Modified Eagle Medium/Ham’s F-12 (DMEM/F-12), 
10% fetal calf serum (FCS), and antibiotics (C-DMEM/F12) to be used for cell exposure. For 
each shape and size of Au NPs, concentrations of the exposed solutions were 0.01, 0.05, 0.1, 
0.25, 0.5, 0.75, 1, 2.5, and 5 mg/ml. The upper limit of exposure concentration was 
determined by NP’s toxic potential reported in the literature (Pan et al. 2007, Hayashi et al. 
2009, Jin Hyoung et al. 2011, Choi et al. 2012, Naha et al. 2015). Nanoparticle exposure 
duration was a minimum of 72 h. 
The viability of ARPE-19 cells, defined as their ability to maintain its growth, was evaluated 
using the MTT assay, which is widely used for in-vitro nanotoxicity assessment (Dumortier et 
al. 2006, Sayes et al. 2007, Warheit et al. 2007, Conde et al. 2014). This technique, while 
requires the acquisition of optical density at a single wavelength has advantages over other 
toxicity assays because it requires minimal physical manipulation of ARPE-19 cells and 
yields quick, reproducible results. Following the exposure of NPs, 100 µL of MTT (1 mg/mL 
in growth medium was added to each well, after which the plate was further incubated for 5 h 
at 37°C in 5% CO2. The resulting blue component, produced by the reduction of tetrazolium 
salt of MTT by mitochondrial dehydrogenase enzyme, was dissolved in 100 µL dimethyl 
sulfoxide (DMSO). The optical density of the colored product was read photometrically using 
a spectrophotometer at 540 nm. Possible interactions between the nanoparticles and the 
formazan crystals, which form as a result of the reduction of MTT dye, can be minimized by 
selection of the proper dissolution solvent, DMSO, and adjusting the dye concentration as 
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well as the volume added to each well (Kong et al. 2011, Sylvester 2011). On the other hand, 
the spectrophotometer plate readings for both positive controls where the ARPE-19 cells were 
not exposed to Au NPs, and negative controls where the cells were exposed to Au NPs but not 
treated with MTT were also taken. The results were normalized based on both positive and 
negative controls.  The percentage viability of ARPE-19 cells was calculated using the 
following formula: 
Biocompatibility (Cell Viability) = (
Mean optical density of the sample
Control optical density
) ×  100    (2.1) 
The lethal dose is typically reported as the mass concentration of NPs at which the 
biocompatibility is 50%. LD50 values, based on mass concentration, were calculated by using 
a four-parameter logistic equation. Data were plotted as sigmoidal dose-response curves using 
Systat SigmaPlot 11.0 software. LD50,M values were derived from three independent 
experiments in which eight-well replicate measurements were done.  In this work, LD50 
values are defined based on both mass concentration (LD50, M) and surface area concentration 
(LD50,A).  
The cellular characteristics were also analyzed using electric cell-substrate impedance sensing 
(ECIS), a noninvasive technique that continuously measures the impedance across gold 
electrodes present at the bottom of tissue culture wells using various frequencies of alternating 
current (Wegener et al. 2000, Arndt et al. 2004). As the cell morphology and attachment via 
adhesion proteins (Hall et al. 1987, Borradori and Sonnenberg 1999) to the electrodes in the 
bottom of the well changes, the resistance across the electrodes also changes. The change in 
resistance at different frequencies from 400 to 64,000 Hz can be measured over time. The 
impedance at low frequency (less than 4,000 Hz) represents paths around the cells and, hence, 
the layer’s cell-to-cell barrier functions (Arndt et al. 2004). At a frequency of 4,000 Hz, the 
contribution of resistance through the cells was dominant and, at much higher frequencies 
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(8,000 to 64,000 Hz), the contribution is primarily from Au NPs with medium (Kandasamy et 
al. 2010). Hence, a frequency of 4,000 Hz was chosen to monitor cell growth characteristics. 
Cells were studied at high density and in confluence to closely mimic the natural structure and 
physiology of the retinal pigmented epithelial cell monolayer. Before the addition of 
nanoparticles, the confluency was confirmed by ECIS (supporting information, Fig. S1). Cells 
were plated in a 96-well ECIS array identical to those plated for the MTT assay. The 
resistance of cells was monitored for 24 h to ensure confluency before the addition of Au NPs. 
The Au NP solution was introduced on top of the cells at room temperature under sterile 
conditions. 
All tissue culture data (both MTT and ECIS) were expressed as the mean +/- standard error of 
the mean (SEM) values of at least three independent culture experiments. Eight replicates 
were performed for each independent cell culture experiment. Statistical significance was 
evaluated using ANOVA (analysis of variance) to compare with the respective positive 
(untreated cells) and negative (NPs without the cells) control groups. P*< 0.05, P**<0.001, 
the significance level, was statistically acceptable. 
To confirm the presence of NPs inside cells, we investigated the distribution of the Au NPs at 
their critical mass concentrations (LD50, M) using a nanoplasmonic confocal laser scanning 
microscope (LEICA TCS-SP8). The gold nanoparticles have surface plasmon resonance 
property (SPR). For the size range of 5-100 nm, for gold nanoparticles, the SPR wavelength is 
around 520 nm (Huang et al. 2008) depending on the size of the nanoparticles as also 
confirmed by our UV-Vis measurements (Supplementary information Fig. S2). Three lasers 
were used during Confocal imaging (405, 532, and 635 nm). Thus, the detection range is 405-
635 nm which is a wide enough range to detect all sizes of Au NPs in this study.   
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ARPE19 cells were seeded in CELLviewTM plates at 5×104 cells/well for 24 h. After 72 h of 
NP exposure, the cells were fixed and washed with PBS three times before imaging 
(supplementary information). During confocal imaging, 45 images were taken through 
different optical sections by collecting Z-stacks with a thickness of 100 nm. A control sample 
was prepared with and without cells in the absence of nanoparticles.  
To identify the difference between the administered and delivered doses, the amount of 
nanoparticles that failed to enter the cell was quantified in the aliquot obtained from the PBS 
washes prior to confocal imaging.  Using ICP-MS, the aliquot was tested for the presence of 
Au NPs.  The results were presented in supplementary information Fig. S4.  The 
internalization efficiency of 5-, 10-, 20-, and 30- nm was found to be %96.1±7.92, 
%86.3±11.5, %95.88±0.7, %86.81±2.28, respectively.  The concentration of Au in the 
aliquats were found to be be much lower than the administered dose (the LD50 concentration 
of each NP) for 5-, 10-, 20-, and 30- nm Au NPs proving that after a minimum of 72 h of 
exposure to Au NPs, the difference between the administered dose and the delivered dose 
(intracellular concentration of gold) was negligible, as has also been reported elsewhere 
(Bejjani et al. 2005).  On the other hand, it was found that only %9.9 ± 5.1 of 50- and 
%1.5±0.1 of 100- Au NPs were internalized (supplementary information Fig S4).   
2.3 Results and Discussion 
2.3.1 Characterization of synthesized NPs  
Size and morphology characterization by TEM and UV-Vis analysis  
Dimensions and morphology of NPs were analyzed by TEM. The mean diameters of 
Au sphere nanoparticles (Au S) were approximately 5, 10, 20, 30, 50, and 100 nm.  Cubes 
(Au C) were 50 nm, and rod-shaped NPs (Au R) were 90 nm in length and 10 nm in diameter 
(Fig. 2.1). These sizes of gold nanorods and nanocubes were selected to compare their 
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biocompatibility to gold nanospheres of similar sizes.  Standard deviations of the sizes are 
reported in the supplementary information, Table S2. 
Au NPs showed strong interactions at specific wavelengths of light as a function of their size; 
for example, the UV-Vis analysis showed a shift in the absorption peaks that qualitatively 
confirmed the measured particle sizes (supplementary information, Fig. S2). As a result, a 
range of varying NPs with strict control of size was successfully synthesized for 
biocompatibility assessment. 
 
Figure 2.1 Transmission electron micrographs of synthesized NPS: (a) Au 5-nm sphere, (b) Au 10-nm sphere, (c) 
Au 20-nm sphere, (d) Au 30-nm sphere, (e) Au 50-nm sphere, (f) Au 100-nm sphere, (g) Au 50-nm cube, and (h) 
au 10×90 nm rod. 
Hydrodynamic diameter measurements by DLS 
The hydrodynamic sizes of all the Au NPs as measured by DLS were larger than their 
physical size as determined by TEM measurements due to the adhered solvent molecules on 
the particle surface.  Also, the hydrodynamic size increased when Au NPs were dispersed in 
cell culture medium rather than water.   
Surface zeta potential 
Zeta potential is one of the crucial parameters for the measure of particles’ stability. To test 
the stability of NPs and measure their surface charge, the zeta potential was measured using a 
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dielectric cell.  Nanoparticles with zeta potentials greater than 20 mV or less than -20 mV 
have strong electrostatic repulsion and thus remain stable in solution. Results indicated that 
when Au NPs were dispersed in cell culture medium, their zeta potential significantly 
decreased, possibly to a new protein corona formation, increasing the possibility of 
aggregation. No aggregation was observed after particles had been dispersed for 96 h in both 
C-DMEM/F12 and DI water (supplementary information, Table S2).  No microbial growth 
was detected after 72 h of incubation.  
2.3.2 Biocompatibility assessment of the Au NPs with the ARPE-19 cell line 
MTT assay measurements 
The MTT assay was used to investigate how the shape and size of Au NPs affect the 
internalization and viability of ARPE-19 cells. Results clearly showed that Au nanospheres 
with diameters of 5, 10, 20, and 30 nm and nanorods of 10×90 nm, even at the low 
concentration of 0.05 mg/ml, adversely affected cellular viability (Figure 2.2)  
 
Figure 2.2 (a) Percentage biocompatibility of ARPE-19 cells exposed to Au NPs (Data is represented in log scale 
for x axis). (b) ARPE-19 cells’ biocompatibility with Au NPs as a function of surface area and particle diameter, 
with biocompatibility (%) as a function of surface area concentration (cm2/ml) (Data is represented in log scale 
for x axis). (c) The critical surface area concentration (LD50,A) for spherical Au NPs was 23 cm2/ml. The data is 
normalized using both negative and positive controls. Values are expressed in mean ± for each condition, three 
independent experiments were done with eight replicates (n=24, *P<0.05 vs controls). 
 
 
(a) (b) (c) 
  
30 
 
ECIS measurements 
Cell attachment behavior was monitored in the presence of spherical Au NPs having 
diameters ranging between 5 and 30 nm. Fig. 2.3a to f, respectively, show the resistance at 
4,000 Hz over time after the addition of Au NPs of the six different sizes (5, 10, 20, 30, 50, 
and 100 nm).  The exposure concentration range was narrowed down to 0.01–0.50 mg/ml 
based on the MTT assay findings.  According to the cell attachment measurements, it can be 
inferred that the cells become confluent by the end of the 23rd h (Fig. 2.3a-f).  ARPE-19 cells 
show no change in resistance compared to control cells in the presence of all concentrations of 
the 50 and 100 nm Au NPs (Fig. 2.3e, f).  
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Figure 2.3 Electrical cell-substrate impedance sensing measurements for ARPE-19 cells exposed to (a) 5-nm Au 
spheres, (b) 10-nm Au spheres, (c) 20-nm Au spheres, and (d) 30-nm Au spheres when, at critical concentrations 
previously detected in MTT assay results, cells started to detach from the culture plate. (e) 50-nm Au spheres 
with cell detachment unhindered; however, the measured resistance is decreasing as the exposure concentration 
increases. (f) 100-nm Au spheres with no occurrence of cytotoxic effect. Values are expressed in mean ± SEM 
with each condition tested at least in triplicate (n=24, **P<0.001 vs. controls).  
The cells that were exposed to 5 nm Au NPs at 0.030 mg/ml (Fig. 2.3a) and 10 nm Au NPs at 
0.057 mg/ml (Fig. 2.3b) followed the same pattern of change in impedance as did the positive 
control. However, the impedance of cells in contact with higher concentrations of 5 and 10 
nm Au NPs showed a significant decrease after 32 h of exposure (Fig. 2.3a and 2.3b). 
Similarly, when the exposure concentration reached the critical LD50,M value of the selected 
(f) 
(e) 
(d) 
(c) 
(b) 
(a) 
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nanoparticle, the impedance steadily dropped to baseline over 72-76 h, indicating that the 
cells started to round up and detach from the plate soon after NP introduction. 
For particles of all sizes, the cells started to detach at their critical exposure concentration, and 
the death phase started approximately after the 32nd h of particle addition. This finding 
indicated that the MTT assay results, which were measured after 72 h of exposure, were 
representative and covered the entire time span of cell death.  
Confirmation of internalization of Au NPs inside ARPE-19 cells 
Au NPs were tracked inside cells using confocal microscopy. The nanoparticles that could not 
enter cells and floated outside of them were quantified as explained in the supplementary 
information. Both 2D and 3D confocal images were collected. Due to the space limitation, the 
3D images are presented in supplementary information (supplementary information Fig. S3). 
According to ICP-MS results (supplementary information Fig. S4) for Au nanorods (10×90 
nm) and Au nanospheres with diameters of 5, 10, 20, and 30 nm confirmed that almost all 
particles were able to enter cells at their critical LD50,M concentration (Fig. 2.4b-f). We found 
that at their critical LD50,M concentration, Au nanospheres with diameters of 50 and 100 nm 
and nanocubes of 50 nm were not able to penetrate through the cell membrane. This was 
confirmed by both ICP-MS measurements of free-floating NPs in the exposure medium and 
confocal microscopy images (Fig. 2.4g, h).  
On the other hand, for spherical Au NPs, which were able to cross the cell membrane, we 
observed that as NP size increased, their presence inside the nucleus decreased significantly 
(Fig. 2.4b-e). Images taken at 60x magnification showed that cells exposed to 5-nm Au 
spheres had large vacuole-like structures throughout the cell, which can be attributed to 
regional cytoplasm loss (Fig. 2.4b and supplementary information Fig. S3c). Confocal images 
supported the results of MTT assays and ECIS measurements, showing that the 50- and 100-
nm Au spheres, as well as 50-nm nanocubes, did not enter cells. This may explain why 50- 
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and 100-nm sizes did not exert a cytotoxic effect, even up to a 5 mg/ml exposure 
concentration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 3D Confocal microscopic images of nanoparticles inside cells after 72 h of exposure. (a) cells without 
nanoparticle exposure, (b) ARPE-19 cells exposed to 5-nm Au sphere (LD50,M: 0.030 mg/ml) with green dots 
representing Au NPs inside cells in the vicinity of the nucleus and voids (exact areas are shown with white 
arrows) representing loss of cytoplasm on the observed layer.  (c) ARPE-19 cells exposed to 10-nm Au spheres 
(LD50,M: 0.057 mg/ml, with particles inside cells and nuclei. (d) ARPE-19 cells exposed to 20 nm Au spheres at a 
critical concentration of LD50,M: 0.113 mg/ml; the presence of particles inside cells and nuclei is confirmed.  (e) 
ARPE-19 cells exposed to 0.129 mg/ml of 30-nm Au spheres.  (f) LD50,M:0.050 mg/ml of 10×90 nm Au 
nanorods inside cells and nuclei.  (g) 0.129 mg/ml of 50- nm Au spheres.  (h) 0.129 mg/ml of 100-nm Au 
spheres.  Internalization of 50- and 100-nm Au spheres may be hindered by their large size.  The available 
surface area per unit volume, the key metric for biocompatibility, is much less for 50- and 100-nm Au spheres 
compared than for ARPE-19 cells exposed to smaller Au nanospheres.  (i) 0.129 mg/ml of Au nanocubes. 
(b) (a) (c) 
(e) (f) 
(g) (h) (i) 
(d) 
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2.4 Discussion 
The primary objective of this study was to elucidate the relationship between the structure 
(shape and size) and biocompatibility or toxicity of Au NPs with regard to ARPE-19 cells. 
Based on our findings, a possible mechanistic description of NP interactions with 
internalization into RPE cells is hypothesized (Fig. 2.5). 
 
Figure 2.5 The mechanism of NPs’ mediated cytotoxicity is illustrated here by (a) NP exposure to ARPE-19 cell 
growing in DMEM.  (b) Dynamic bi-polymer layer (nano-biointerface) (thick and loose blue color coating) that 
forms when NPs are mixed with DMEM), creating a superficial surface exposed to the cell membrane.  (c-d) NP 
internalization by endocytosis in which the pH of the endocytic vesicle is same as cell’s physiological pH. (e) 
Fusion of endocytic vesicle with lysosome where pH of lysosome is acidic, (f) Internalized NP in lysosome, 
where the protein coating, the nano-biointerface, disappears because of degradation of protein by the hydrolytic 
mechanism of the acid hydrolases enzyme of lysosome. (g) NP can cross a single membrane of lysosome and 
may penetrate the mitochondrial intermembrane space where the apoptosis signal is initiated. (h) 
Cytoplasmically accumulated NPs cause cell death by activating subcellular downstream signaling for apoptosis, 
initializing cell shrinkage, cytoplasm decrease, and the beginning of subcellular fragmentation. For ease of 
visualizing, the structure of NP and cell is not according to size scale.   
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The Au NPs were first suspended in C-DMEM/F12 and exposed to ARPE-19 cells (Fig. 2.5a, 
b). The pristine NPs were coated with a layered nanostructure in which a protein corona, 
consisting of a dynamic biopolymer layer (nano-biointerface), formed on the NP surface. The 
hydrodynamic sizes of all studied Au NPs dispersed in DI water were larger than their 
physical sizes as determined by TEM and DLS measurements. That size was further increased 
when NPs were dispersed in DMEM cell culture medium (supplementary information, Table 
S2). The latter finding demonstrates that the increase in size was probably the result of serum 
protein adsorption on the NP surface, as illustrated in Fig. 2.5b. This finding is consistent with 
the results of a study by Tarantola et al. (2011) in which spectral shifting and changes in 
hydrodynamic diameter changed with solvent type. The change in zeta potential of the 
pristine Au NPs, when exposed to cell culture medium, provides further confirmation of the 
presence of an outer layer.  
Cell membrane receptors recognize Au NPs and signal the beginning of an internalization 
process (Fig. 2.5c, d). The interaction of NPs with the external surface of the cell membrane 
depends on surface properties such as charge (zeta potential) and coating by components of 
C-DMEM/F12. As also reported in previous studies (Dykman and Khlebtsov 2011, Dykman 
and Khlebtsov 2012), our results indicate that a possible pathway of internalization maybe 
receptor-mediated endocytosis, in which the protein-coated Au NPs are recognized by a 
membrane receptor and then internalized.  
An interesting shape effect is observed on internalization. Internalization efficiency depends 
mainly on the local mean curvature of the particle, the contact angle, and the available area of 
contact between particles and cell membrane receptors (Li et al. 2012, Li et al. 2015).  Cubic 
Au NPs have small local mean curvatures, at which the cell membrane is less strongly bent 
compared to spherical Au NPs. Therefore, their internalization into ARPE-19 cells may be 
hindered (Li et al. 2015). Au nanospheres with diameters less than 30 nm and rod-shaped (10 
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× 90nm) Au NPs are internalized, as shown by their lower biocompatibility (Fig. 2.2a) and 
confocal images (Fig. 2.4). Gold nanorods with a particle diameter of 10 nm were found to be 
less biocompatible than gold nanospheres of similar size (Fig. 2.2a). The lower 
biocompatibility of gold nanorods than nanospheres may be attributable to the disruption of 
lipid membranes, leading to loss of cytoplasmic substance and culminating in cell death 
(Gratton et al. 2008, Nangia and Sureshkumar 2012). Internalization of NPs depends on cell-
surface receptors (Chithrani et al. 2006) and occurs by direct penetration or passive density 
gradient diffusion.  Both internalization mechanisms are specific to particle dimensions while 
the cell membrane receptors and lipid bilayer barriers are specific to cell type.  
Inside the cell, Au NPs fuse with the lysosome (Fig. 2.5e, f).  The low pH (4.5) in the 
lysosome, where the digestive protease enzymes are active, results in degradation of the 
protein layer, but not the nanoparticle core (Luzio et al. 2007, Sabella et al. 2014). The 
resulting Au NP, stripped of its protein corona, leaves the lysosome with a new lysosomal 
corona and penetrates the mitochondrial membrane (Fig. 2.5g). Mitochondria are the central 
coordinators of cell death and affect metabolic activity. This is the basis of our MTT assay 
measurements of the enzymatic activity in mitochondria (Fig. 2.2a).  
We also investigated the effect of size (5 to 100 nm) of spherical Au NPs. Our data (Fig. 2.2a) 
indicates that for the same mass concentration of Au NP, the biocompatibility is higher as size 
increases (in the range of 5 to 30 nm). At the same mass concentration of different sizes, the 
number of NPs and the total surface area concentration is different. To better elucidate the 
results, we plotted the biocompatibility data as a function of the surface area concentration for 
all the Au spheres that exerted significant toxicity (Fig. 2.2b). As can be seen, the data 
collapses into a single curve irrespective of sphere size. As long as the surface area 
concentration was similar, the biocompatibility values were the same for NPs of different 
sizes (23 cm2/ml).  
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Although our detailed search of the literature identified no studies of ocular cells, we found 
studies in which the biocompatibility of different sizes of Au NPs was reported with different 
cell types.  For example, Pan et al.(Pan et al. 2007) studied the biocompatibility of different 
sizes of Au NPs with HeLa cells.  We plotted their biocompatibility data as a function of the 
surface area concentration of the Au NPs and found a similar trend (Fig. 2.6a).  In another 
case, (Misawa and Takahashi 2011) reported a similar surface area dependence with the ROS 
(reactive oxygen species) generation by different sizes of Au NPs (Fig. 2.6b).  These authors 
also emphasized that the key parameter should be the surface area concentration rather than 
the mass concentration of NPs.  These findings indicate that the surface area concentration is 
the determinant metric of biocompatibility in the range of particle sizes studied.  The observed 
toxicity was a result of the surface interactions inside the cell, which is directly correlated to 
the surface area concentration of the pristine NPs.   
 
Figure 2.6 The surface area concentration required to affect 50% of the cells (LD50,A) is independent from 
particle size, as is ROS generation. (a) LD50 based on surface area concentration (cm2/ml) versus particle size for 
two different data sets in which the biocompatibility of Au NPs was tested on different cells.  Pan et al. 2005, 
tested the biocompatibility of Au NPs with HeLa cells whereas we exposed retinal cells to Au NPs.  The critical 
surface area concentration for retinal cells was 23 cm2/ml; the LD50,A amount for HeLa cells was 83 cm2/ml. (b) 
Misawa et al. (2011) measured ROS generation for different sizes of Au NPs at different concentrations.  The 
ROS generation is plotted as a function of surface area concentration. (Data is represented in log scale for x 
axis). 
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Au nanospheres found to be nonbiocompatible were further tested by ECIS, so that cell 
adhesion was monitored in real time (Fig. 2.3). Most biocompatibility assays are end-point 
assays in which cell viability is measured by the end of a certain exposure period; with ECIS 
measurements, however, cell attachment behavior was recorded throughout the entire 
exposure period without terminating the experiment (Yun et al. 2010, Kling et al. 2014, Liang 
et al. 2016). Cell attachment behavior is crucial for biocompatibility assessment because it 
provides a direct measure of cellular activity. When a cell enters the apoptosis phase, the 
integrity of the cell structure cannot be maintained, and the adhesion proteins start losing their 
functionality (Borradori and Sonnenberg 1999). At critical exposure concentrations, which 
were determined via MTT assay measurements, the cells started to detach from the plate, 
resulting in a decrease in impedance (Fig. 2.3). The ECIS measurements were in perfect 
agreement with the MTT assay findings. 
The particles tend to escape from intracellular trafficking when they are a part of endocytic 
vesicles (Shang et al. 2014). Once they escape from these vesicles, they can cause damage to 
the nucleus (Fig. 2.5h), which is consistent with our findings since the particles were inside 
nuclei (Fig. 2.4b, c, d, e). It is hypothesized that they activate cell-induced apoptosis 
(programmed cell death) signals, which lead to cell death (Kim et al. 2009, Shang et al. 2014). 
Larger Au spheres were subjected to retarded internalization and, upon entering the cytosol, 
could not enter mitochondria or nuclei because of their larger sizes (Fig. 2.5g and 2.5h). This 
led to higher biocompatibility results.  
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2.5 Conclusions 
Use of Au NPs is being explored for treatment or imaging of the retina. However, there has 
been no detailed study on the biocompatibility of Au NPs with retinal cells. In this study, we 
report the in-vitro biocompatibility of Au NPs exposed to cells of the retinal pigment 
epithelium. The results indicate that NP biocompatibility depends on both the shape and the 
size of nanoparticles. Cubic Au nanoparticles with a size of 50 nm and spherical Au 
nanoparticles with diameters of 50 and 100 nm were found to be biocompatible up to an 
exposure concentration of 5 mg/ml. Au spheres with diameters of 5-30 nm and rod-shaped Au 
NPs of 10×90nm exert toxicity in concentration ranges from 0.01 to 0.2 mg/ml. Size-
dependent biocompatibility trends were also found for spherical Au NPs with diameters of 5 
to 30 nm. At the same mass concentration, the compatibility of Au NPs decreased with 
decreasing particle size.  
The key observation, however, is that when the concentration is expressed as a function of 
surface area per unit volume, the effect of size is no longer relevant. For similar surface area 
concentrations, Au NPs in the range of 5–30 nm had almost the same biocompatibility.  
Similar surface area dependence has been observed in other cited works. We recommend that 
to use Au NPs intracellularly for therapeutic purposes; it may be necessary only to modulate 
the surface area. The overall assessment and generalization of cytotoxicity is, however, more 
complex and depends on the various parameters and factors we have discussed here. The 
reported critical doses for specific shapes and sizes of Au NPs and the proposed possible 
toxicity mechanism can serve as a guide when Au NPs will potentially be used in ophthalmic 
studies, especially when targeted to retinal cells. 
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Chapter 3: Hyaluronate Coating as a 
Solution to Toxicity of Gold Nanoparticles 
 
 
 
 
 
 
 
 
 
 
The results of this chapter have been reprinted with permission from Karakocak, B. B., Liang, 
J., Biswas, P., Ravi N. (2018). Hyaluronate Coating Enhances the Delivery and 
Biocompatibility of Gold Nanoparticles. Carbohydr. Polym. 186:243-251. Copyright 2018 
Elsevier 
Supplementary information along with figures and tables are available in Appendix II. 
  
45 
 
 
Abstract  
For targeted delivery with nanoparticles (NPs) as drug carriers, it is imperative that the NPs are 
internalized into the targeted cell. Surface properties of NPs influence their interactions with 
cells. We examined the responses of retinal pigment epithelial cells, NIH 3T3 fibroblast cells, 
and Chinese hamster ovary cells to gold nanoparticles (Au NPs) in their nascent form as well 
as coated with end-thiolated hyaluronate (HS-HA). The grafting density of (HA-HS) on Au 
NPs was calculated based on total organic carbon measurements and thermal gravimetric 
analysis. We imaged the intracellular NPs by 3D confocal microscopy. We quantified viability 
and generation of reactive oxygen species (ROS) of the cells to Au NPs and monitored cell-
surface  attachment via electrical cell-substrate impedance sensing. The results confirmed that 
receptors on cell surfaces, for HA, are critical in internalizing (HA-S-Au NPs), and HA may 
mitigate ROS pathways known to lead to cell death. The 50- and 100-nm HA-S-Au NPs were 
able to enter the cells; however, their nascent forms could not. This study shows that the 
delivery of larger Au NPs is enhanced with HS-HA coating and illustrates the potential of HA-
coated NPs as a drug delivery agent for inflamed, proliferating, and cancer cells that express 
CD44 receptors. 
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3.1 Introduction 
Gold nanoparticles (Au NPs) have been widely explored in medicine as potential delivery 
agents for various biopharmaceuticals (Kim et al. 2011, Kumar et al. 2015). Although Au NPs 
are usually more biocompatible than other metal or metal oxide nanoparticles, their inherent 
positively charged surface disrupts the negatively charged cell membrane, while their 
production of reactive oxygen species (ROS) causes cytotoxicity (Moghadam et al. 2012). 
Moreover, plasma proteins can spontaneously adsorb to nascent Au NPs, affecting the surface 
properties of the particles and their interaction with cells (Nel et al. 2009). As a result, surface 
modification is essential ideally to prevent protein adsorption (Larson et al. 2012), and 
nonspecific delivery of Au NPs (Rana et al. 2012), to decrease opsonization by the immune 
system (Papasani et al. 2012), and finally mitigate their toxicities.  
Many coating conjugates, ranging from synthetic ligands to natural biomolecules, have been 
used to improve the stability of particles and their delivery to specific cells or tissues (Yilmaz 
et al. 2016, Lin et al. 2017). Our focus is on hyaluronic acid (HA) as a coating material. HA is 
a bioactive linear polysaccharide that prevents adsorption of proteins on surfaces of 
biomaterials (Hans and Lowman 2002) and has an antifouling effect that arises from its 
hydrophilic and polyanionic characteristics (Lee et al. 2008, Santhanam et al. 2015). HA also 
scavenges free radicals and chelates pro-oxidant metals (Glucksam-Galnoy et al. 2012). HA 
serves as a ligand for several cell-surface receptors and thereby has an important 
physiological role. Cluster of differentiation 44 (CD44) is the most well-studied cell 
membrane receptor (Jaggupilli and Elkord 2012). It is present on, for example, the lymphatic 
vessel endothelial HA receptor (LYVE-1) (Chen et al. 2005), the receptor for hyaluronate-
mediated motility (RHAMM) (Nedvetzki et al. 2005), and the HA receptor for endocytosis 
(HARE) (Pandey and Weigel 2014). The type of HA receptor on the cell membrane depends 
on the function of the tissue.  
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The role of HA receptors in healthy and diseased cells is not well understood. CD44 had been 
identified during the development, differentiation, and proliferation of cells, for example, the 
neural retina and in Muller cells (Chaitin and Davis 1995). CD44 has also been found under 
pathologic conditions, such as inflammation and proliferative vitreoretinopathy, where retinal 
pigment epithelial (RPE) cells actively proliferate in the subretinal space, on the surface and 
undersurface of the retina, and in the vitreous cavity. Hence, RPE cells exhibit significantly 
higher CD44 receptors compared to their quiescent and stationary state (Moysidis et al. 2012). 
Furthermore, it has been reported that cancer cells also express CD44 receptors and have a 
significant regulatory role in almost all cancer types (Kesharwani et al. 2015, Wang et al. 
2016). It is now well recognized that a threshold of CD44 expression is required before HA 
binding is observed (Perschl et al. 1995, Tzircotis et al. 2005). Therefore, cells like NIH 3T3, 
which express relatively less number of CD44 receptors, may lack HA binding while cells 
like Chinese hamster ovary (CHO) cells with high CD44 receptor density show strong HA 
binding (Katoh et al. 1995, Tzircotis et al. 2005). 
In the previous chapter, we have found that for a fixed total surface area, Au NPs (particle 
diameter, dp < 50 nm) were toxic to retinal pigment epithelial cells, independent from the 
particle size (Karakocak et al. 2016). The toxicity of Au NPs arises from reactive oxygen 
species (ROS) activity, which was shown to be correlated to the available total surface area 
(Pan et al. 2007, Jiang et al. 2008). HA is a known free radical quencher; it is natural and 
consequently biocompatible (Balogh et al. 2003). Our objective in the current work is to 
expand the usefulness of Au NPs by mitigating their toxicity via coating them with HA. As 
expected, we observed that HA coating significantly enhanced the biocompatibility of Au 
NPs; unexpectedly, the coating also greatly improved the internalization of larger Au NPs, 
which in their nascent form could not enter the cell. The outcomes of this study could be 
valuable in treating inflamed, proliferating, or cancer cells that express CD44 receptors.  
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3.2 Materials and Methods 
3.2.1 Reagents 
1-Ethyl-3-[3-(dimethylamino)propylcarbodiimide (EDC), sodium citrate, hydrogen 
tetrachloroaurate (HAuCl4), cystamine dihydrochloride, sodium cyanoborohydride 
(NaBH3CN), Dulbecco’s modified Eagles’s medium/nutrient mixture F-12 Ham 
(DMEM/F12), trypsin-ethylenediaminetetraacetic acid (EDTA) solution 10x, and fetal calf 
serum (FCS), and DAPI for nucleic acid staining were obtained from Sigma-Aldrich (St. 
Louis, MO). ARPE-19 (Retinal pigment epithelial) (ATCC® CRL¬ 2302™), NIH 3T3 
(ATCC® CRL¬ 1658TM) and CHO (CCL¬ 61™) cells were purchased from American Type 
Culture Collection (Manassas, VA). Dithiothreitol (DTT) was obtained from Duchefa 
Biochemie (Haarlem, Netherlands). HiLyte-FluorTM 647 amine was purchased from AnaSpec 
(San Jose, CA). Sodium hyaluronate having a molecular weight of 10,000 Da was obtained 
from Lifecore (Chaska, MN). The Apo Tox-GloTM and ROS-GloTM H2O2 assay kits were 
purchased from Promega Biosciences (San Luis Obispo, CA). All chemicals and reagents 
were of analytical grade. 
3.2.2 Synthesis of Au NPs 
We synthesized Au NPs by the citrate reduction method (Frens 1973, Kimling et al. 2006). 
HAuCl4 (10 mg) was dissolved in 90 ml of deionized (DI) water, and this solution was heated 
to boiling. We added sodium citrate solution (250 mM) to the boiling solution in amounts 
ranging from 400 µl to 900 µl and stirred for 20-30 min until the solution became wine-red. 
The solution was then left undisturbed in the dark for 24 h at room temperature. Subsequently, 
Au NP solutions were centrifuged at 10,000 rpm for 20 min and suspended in DI water. We 
confirmed the final size using transmission electron microscopy (TEM) analysis and dynamic 
light scattering (DLS) measurements. The detailed procedure for particle size measurements 
is given as supporting information. 
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3.2.3 Preparation of end-thiol modified HA (HS-HA) 
We prepared HS-HA by reductive amination as described elsewhere (Lee et al. 2012, Kumar 
et al. 2015). HA (MW: 10,000 Da, 100 mg) and cystamine dichloride (60 mg) were dissolved 
in 0.1 M borate buffer (10 ml, pH 8.5) with 0.4 M NaCl and stirred for 2 h. NaBH3CN was 
added to the solution at a final concentration of 0.2 M and reacted at 50°C for three days. The 
reaction mixture was then incubated with 0.1 M DTT for 12 h to introduce a free thiol group 
(Fig. 1). The resulting solution was dialyzed against a large excess of 0.1 M NaCl solution for 
one day, 25% ethanol for one day, and pure water for one day to remove unreacted chemicals. 
The efficiency of thiol-end functionalization of HA was higher than 90%, and the ratio of 
[SH] to [HA repeating units] was 0.025 as determined by Ellman’s assay. Physicochemical 
properties of the HS-HA were obtained using Proton Nuclear Magnetic Resonance (1H-
NMR), Fourier Transform Infrared (FTIR) spectroscopy, and Gel Permeation 
Chromatography (GPC) analysis. Please refer to supporting information for details of 
Ellman’s assay, 1H-NMR, FTIR, and GPC analysis. 
3.2.4 Conjugation of HS-HA with Au NPs and quantification of the coating 
Before initiating the conjugation process, we calculated the average number of HA molecules 
(MW: 19.69 kDa, 5.42 nm hydrodynamic radius (Rh)) that can bind to one Au NP (particle 
size based on the TEM and DLS measurements). From that, we calculated the approximate 
HA to Au NP conjugation mass ratio and ensured that we used at least 1.5x in excess of this 
amount. HS-HA was added dropwise to the dispersed Au NPs in DI water at room 
temperature with moderate stirring. The solution was stirred overnight. The HA-Au NP 
conjugate was further purified by centrifuging it twice at 10,000 rpm for 20 min to remove 
unbounded HA molecules and was finally redispersed in DI water. To take further 
measurements in the solid phase, the coated nanoparticle solution was lyophilized for two 
days at -105 oC. We used total organic carbon (TOC) and thermal gravimetric analysis (TGA) 
  
50 
 
to determine the amount of coating around the nanoparticles. Please refer to supporting 
information for details of TOC and TGA analysis.  
The number of bound HA molecules per unit surface area, grafting density (σ) was calculated 
based on both TOC (σTOC) and TGA (σTGA) measurements as described previously (Benoit et 
al. 2012). In summary, first, the number of Au NPs in a sample was calculated based on the 
hydrodynamic diameter of the Au NP and the density of Au. Next, the total available surface 
area of Au NPs in a sample for HA molecules to bind was determined. The number of HA 
molecules present in a sample was calculated taking the molecular weight of HA which is 
determined by GPC analysis. Finally, grafting density was calculated by dividing the number 
of HA molecules in a sample to the available surface area of Au NPs.  
3.2.5 Investigation of the internalization of NPs 
The cellular internalization of coated and nascent Au NPs was determined by exposing NPs to 
ARPE-19, NIH 3T3, and CHO cell lines. This was followed by careful washing to remove 
NPs that may have reached and been adsorbed on the cell surface (Cho et al. 2011). The 
intracellular concentrations of Au were quantified with an ELAN DRC II Inductively coupled 
plasma mass spectrometry (ICP-MS) (Perkin Elmer, Inc., USA). To identify the difference 
between the administered and delivered doses, the number of nanoparticles that failed to enter 
the cell, as well as the specific Au NP intracellular concentrations, were quantified in aliquots 
from the phosphate buffer saline (PBS) washes done before confocal imaging. Using ICP-MS, 
the aliquots were tested for the presence of Au NPs.   
3.2.6 In-vitro toxicity measurements on ARPE-19 cells with MTT, ApoTox-
GloTM, and ROS-GloTM H2O2 assays 
Cell metabolic activity, and hence the viability of retinal cells in the presence of Au NPs, was 
assessed with MTT (3-[4, 5 dimethyl-thiazoly-2-yl] 2-5 diphenyl tetrazolium bromide). The 
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relative amount of apoptotic cells and ROS generation were measured, respectively, by 
ApoTox-Glo™ and ROS GloTM H2O2 assays. See the supporting information for the details 
3.2.7 Confocal microscopy analysis 
To confirm the presence of NPs inside cells, we investigated the distribution of Au NPs at 
their critical mass concentrations (LD50,M), determined previously (Karakocak et al. 2016), 
using a nanoplasmonic confocal laser scanning microscope (Leica TCS-SP8). Au NPs have a 
surface plasmon resonance property (SPR). For Au NPs in size range of 5-100 nm, the SPR 
wavelength is around 520 nm (Huang et al. 2008), depending on the sizes of the 
nanoparticles. See the supporting information for the details. 
3.2.8 Cell attachment measurements by electrical impedance spectrometry 
(ECIS) 
We analyzed the biocompatibility of Au NPs as they were exposed to ARPE-19 cells using 
ECIS, a noninvasive technique that measures the impedance across gold electrodes at the 
bottom of tissue culture wells, using a range of frequencies of alternating current (Wegener et 
al. 2000, Arndt et al. 2004). As adhesion proteins changed the cell morphology and 
attachment to the electrodes in the bottom of wells, the resistance across the electrodes also 
changed (Borradori and Sonnenberg 1999, Santhanam et al. 2016). The change in resistance at 
frequencies ranging from 400 to 64,000 Hz was measured over time. Low-frequency 
impedance can be used to monitor the solution paths around the cells, and hence the layer’s 
cell-to-cell barrier functions (Wegener et al. 2000). The addition of Au NPs complicates the 
impedance of the system. However, at a frequency of 4,000 Hz, the contribution to resistance 
from cells was dominant over the contribution to resistance from Au NPs with the medium 
(Kandasamy et al. 2010). Therefore, we chose a frequency of 4,000 Hz to monitor cell growth 
and biocompatibility. 
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3.2.9 Statistical analysis 
Results are presented as means ± standard deviation on the graphs for experiments done at 
least with three biological replicates per condition or group. First, each test result (viability 
measurements, the relative amount of apoptotic cells, and ROS generation) was compared 
with the corresponding negative (untreated cells) and positive (NPs without the cells) control 
groups with Student’s t-test. P* < 0.05, the significance level, was statistically acceptable. 
Second, Two-Factor ANOVA (analysis of variance) was used to evaluate the results of 
viability measurements, the relative number of apoptotic cells, and ROS generation. For cell 
attachment measurements, eight replicates were performed for each independent experiment. 
Statistical significance was evaluated using ANOVA to compare the results with the 
respective negative (untreated cells) and positive control (only cell media) groups. P* < 0.05, 
the significance level, was statistically acceptable. 
3.3 Results and Discussion 
3.3.1 Synthesis of end-thiolated hyaluronic acid (HS-HA) 
HS-HA was synthesized by a previously reported method (Lee et al. 2012), outlined in Fig. 
3.1. HA has multiple hydroxyl and carboxyl groups, but only the end six-member ring can 
open up and form an aldehyde group.  
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Figure 3.1 HS-HA synthesis chemistry. In the presence of borate buffer at pH 9, the terminal cyclic hemiacetal 
ring opens and changes to a linear aldehyde form. A Schiff base forms with cystamine. Thus, the terminal 
saccharide reverses between two states to reach the final form. The Amadori compound, sodium 
cyanoborohydride (NaBH3CN), is added, and then Dithiothreitol (DTT) is added to reduce the disulfide and 
produce HS-HAs.  
We took advantage of this lone functional group, modifying it with an amine to introduce an 
end thiol group and covalently binding it to Au (Fig. 3.2). Ellman’s assay results confirmed 
~90% of thiolation of HA, and the molar ratio of SH to HA was found to be ~0.025. However, 
1H-NMR and FTIR analysis could not clearly detect the end-thiol content of hyaluronate as 
[SH]/[HA repeating units] is low (Fig. S1 and Fig. S2). On the other hand, based on gel 
permeation chromatography (GPC) analysis, we determined that the hydrodynamic radius of 
HS-HA was 5.42 nm. Its number average molecular weight was 15.51 kDa, its polydispersity 
1.27, and its intrinsic viscosity was 0.58 dl/g (Table 3.1). The Mark-Houwink constant 
changes linearly with the logarithm of MW of HA which can correspond to a change in 
conformation of HA from a random coil to a rigid structure (La Gatta et al. 2010).  
In the presence of borate buffer (pH 9), the hemiacetal end group of HA 
opens up and forms an aldehyde: 
Schiff base forms 
with cystamine 
Reduced with NaBH3CN to form 
a more stable amine compound 
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The Mark-Houwink constant, based on GPC analysis of the HS-HA, was 0.70, suggesting the 
presence of a random coil. 
 
Figure 3.2 Illustration of coated Au NPs with end-thiolated HA (HS-HA), where the thiol group at the end of 
each HA chain is attracted to the Au NP surface. 
 
Table 3.1 Gel permeation chromatography results for HS-HA 
Parameter Value 
Number average molecular weight (Mn) 15.51 kDa 
Weight average molecular weight (Mw) 19.69 kDa 
Polydispersity 1.27 
Hydrodynamic radius 5.42 nm 
Intrinsic viscosity 0.58 dl/g 
Mark-Houwink constant 0.70 
 
Au NP 
End-thiolated 
HA (HS-HA) 
HA (Hyaluronate) 
-SH (thiol group) 
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3.3.2 Synthesis of Au NPs conjugated with HS-HA and confirmation of the 
presence of the coating 
We synthesized Au NPs with sizes of 5-, 10-, 20-, 50-, and 100-nm, the sizes most preferred 
for targeted drug delivery studies (Karthikeyan et al. 2010, Ngwa et al. 2012). The high-
resolution TEM (HR-TEM) images of the uncoated Au NPs can ben found in supporting 
information (Fig. S3). The Au NPs were conjugated with HS-HA (see Methods). The amount 
of coating on Au NPs was determined with TOC analysis and TGA. These two approaches are 
well suited to probe the content of inorganic and organic compounds on nanoparticle surfaces 
(Benoit et al. 2012). The presence of the coating was first confirmed and quantified by TOC 
measurements by determining the extent of organic and inorganic carbon. Because inorganic 
carbon was negligible, the total carbon content was equivalent to the organic carbon content 
which was attributed to HA coating. To further confirm and quantify the presence of the 
coating, we used TGA which records the change in mass as a function of temperature. The 
peak at ~280 oC corresponded to the decomposition of HA (Fig. 3.3). The exact quantity of 
the coating was determined by calculating the change in mass around the temperature at 
which HA is known to decompose (Ahire et al. 2016). 
 σ (# HA molecules/nm2) 
Au dp (nm) TOC TGA 
3.75 ± 0.9 0.18 ± 0.04 0.16 ± 0.03 
7.43 ± 3.2 0.09 ± 0.02 0.10 ± 0.02 
13.30 ± 3.2 0.05 ± 0.01 0.06 ± 0.01 
48.51 ± 19.4 0.03 ± 0.01 0.03 ± 0.01 
82.55 ± 24.6 0.03 ± 0.01 0.03 ± 0.01 
 
Figure 3.3 Thermal gravimetric analysis plot for the HS-HA coated Au NPs. HA decomposition occurs at around 
280 oC, and Au NPs melt approximately at 500 oC. Au NP grafting density (the number of HA molecules/nm2) 
determined by TOC and TGA measurements. Errors provided reflect standard deviation of the replicate error in 
repeated measurements of the sample. At least two measurements were taken for each analysis technique. 
               5nm,                   10 nm                        20 nm,                           50 nm,                          100 nm 
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As detailed in a previous study (Benoit et al. 2012), we calculated the grafting density of HA 
molecules, the number of bound HA per unit surface area (# HA molecules/nm2) based on 
results of both TOC (σTOC) and TGA (σTGA) measurements (Fig. 3.3 and Table S1). The results 
showed that, for both measurement techniques, the number of HA molecules adsorbed per 
unit surface area of Au NP decreases as the particle size increases. This trend may be 
attributed to the HA-HA interactions which could be geometrically minimized due to the 
increased curvature of the smaller particles (Nasir et al. 2015). One should note that these 
calculations were based on two main assumptions: Au surface is smooth, even though it is 
known that the surface of Au has irregularities at the atomic scale (Loskutov et al. 2009) and 
secondly, end-thiolation allows only a single covalent attachment per HA molecule. We do 
not have any evidence on the orientation of HA on the surface of Au. However, polymers 
with a single point attachment to the core nanoparticle generally take on brush-like 
confıguration (Benoit et al. 2012 and Dukes et al. 2010). 
3.3.3 Characterization of HS-HA conjugated Au NPs 
The hydrodynamic sizes and zeta potential of both nascent and coated Au NPs in DI water 
and DMEM were measured by dynamic light scattering (DLS) analysis (Figs. S4 and S5). 
When the nascent particles were dispersed in cell medium, the results indicated a substantial 
increase in particle size and a decrease in zeta potential. The HS-HA coating also had a major 
effect on particle size. The increase in size for nascent NPs in cell culture media was 
attributed to nonspecific protein adsorption on the Au NP. When the Au NPs are coated with 
HS-HA, and then dispersed in DMEM, the extent of protein adsorption was less, which is 
consistent with the known property of HA to decrease protein adsorption (Pitarresi et al. 
2007). 
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3.3.4 Cellular uptake of nascent and coated Au NPs 
Our uptake studies were based on the measurement of intracellular gold concentration. We 
had previously determined the critical mass (LD50,M) concentration of Au nanoparticles of 
different sizes and used these critical mass concentrations in the rest of the cellular 
experiments, including the uptake study (Karakocak et al. 2016). Our earlier study with RPE 
cells indicated that the LD50,M concentrations of Au NPs with sizes of 5-, 10-, 20-nm were, 
0.03 mg/ml, 0.08 mg/ml, and 0.11 mg/ml respectively (Karakocak et al. 2016). Furthermore, 
Au NPs 50 nm and 100 nm in diameter did not exert any toxic effect up to 5 mg/ml, because 
they did not enter the cells. Here, we extended our study using two additional different cell 
lines: ARPE-19 cells and CHO cells with high-density CD44 receptors (Jaggupilli and Elkord 
2012) and NIH 3T3 cells with relatively less CD44 receptors (Culty et al. 1992) to investigate 
the CD44 receptor-mediated internalization of 50-nm Au NPs. 
According to the ICP-MS results, the number of NPs internalized by ARPE-19 cells changed 
with the presence of the coating. Indeed, the coating played a significant role, especially for 
particles with diameters larger than 50 nm. Nascent particles with a diameter larger than 50 
nm were not able to enter cells (Fig. 3.4A). However, when the same particles were coated 
with HS-HA, their size increased to 58.41 nm in DMEM, and the number of particles 
internalized by the retinal cells increased considerably (Figs. S4 and S6). Conversely, HS-HA 
coating increased the size of smaller Au NPs significantly and slightly decreased the number 
of intracellular Au NPs (Figs. S4 and S6). This difference may be attributed to increase of the 
coated NP size and the presence of HA coating, therefore the internalization pathway of 
nanoparticles is predominantly CD44 receptor-mediated endocytosis (Almalik et al. 2013). 
To test whether the internalization was CD44 receptor-mediated, nascent (53.81-nm) and 
coated (58.41-nm) Au NPs in DMEM were exposed to two more cell lines: NIH 3T3 cells, 
which have significantly fewer CD44 receptors than ARPE-19 cells, and CHO cells which are 
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also known to express CD44 but a cancer cell line, unlike ARPE-19 cells (Culty et al. 1992). 
The amount of HA-S-Au NPs internalized by NIH 3T3 cells was significantly less than the 
amount internalized by ARPE-19 and CHO cells. Therefore, it can be concluded that the 
internalization of Au NPs coated with HS-HA depends on the density of cell-surface receptors 
for HA, in this case, CD44 (Fig. 3.4B).  
 
Figure 3.4 (A) Cellular uptake of Au NPs of different sizes, with and without HS-HA coating by ARPE-19 cells. 
(B) 50 nm Au NPs (0.11 mg/ml) exposed to ARPE-19, NIH 3T3, and CHO cells with and without pretreatment 
with 10x HS-HA. CD44 receptor density of NIH 3T3 cells is significantly less than that of ARPE-19 cells; 
therefore, blocking the CD44 receptors of NIH 3T3 cells did not significantly affect internalization of HA-S-Au 
NPs, unlike the results for ARPE-19 and CHO cells. Overall, cells like ARPE-19 and CHO cells, which express 
high enough number of CD44 receptors and meet the threshold for HA binding, internalize more coated NPs 
than NIH 3T3 cells. ARPE-19 cells exposed to             HA-S-Au NPs,        Nascent Au NPs,     ARPE-19 cells 
treated with 10x HS-HA, and then exposed to HA-S-Au NPs. 
As a step toward confirming this finding, all cells were treated with 10x HS-HA, to saturate 
the CD44 receptors, and then exposed to 50-nm HA-S-Au NPs. As expected, we found that 
the number of internalized particles was significantly decreased (Fig. 3.4B). Cell membrane 
receptors and lipid bilayer barriers are specific to cell type. Because of the presence of CD44 
receptors, the amount of internalized HA-S-Au NPs was significantly different in various 
types of cells. As the size of the nanoparticles decreases, the internalization pathway may 
involve passive diffusion; however, as particle size increases, receptor-mediated endocytosis 
may become more prominent (Zhang et al. 2009, Panariti et al. 2012, Gupta and Rai 2017). 
For smaller particles, there are alternate size-dependent internalization paths that do not 
involve CD44 receptors. Therefore, the internalized number of coated nanoparticles may 
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slightly decrease because of the increased size of coated Au NPs (Figs. S5 and S7). For RPE 
cells, we found that internalization of 5-, 10-, and 20-nm particles was only minimally 
decreased by the presence of the coating. In contrast, internalization of 50- and 100-nm HS-
HA coated Au NPs was significantly increased (Fig. 4A). Furthermore, when we blocked the 
receptors for HA by adding excess HA to saturate the receptors before administering HA-S-
Au, there was less internalization (Fig. 4B). Thus, although several pathways exist for 
internalization of nanoparticles, CD44-mediated endocytosis is particularly important for 
larger particles. This finding is noteworthy in that coating with HA provides a “Trojan horse” 
approach to the delivery of large Au NPs and possibly to other hydrophobic particles into cells 
with receptors for HA.  
3.3.5 The fate of nascent and coated Au NPs in the cells 
To confirm the presence of NPs inside cells, we investigated the distribution of Au NPs using 
a nano-plasmonic confocal laser scanning microscope (Leica TCS-SP8) (see Methods). We 
first studied the effect of exposure of different sizes of nascent and coated Au NPs to ARPE-
19 cells.  
Per the 2D and 3D confocal images (Figs S6 and S7, respectively), it can be inferred that for 
smaller NPs (dp < 50 nm), the presence of an HA coating slightly decreased the number of Au 
NPs inside retinal cells. Nascent particles with diameters of 50 nm and above could not enter 
retinal cells (Figs. S6H/S7H and S6J/S7J). However, when these particles were coated with 
HA, their presence within cells significantly increased (Figs. S6I/S7I and S6K/S7K), as also 
confirmed by the ICP-MS results shown in Fig. 3.4. In other words, the HA coating enabled 
NPs larger than 50-nm (58.41 nm in DMEM) to enter retinal cells (Fig. 3.5), even though 
DLS measurements showed that the size of these particles had significantly increased (Figs S4 
and S5). This lends credence to the hypothesis that internalization of larger HS-HA coated Au 
NPs occurs via the HA receptor-mediated CD44 pathway. Because large HS-HA-coated 
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particles can enter cells, they can efficiently deliver a greater payload than previously reported 
targeted drug delivery vehicles (Diebold and Calonge 2010). 
 
Figure 3.5 3D Confocal microscopy images of Au NPs with ARPE-19 cells. The red staining corresponds to 
actin, the nucleus is blue, and Au NPs are green. ARPE-19 cells exposed to (A) no particles, the negative 
control. 50-nm (B) nascent Au NPs (C) HA-S-Au NPs (D) ARPE-19 cells pretreated with 10x HS-HA and then 
exposed to 50-nm HA-S-Au NPs. The HS-HA coating significantly enhanced the intracellular concentration of 
Au NPs, whereas when the same particles were exposed to the retinal cells after blocking the CD44 receptors, 
the amount internalized is significantly decreased. The exposure concentration was selected as 0.11 mg/ml. Scale 
bars are 20 µm.  
Additionally, our observations also extend to non-ocular tissues. Nascent and HS-HA-coated 
50-nm Au NPs were administered to NIH 3T3 cells and CHO cells. Both ICP-MS findings 
(Fig. 3.4B) and 3D confocal microscopy (Figs. S8 and S9) showed that significantly increased 
number of particles entered NIH 3T3 and CHO cells. This observation confirmed our 
hypothesis that the number of HA-S-Au NPs internalized is dictated by the presence or 
absence of the relevant receptors on the cell membrane (in this case, CD44). 
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3.3.6 Biocompatibility assessment of HS-HA-coated Au NPs with ARPE-19 
cells 
We next studied the biocompatibility of HS-HA Au NPs with ARPE-19 cells. Three different 
independent end-point assays were used: viability based on enzymatic activity in 
mitochondria; the percent of apoptotic cells based on caspase 3/7, and activity ROS 
generation, which is proportional to luciferase activity (see Methods). The results indicated 
that nascent Au NPs with diameters smaller than 50 nm were not biocompatible above 0.03 
mg/ml (Fig. 3.6A), initiated apoptotic cell death (Fig. 3.7A), and induced ROS generation 
(Fig. 3.7C). On the other hand, no toxicity was observed for HA-S-Au NPs with a 
concomitant negligible generation of ROS (Figs. 3.6B, 7B, and 7D). Most of the toxicity of 
Au originate from ROS production because of its surface chemistry in the cell’s cytoplasm 
(Balogh et al. 2003). Coating with HA significantly decreases the available surface on Au by 
steric hindrance. In addition, HA and its degradation products (tetrasaccharides) have an 
exceptional ability to quench free radicals (Balogh et al. 2003). Thus, any ROS formed at the 
surface of Au NPs has very little opportunity to escape the HA coating, as was confirmed by 
our ROS GloTM H2O2 assay results (Figs. 3.7C and 7D).
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Figure 3.6 Biocompatibility results of (A) nascent Au NPs and (B) HA-S-Au NPs. HS-HA coating significantly 
increased the compatibility of NPs with ARPE-19 cells. Values are expressed in mean ± SEM for each 
condition; three independent experiments were done with eight replicates (n = 24; Student’s t-test, *P < 0.05 
versus controls). The results were compared to each other using two-factor ANOVA analysis. For nascent 
particles, in terms of both particle size and exposure concentration, the results were significantly different from 
each other (*P < 0.05). For coated particles, the results were found to be independent of the exposure 
concentration (**P > 0.05) but statistically different among each nanoparticle size tested (P* < 0.05)  
                5nm,                   10 nm,                    20 nm,                   50 nm,                   100 nm    
                   5nm,                     10 nm,                         20 nm,                               50 nm,                             100 nm                                                            
ıııııııı              untreated cells,                             media (DMEM) only 
Cell morphology was observed by 3D confocal microscopy. There was a significant structural 
change in cytoskeleton fibers (actin) in retinal cells exposed to nascent NPs (dp < 50 nm) 
(Fig. S7). The nuclear morphology was disrupted, and the density of actin significantly 
decreased (see supporting information, Figs. S7B, S7D, S7F). In a previous study degradation 
of actin was linked to cell death (Tezel et al. 1999), consistent with our confocal imaging 
observations.  
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Cells exposed to HA-S-Au NPs maintained good actin density and intact nuclei (Figs. S7C, 
S7E, S7G, S7I, S7K). These observations are consistent with our biocompatibility results, 
which indicated that coated Au NPs are not toxic and do not initiate apoptosis.  
   
   
Figure 3.7 Measurement of apoptotic cells amounts using the Apo Tox-GloTM assay when the cells are exposed 
to (A) nascent Au NPs and (B) HA-S-Au NPs. Measurement of ROS levels using the ROS GloTM H2O2 assay, 
when the cells are exposed to (C) nascent Au NPs and (D) HA-S-Au NPs. The HS-HA coating prevented both 
apoptosis and ROS generation in ARPE-19 cells for all particle sizes tested. (n = 24; Student’s t-test, *P < 0.05 
versus controls). The results were compared to each other using two-factor ANOVA analysis. In both 
measurements, for nascent particles, in terms of both particle size and exposure concentration, the results were 
significantly different from each other (*P < 0.05). For coated particles, the results were found to be independent 
of the exposure concentration (**P > 0.05) but statistically different among each nanoparticle size tested (*P < 
0.05). 
               5nm,                   10 nm,                   20 nm,                    50 nm,                    100 nm    
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3.3.6 Cell attachment behavior with ECIS measurements in response to Au 
NPs 
We monitored retinal cells’ attachment in the presence of both nascent and coated Au NPs via 
electrical impedance measurements. Retinal cells exposed to nascent NPs less than 50 nm in 
diameter, at their critical LD50, M concentrations, almost immediately started to detach from 
the plate (Fig. 3.6C). On the other hand, cell attachment was not hindered when the ARPE-19 
cells were exposed to HA-S-Au NPs (Fig. 3.6D). Following the addition of HA-S-Au NPs, 
the impedance curves, which show the real-time cellular response, fall in line with the 
negative control group, in which neither coated nor nascent NPs were exposed to the cells 
(Fig. 3.6D). The cell attachment behavior is directly correlated to cell viability. Therefore, it 
can be inferred that cell viability is not compromised in the presence of HA-S-Au NPs. As a 
result, it is clear that not only HA coating plays a significant role in the internalization of Au 
NPs, but also that its presence, independent of particle size and the amount of Au NPs inside a 
cell, protects the cell from ROS damage, does not initiate cell death. 
3.4 Conclusions 
Our TOC and TGA results indicated that we successfully coated Au NPs with HS-HA. The 
grafting density varied from 0.18 to 0.03 # of HA molecules/nm2 as the size of Au NPs 
increased from 5 to 100 nm. HS-HA coating decreased Au NPs’ toxicity to the cells. The 
improved biocompatibility is associated with HA’s ability to act as a free-radical quencher as 
revealed by our ROS measurements. The native 50- and 100-nm Au NPs could not enter the 
cell; however, the HS-HA coating enabled their entry in the cells via CD44 receptors, acting 
as a Trojan horse for the larger particles. The endocytosis of large particles coated with HS-
HA is a significant observation for targeted drug and gene delivery applications. 
Internalization was a function of the density of CD44 receptors as evidenced by percent 
internalization results with three different cell lines: CHO>ARPE-19>NIH 3T3.  
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In conclusion, we showed that HS-HA coating facilitates entry of Au NPs in size range of 5-
100 nm into cells that express CD44 receptors and renders the NPs biocompatible. This 
observation portends that HS-HA can be used as a biocompatible carrier to deliver larger 
payloads for treating inflamed, proliferating, and cancer cells that are associated with 
increased expression of CD44 receptors. 
3.5 Acknowledgements 
This work was supported by NIH  RO1 ECS-0335765, a Lacey and Nelson grant, a Core 
grant from the Association for the Prevention of Blindness, and a Veteran Affairs Merit 
review grant. Veteran Affairs Office of Research and Development IO1BX007080 grant to 
Kelle H. Moley supported confocal imaging. (NR). Partial support from McDonnell Academy 
Global Energy and Environment Partnership (MAGEEP) and the Lopata Endowment are 
gratefully acknowledged (PB). 
 
 
  
66 
 
3.6 References 
1. Ahire, J. J., D. Robertson, D. P. Neveling, A. J. van Reenen and L. M. T. Dicks 
(2016). "Hyaluronic acid-coated poly(d,l-lactide) (pdlla) nanofibers prepared by 
electrospinning and coating." RSC Advances 6(41): 34791-34796. 
2. Almalik, A., S. Karimi, S. Ouasti, R. Donno, C. Wandrey, P. J. Day and N. Tirelli 
(2013). "Hyaluronic acid (ha) presentation as a tool to modulate and control the receptor-
mediated uptake of ha-coated nanoparticles." Biomaterials 34(21): 5369-5380. 
3. Arndt, S., J. Seebach, K. Psathaki, H. J. Galla and J. Wegener (2004). "Bioelectrical 
impedance assay to monitor changes in cell shape during apoptosis." Biosensors & 
Bioelectronics 19(6): 583-594. 
4. Balogh, G. T., J. Illes, Z. Szekely, E. Forrai and A. Gere (2003). "Effect of different 
metal ions on the oxidative damage and antioxidant capacity of hyaluronic acid." Archives of 
Biochemistry and Biophysics 410(1): 76-82. 
5. Benoit, D. N., H. G. Zhu, M. H. Lilierose, R. A. Verm, N. Ali, A. N. Morrison, J. D. 
Fortner, C. Ayendano and V. L. Colvin (2012). "Measuring the grafting density of 
nanoparticles in solution by analytical ultracentrifugation and total organic carbon analysis." 
Analytical Chemistry 84(21): 9238-9245. 
6. Borradori, L. and A. Sonnenberg (1999). "Structure sand function of 
hemidesmosomes: More than simple adhesion complexes." Journal of Investigative 
Dermatology 112(4): 411-418. 
7. Chaitin, M. H. and A. A. Davis (1995). "Cd44 in the human retina." Investigative 
Ophthalmology & Visual Science 36(4): S279-S279. 
8. Chen, L., C. Cursiefen, S. Barabino, Q. Zhang and M. R. Dana (2005). "Novel 
expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (lyve-
1) by conjunctival cells." Investigative Ophthalmology & Visual Science 46(12): 4536-4540. 
9. Culty, M., H. A. Nguyen and C. B. Underhill (1992). "The hyaluronan receptor (cd44) 
participates in the uptake and degradation of hyaluronan." Journal of Cell Biology 116(4): 
1055-1062. 
10. Diebold, Y. and M. Calonge (2010). "Applications of nanoparticles in 
ophthalmology." Progress in Retinal and Eye Research 29(6): 596-609. 
11. Frens, G. (1973). "Controlled nucleation for regulation of particle-size in 
monodisperse gold suspensions." Nature-Physical Science 241(105): 20-22. 
12. Glucksam-Galnoy, Y., T. Zor and R. Margalit (2012). "Hyaluronan-modified and 
regular multilamellar liposomes provide sub-cellular targeting to macrophages, without 
eliciting a pro-inflammatory response." Journal of Controlled Release 160(2): 388-393. 
13. Gupta, R. and B. Rai (2017). "Effect of size and surface charge of gold nanoparticles 
on their skin permeability: A molecular dynamics study." Scientific Reports 7:45292. 
14. Hans, M. L. and A. M. Lowman (2002). "Biodegradable nanoparticles for drug 
delivery and targeting." Current Opinion in Solid State & Materials Science 6(4): 319-327. 
15. Huang, X. H., P. K. Jain, I. H. El-Sayed and M. A. El-Sayed (2008). "Plasmonic 
photothermal therapy (pptt) using gold nanoparticles." Lasers in Medical Science 23(3): 217-
228. 
16. Jaggupilli, A. and E. Elkord (2012). "Significance of cd44 and cd24 as cancer stem 
cell markers: An enduring ambiguity." Clinical & Developmental Immunology: 11. 
17. Jiang, J., G. Oberdorster, A. Elder, R. Gelein, P. Mercer and P. Biswas (2008). "Does 
nanoparticle activity depend upon size and crystal phase?" Nanotoxicology 2(1): 33-42. 
18. Kandasamy, K., C. S. Choi and S. Kim (2010). "An efficient analysis of nanomaterial 
cytotoxicity based on bioimpedance." Nanotechnology 21(37): 10. 
  
67 
 
19. Karakocak, B. B., R. Raliya, J. T. Davis, S. Chavalmane, W.-N. Wang, N. Ravi and P. 
Biswas (2016). "Biocompatibility of gold nanoparticles in retinal pigment epithelial cell 
line." Toxicology in Vitro 37: 61-69. 
20. Karthikeyan, B., K. Kalishwaralal, S. Sheikpranbabu, V. Deepak, R. Haribalaganesh 
and S. Gurunathan (2010). "Gold nanoparticles downregulate vegf-and il-1 beta-induced cell 
proliferation through src kinase in retinal pigment epithelial cells." Experimental Eye 
Research 91(5): 769-778. 
21. Katoh, S., Z. Zheng, K. Oritani, T. Shimozato and P. W. Kincade (1995). 
"Glycosylation of cd44 negatively regulates its recognition of hyaluronan." Journal of 
Experimental Medicine 182(2): 419-429. 
22. Kesharwani, P., S. Banerjee, S. Padhye, F. H. Sarkar and A. K. Iyer (2015). 
"Hyaluronic acid engineered nanomicelles loaded with 3,4-difluorobenzylidene curcumin for 
targeted killing of cd44+stem-like pancreatic cancer cells." Biomacromolecules 16(9): 3042-
3053. 
23. Kim, J. H., M. H. Kim, D. H. Jo, Y. S. Yu and T. G. Lee (2011). "The inhibition of 
retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation." 
Biomaterials 32(7): 1865-1871. 
24. Kimling, J., M. Maier, B. Okenve, V. Kotaidis, H. Ballot and A. Plech (2006). 
"Turkevich method for gold nanoparticle synthesis revisited." Journal of Physical Chemistry 
B 110(32): 15700-15707. 
25. Kumar, C. S., M. D. Raja, D. S. Sundar, M. G. Antoniraj and K. Ruckmani (2015). 
"Hyaluronic acid co-functionalized gold nanoparticle complex for the targeted delivery of 
metformin in the treatment of liver cancer (hepg2 cells)." Carbohydrate Polymers 128: 63-74. 
26. La Gatta, A., M. De Rosa, I. Marzaioli, T. Busico and C. Schiraldi (2010). "A 
complete hyaluronan hydrodynamic characterization using a size exclusion chromatography–
triple detector array system during in vitro enzymatic degradation." Analytical Biochemistry 
404(1): 21-29. 
27. Larson, T. A., P. R. Joshi and K. Sokolov (2012). "Preventing protein adsorption and 
macrophage uptake of gold nanoparticles via a hydrophobic shield." ACS Nano 6(10): 9182-
9190. 
28. Lee, H., K. Lee, I. K. Kim and T. G. Park (2008). "Synthesis, characterization, and in 
vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes." Biomaterials 
29(35): 4709-4718. 
29. Lee, M. Y., J. A. Yang, H. S. Jung, S. Beack, J. E. Choi, W. Hur, H. Koo, K. Kim, S. 
K. Yoon and S. K. Hahn (2012). "Hyaluronic acid-gold nanoparticle/interferon alpha 
complex for targeted treatment of hepatitis c virus infection." ACS Nano 6(11): 9522-9531. 
30. Lin, W. J., W.-C. Lee and M.-J. Shieh (2017). "Hyaluronic acid conjugated micelles 
possessing cd44 targeting potential for gene delivery." Carbohydrate Polymers 155: 101-108. 
31. Moghadam, B. Y., W. C. Hou, C. Corredor, P. Westerhoff and J. D. Posner (2012). 
"Role of nanoparticle surface functionality in the disruption of model cell membranes." 
Langmuir 28(47): 16318-16326. 
32. Moysidis, S. N., A. Thanos and D. G. Vavvas (2012). "Mechanisms of inflammation 
in proliferative vitreoretinopathy: From bench to bedside." Mediators of Inflammation: 11. 
33. Nasir, I., M. Lundqvist and C. Cabaleiro-Lago (2015). "Size and surface chemistry of 
nanoparticles lead to a variant behavior in the unfolding dynamics of human carbonic 
anhydrase." Nanoscale 7(41): 17504-17515. 
34. Nedvetzki, S., E. Gonen, N. Assayag, R. Reich, R. O. Williams, R. L. Thurmond, J. F. 
Huang, B. A. Neudecker, F. S. Wang, E. A. Turley and D. Naor (2005). "Rhamm, a receptor 
for hyaluronan-mediated motility, compensates for cd44 in inflamed CD44-knockout mice: A 
  
68 
 
different interpretation of redundancy (vol 101, pg 18081, 2004)." Proceedings of the 
National Academy of Sciences of the United States of America 102(4): 1263-1263. 
35. Nel, A. E., L. Madler, D. Velegol, T. Xia, E. M. V. Hoek, P. Somasundaran, F. 
Klaessig, V. Castranova and M. Thompson (2009). "Understanding biophysicochemical 
interactions at the nano-bio interface." Nature Materials 8(7): 543-557. 
36. Ngwa, W., M. Makrigiorgos and R. Berbeco (2012). "Enhancing stereotactic 
radiosurgery for neovascular age-related macular degeneration, using gold nanoparticles." 
Medical Physics 39(6): 3798-3798. 
37. Pan, Y., S. Neuss, A. Leifert, M. Fischler, F. Wen, U. Simon, G. Schmid, W. Brandau 
and W. Jahnen-Dechent (2007). "Size-dependent cytotoxicity of gold nanoparticles." Small 
3(11): 1941-1949. 
38. Panariti, A., G. Miserocchi and I. Rivolta (2012). "The effect of nanoparticle uptake 
on cellular behavior: Disrupting or enabling functions?" Nanotechnology, Science and 
Applications 5: 87. 
39. Pandey, M. S. and P. H. Weigel (2014). "Hyaluronic acid receptor for endocytosis 
(hare)-mediated endocytosis of hyaluronan, heparin, dermatan sulfate, and acetylated low 
density lipoprotein (acldl), but not chondroitin sulfate types a, c, d, or e, activates nf-kappa b-
regulated gene expression." Journal of Biological Chemistry 289(3): 1756-1767. 
40. Papasani, M. R., G. K. Wang and R. A. Hill (2012). "Gold nanoparticles: The 
importance of physiological principles to devise strategies for targeted drug delivery." 
Nanomedicine-Nanotechnology Biology and Medicine 8(6): 804-814. 
41. Perschl, A., J. Lesley, N. English, I. Trowbridge and R. Hyman (1995). "Role of cd44 
cytoplasmic domain in hyaluronan-binding." European Journal of Immunology 25(2): 495-
501. 
42. Pitarresi, G., E. F. Craparo, F. S. Palumbo, B. Carlisi and G. Giammona (2007). 
"Composite nanoparticles based on hyaluronic acid chemically cross-linked with alpha,beta-
polyaspartylhydrazide." Biomacromolecules 8(6): 1890-1898. 
43. Rana, S., A. Bajaj, R. Mout and V. M. Rotello (2012). "Monolayer coated gold 
nanoparticles for delivery applications." Advanced Drug Delivery Reviews 64(2): 200-216. 
44. Santhanam, S., J. Liang, R. Baid and N. Ravi (2015). "Investigating thiol-
modification on hyaluronan via carbodiimide chemistry using response surface 
methodology." Journal of Biomedical Materials Research Part A 103(7): 2300-2308. 
45. Santhanam, S., J. Liang, J. Struckhoff, P. D. Hamilton and N. Ravi (2016). 
"Biomimetic hydrogel with tunable mechanical properties for vitreous substitutes." Acta 
Biomaterialia 43: 327-337. 
46. Tezel, G., G. M. Seigel and M. B. Wax (1999). "Density-dependent resistance to 
apoptosis in retinal cells." Current Eye Research 19(5): 377-388. 
47. Tzircotis, G., R. F. Thorne and C. M. Isacke (2005). "Chemotaxis towards hyaluronan 
is dependent on cd44 expression and modulated by cell type variation in cd44-hyaluronan 
binding." Journal of Cell Science 118(21): 5119-5128. 
48. Wang, S. J., Y. Tian, W. Tian, J. Sun, S. Zhao, Y. Liu, C. Y. Wang, Y. X. Tang, X. Q. 
Ma, Z. G. Teng and G. M. Lu (2016). "Selectively sensitizing malignant cells to 
photothermal therapy using a cd44-targeting heat shock protein 72 depletion nanosystem." 
ACS Nano 10(9): 8578-8590. 
49. Wegener, J., C. R. Keese and I. Giaever (2000). "Electric cell-substrate impedance 
sensing (ecis) as a noninvasive means to monitor the kinetics of cell spreading to artificial 
surfaces." Experimental Cell Research 259(1): 158-166. 
50. Yilmaz, G., B. Demir, S. Timur and C. R. Becer (2016). "Poly(methacrylic acid)-
coated gold nanoparticles: Functional platforms for theranostic applications." 
Biomacromolecules 17(9): 2901-2911. 
  
69 
 
51. Zhang, S. L., J. Li, G. Lykotrafitis, G. Bao and S. Suresh (2009). "Size-dependent 
endocytosis of nanoparticles." Advanced Materials 21: 419-424. 
 
  
70 
 
 
 
 
 
 
 
Chapter 4: Nitrogen-doped Carbon Dots as 
a Biocompatible Alternative for Bioimaging 
 
 
 
 
 
 
 
 
 
The results of this chapter have been reprinted with permission from Karakocak, B. B.; Liang, 
J.; Kavadiya, S.; Berezin, M. Y.; Biswas, P.; Ravi, N. Optimizing the Synthesis of Red-
Emissive Nitrogen-doped Carbon Dots for Use in Bioimaging. ACS Appl. Nano Mater. DOI: 
10.1021/acsanm.8b00799. Copyright 2018 American Chemical Society 
Supplementary information along with additional figures and tables are available in 
Appendix III 
  
71 
 
Abstract  
Synthesizing highly efficient red-emissive carbon dots (CDs) is a challenge that still impedes 
widespread applications of CDs in bioimaging. Herein, we demonstrate a facile, isolation-free 
synthesis of deep red (600-700 nm) emissive nitrogen-doped CDs (nCDs) based on 
microwave-assisted pyrolysis of citric acid and ethylenediamine. The duration of pyrolysis, 
the molar ratio of acid to amine, and the concentration of reactants were optimized by means 
of Central Composite Design and Response Surface Methodology (CCD-RSM) to yield deep 
red to near-infrared fluorescence. We demonstrated their applicability on three different cell 
lines (retinal epithelial, lens epithelial, and Chinese hamster ovary cells (CHO)). We 
measured the viability, the generation of reactive oxygen species, and percentage of apoptotic 
cells to determine their level of toxicity in cell culture. Confocal images showed that the 
nCDs fluoresced at different wavelength depending upon the excitation wavelength and were 
excitable up to 635 nm. Furthermore, the ex vivo imaging of porcine ocular globes and post-
mortem imaging of a whole mouse exemplified the utility of nCDs.  
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4.1 Introduction 
Carbon dots, a rising star in the bioimaging field (Luo et al. 2013, Berezin 2014, Cherukula et 
al. 2016, Gan et al. 2016), have attracted considerable attention due to their numerous and 
unique intrinsic properties such as wavelength dependent excitation/emission (Jiang et al. 
2015, Ding et al. 2016) a long fluorescence lifetime (Dong et al. 2015) good photostability 
(Zhang et al. 2015) and high biocompatibility (Tao et al. 2012). With these unique properties, 
carbon dots (CDs) have demonstrated promise for bioimaging applications.(Hola et al. 2014, 
Choi et al. 2016, Zhang et al. 2016) Even though, many kinds of CDs have been reported; 
most show intense emission only in blue-green regions following excitation with ultraviolet or 
blue light (Bourlinos et al. 2008, Peng and Travas-Sejdic 2009, Wang et al. 2010, Bourlinos et 
al. 2012, Zhu et al. 2013, Yang et al. 2015, Qu et al. 2017). The well-known blue 
autofluorescence of native biological matrix and the severe photodamage caused by 
ultraviolet excitation further hinder their application. Although, there have been a handful of 
attempts to create red-emissive CDs (Nie et al. 2014, Ge et al. 2015, Ding et al. 2016, Sun et 
al. 2016, Feng et al. 2017, Miao et al. 2017), either the excitation was limited to green light or 
the synthesis method was quite involved. Therefore, it remains highly desirable to achieve 
red-emissive CDs that can be excited with longer wavelengths, penetrating deep in tissue 
without causing damage to the target cell/tissue/organ, via a truly facile synthesis method.  
Various methods for creating CDs, ranging from relatively simple to rather complex 
procedures, have been reported (Luo et al. 2013, Nie et al. 2014, Ding et al. 2016, Feng et al. 
2016, Feng et al. 2017, Lin et al. 2017, Lin et al. 2018). Certain synthesis methods produce 
great variety of CDs with a broad distribution of fluorescence emission, and hence necessitate 
separation (i.e., silica column chromatography (Nie et al. 2014, Ding et al. 2016, Feng et al. 
2017), capillary electrophoresis (Hu et al. 2013)) to isolate those nanoparticles with desired 
optical properties. For clinical applications, it would be ideal to scale up the synthesis,(Wang 
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and Hu 2014) preferably using a simple method involving commercially available reactants 
and environmentally friendly techniques (Xu et al. 2014). Among existing methods, 
microwave pyrolysis has the distinct advantages of shorter reaction times, milder reaction 
conditions, lower energy consumption, better stability, easy reproducibility, and higher 
product efficiency (Zhu et al. 2009, Zhai et al. 2012, Hu et al. 2013). Thus, microwave 
pyrolysis exhibits great promise as opposed to other synthesis methods which are quite 
involved and require isolation of the desired red-emissive CDs. 
In this study, we optimized an isolation-free method of synthesizing red-emissive CDs (red-
CDs) with deep red to near-infrared (NIR) fluorescence (600 - 700 nm). Such long-
wavelength emitters are highly desired in optical imaging of tissue, due to the decreased 
interference from tissue autofluorescence at longer wavelengths (Hola et al. 2014, 
Ostadhossein and Pan 2017). The deep-red emitters were based on nitrogen-doped carbon 
dots (nCDs) prepared by microwave-assisted pyrolysis of a mixture of citric acid and aliphatic 
diamines without the need for intensive isolation of the red-emissive nCDs. The duration of 
pyrolysis, the molar ratio of acid to amine, and the concentration of reactants were optimized 
to maximize fluorescence efficiency. The biocompatibility of the nCDs was assessed on three 
different cell lines by measuring cell viability, generation of reactive oxygen species (ROS), 
and the extent of apoptosis. Confocal microscopy images of the three cell lines showed that 
the nCDs were excitable also at different wavelengths including the NIR region. Finally, to 
demonstrate the potential of red-nCDs as bioimaging agents, the nCDs were injected 
intravitreally into ex vivo porcine ocular globes and subcutaneously in euthanized mice, where 
they are easily detected.  
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4.2 Methods 
4.2.1 Materials 
All chemicals were used as received. Ethylenediamine (EDA) (99%, cat# E26266), and 
Rhodamine 6G (99%, cat# 252433) were purchased from Sigma-Aldrich. Citric acid (CA) 
was purchased from J.T. Baker Chemical Co. Dulbecco’s modified Eagles’s medium/nutrient 
mixture F-12 Ham (DMEM/F12), trypsin-ethylenediaminetetraacetic acid (EDTA) solution 
10x, and fetal calf serum (FCS), TritonTM X-100, phosphate buffer saline (PBS), 100x 
antibiotic-antimycotic solution, and thiazolyl blue tetrazolium bromide (MTT) (98%, cat# 
M2128) were obtained from Sigma-Aldrich (St. Louis, MO). SlowFade® Gold Antifade 
Mountant with DAPI (cat# S36938) was purchased from Thermo Fisher Scientific (St. Peters, 
MO). Retinal pigment epithelial (ARPE-19) (ATCC® CRL¬ 2302™), lens epithelial cells 
(ATCC® CRL¬ 11421TM), and CHO (CCL¬ 61™) cells were purchased from American Type 
Culture Collection (Manassas, VA). ApoTox-Glo™ (cat# G6320) and ROS GloTM H2O2 (cat# 
G8820) assays were purchased from Promega Corporation (Madison, WI).  
4.2.2 Synthesis of nCDs 
We evaluated the effect of three factors in the synthesis of nCDs – the molar ratio of amine to 
acid, the duration of pyrolysis (microwave exposure time), and the concentration of the 
reactants on creating red-nCDs. For this, a Central-Composite Design Response Surface 
Methodology (CCD-RSM) design was utilized (Stat-Ease, Design-Expert® software, version 
9.0). Each factor was varied at five levels: amine/acid (molar ratio) = 0.30, 0.48, 0.75, 1.02, 
and 1.20; microwave exposure time = 70 s, 75 s, 88 s, 95 s, and 100 s; and concentration of 
citric acid (wt/v %) = 8.0, 8.8, 10.0, 11.2, and 12.0. There were twenty runs of carbon dots 
synthesis, as tabulated in Table S1. 
A stock solution of 12 wt/v % of citric acid was prepared by dissolving 28.39 g of citric acid 
in 220 mL of water. The desired amount (see Table S1) of this stock solution was added to a 
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glass beaker (capacity 100 mL), then DI water was added to make the volume up to 10 mL, 
and then the desired amount of ethylenediamine (see Table S1) was added. The mixture was 
shaken and heated in a microwave oven (General Electric, 1,100 watts) for a varying 
durations as listed in Table S1. Products of these 20 different synthesis experiments yielded a 
brittle solid, whose color varied from yellow to brown. This solid was dissolved in 3 mL of 
water and transferred to a 20 mL vial. The beaker was rinsed with another 2 mL of water, and 
the liquids were combined. The solution was dialyzed against water (Molecular weight cut-off 
(MWCO) = 500 Da, Spectra Por 131084 Biotech-Grade CE dialysis tubing) for 24 hours. 
4.2.3 Physico-chemical characterization of nCDs 
The morphologies and the size of the synthesized nCDs were examined by high-resolution 
transmission electron microscopy (HR-TEM, Tecnai TM Spirit, FEI Co.), operated at 200 kV 
accelerating voltage. Atomic force microscopy (AFM) was carried out using Veeco 
Dimension 3100 V (Parkafm, Santa Clara, CA). For AFM analysis, the sample was prepared 
by electrospraying (6 kV) ~5 µL of nCDs solution (0.625 µg/mL) on Si wafer to get a clear 
snapshot of individual nCDs. Dynamic light scattering (DLS) analysis was conducted with a 
Malvern Zetasizer Nano ZS (Malvern Instruments, Westborough, MA) equipped with a 
backscattering detector (173º) to measure hydrodynamic sizes and zeta potential of 
synthesized nCDs. For DLS measurements, the samples were dispersed in water, sonicated for 
15 min, filtered through a prerinsed 0.22 μm polyethersulfone filter. At least three 
measurements per sample were taken.  
UV-Vis absorption spectra were recorded on a Thermo Fisher Biomate 3 UV-Vis 
spectrophotometer. Fluorescence spectra were measured on a SpectraMax Gemini EM 
fluorescence reader at ambient conditions. The photoluminescence (PL) emission was 
determined with a Varian Cary 5000 spectrophotometer. For the measurement of fluorescence 
homogeneity of the sample and resolving fluorescent impurities, 3D emission-excitation maps 
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of synthesized nCDs were recorded using a fluorescence excitation-emission spectroscopy 
method. The measurements were conducted using Vis-NIR (300-1600 nm) spectrofluorometer 
equipped with an imaging spectrograph iHR320 and a diode array deep-cooled CCD detector 
Synapse (all from Horiba Jobin Yvon Inc.). Emission spectra acquired at different excitation 
were corrected for the excitation light intensity. For optical measurements, the samples were 
diluted until clear and sonicated for 5 minutes before the measurements. At least three 
measurements per sample were taken.  
The quantum yield (ΦS), the ratio of photons emitted to photons absorbed, of the nCDs in 
water was determined by a comparative method with Rhodamine 6G as a reference at 540 nm 
excitation in a 10-mm quartz cuvette. To minimize self-absorption, the absorbance was kept 
under 0.1 au. Integrated PL intensity in the range of 590-720 nm vs. absorbance was plotted at 
different concentrations. The ΦS of the nCD samples was calculated using the following 
equation(Brouwer 2011): 
𝜙𝑆 =  𝜙𝑅 (
𝐺𝑟𝑎𝑑𝑠
𝐺𝑟𝑎𝑑𝑅
) (
𝜂𝑆
2
𝜂𝑅
2)                                                      (𝐸𝑞. 1) 
where the subscripts S and R refer to the sample and reference, respectively. Grad is the 
gradient from the plot of integrated PL intensity against absorbance, and η is the refractive 
index of the solvent, which is deionized water for both the reference and nCDs solutions.  
For molecular weight distribution study, matrix-assisted laser desorption/ionization-time of 
flight (MALDI-TOF) mass spectrometric analysis of the nCDs was performed with a Bruker 
UltraFlextreme MALDI-TOF instrument with SmartbeamTM Laser (337 nm) in the positive-
ion mode using 2,5 dihydroxybenzoic acid (DHB) as a matrix. The chemical composition of 
nCDs was determined with X-ray photoelectron spectra (XPS) using a Kratos Axis Ultra 
spectrometer (DLD, Japan) and a monochromatic Al Kα source (1486.6 eV). 
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4.2.4 In-vitro Cytotoxicity measurements on Retinal Pigment Epithelial 
(ARPE-19), lens epithelial, and Chinese Hamster Ovary (CHO) Cells with 
MTT, Apotox-GloTM, and ROS-Glo™ H2O2 assays.   
Cell metabolic activity, and hence the viability of cells in the presence of nCDs (0.01-0.6 
mg/ml), was assessed with MTT (3-[4, 5 dimethyl-thiazoly-2-yl] 2-5 diphenyl tetrazolium 
bromide). The relative amounts of apoptotic cells and reactive oxygen species (ROS) 
generation were measured by ApoTox-Glo™ and ROS GloTM H2O2 assays, respectively. Each 
test result (viability measurement, the relative amount of apoptotic cells, and ROS generation) 
was compared with the corresponding negative (untreated cells) and positive (NPs without the 
cells) control groups with Student’s t-test. P* < 0.05, the significance level, was statistically 
acceptable. Please refer to the Supplementary Information for further details of the 
cytotoxicity analysis. 
4.2.5 In-vitro Imaging of Cells Treated with nCDs 
To confirm the presence of nCDs inside cells, we investigated the distribution of nCDs at 
0.01-0.6 mg/mL, using a nanoplasmonic confocal laser-scanning microscope (Leica TCS-
SP8). Four laser wavelengths (405, 488, 532, and 635 nm) were used during confocal 
imaging.  
Retinal epithelial, lens epithelial, and CHO cells were separately seeded in CELLviewTM 
plates at 5 × 104 cells/well for 24 h. After 24 h of nCD exposure, nCDs that were adsorbed on 
the cell surface or failed to enter the cells were removed by careful washing with 1x PBS 
three times. The cells were then fixed by immersion in 4% paraformaldehyde (PFA) as the 
cross-linking solution for 10 min at room temperature and washed with 1x PBS three times 
before imaging. For the cell fixation details and preparation for confocal imaging, see the 
Supplementary Information. A negative control sample (untreated cells) was prepared with 
cells in the absence of nCDs.  
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4.3 Results and Discussion 
4.3.1 Effects of synthesis conditions on short and long-wavelength emission 
abilities 
Microwave-assisted pyrolysis of organic compounds is a rapid, facile, and cost-effective 
method for synthesizing CDs (Zhai et al. 2012, Hu et al. 2013, Xu et al. 2014). Generally, a 
carbon source (a compound containing carbon atoms) and a nitrogen source (a compound 
containing nitrogen atoms) are dissolved in an aqueous solution, and the mixed solution is 
heated in a microwave oven. Various types of carbon sources and nitrogen sources have been 
used in this method, as reported in the literature (Wang and Hu 2014). Among them, using 
citric acid as the carbon source and a diamine or multi-amine as the nitrogen source has been 
demonstrated as a successful combination (Zhai et al. 2012). The amine molecules serve as a 
surface passivating agent and an N-doping precursor. nCDs that were synthesized with this 
method exhibited excitation-dependent PL (Goh et al. 2012, Zhai et al. 2012). The excitation-
dependent emission is due to the heterogeneity of the chemical composition of CDs, in other 
words, the formation of different functional groups on the surface (Gan et al. 2016, Sharma et 
al. 2016). Zhai et al. investigated several amine molecules and determined that using 1,2-
ethylenediamine led to the highest PL intensity (Zhai et al. 2012). They also varied the 
amine/acid ratio from 0 to 1.33 and determined that an NH2/COOH (amine/acid) ratio of 0.67 
resulted in the strongest emission. Since then, other groups have also used a similar 
amine/acid ratio (0.67-0.75) in their research (Zhu et al. 2013, Shi et al. 2014, Jia et al. 2016). 
However, Zhai’s approach was limited to nCDs with a relatively short wavelength optical 
property with excitation/emission combination (λex∕em = 350/460). For in vivo imaging, 
however, such a short wavelength cannot penetrate through the skin and tissues, and it might 
be harmful to cells at longer exposure times.(Hola et al. 2014) Therefore, we developed nCDs 
for long wavelength optical activity with deep red fluorescence (λex∕em = 540 nm/600 nm) 
  
79 
 
PL. To optimize the composition of nCDs, we varied three critical factors: amine/acid ratio, 
citric acid (CA) concentration, and reaction time.  
Design of Experiment (DOE) (Liang et al. 2015, Santhanam et al. 2015) (Design Expert® 
software, version 9.0, Stat-Ease, Minneapolis, MN) was used to outline the optimization space 
and develop a relationship between the responses of interest and associated factors : the molar 
ratio of amine to acid, the microwave exposure time, and the concentration of the reactants. In 
central-composite design we used three factors were varied at five levels, resulting in 20 runs 
(Table S1). We characterized the PL of the 20 products at both a short wavelength (λex∕em = 
350 nm/460 nm) and a long wavelength (λex∕em = 540 nm/600 nm), (Table S1). The details 
of optimization design and statistical analysis are provided in Supplementary Information. 
According to the statistical analysis, the PL at λex∕em = 350 nm/460 nm could be adjusted by 
changing the amine/acid ratio and by changing the reaction time; however, changing the 
concentration of CA within our experimental range did not have a significant effect. Our 
optimized amine/acid ratio (0.75) is close to the finding from Zhai’s work (0.67), this small 
difference in ratio (0.75-0.67) may be due to their longer microwave exposure time (88 
seconds versus 120 seconds) and lower microwave power (1,100 versus 700 W). Using our 
model, one can precisely predict and control the PL of CDs. Our model also allows changing 
the value of one factor within a certain range while maintaining the same PL intensity, by 
changing the other factor on the basis of this equation (Eq. S1). Therefore, the reaction 
conditions can be tailored to meet specific requirements or limitations.  
Furthermore, we determined whether the long wavelength PL follows a similar acid/amine 
trend to that at a short wavelength as the experimental conditions change (Fig. 4.1A). Our 
investigation shows it does not, which is a very interesting and valuable result (Fig. 1A vs 
Fig. 1B). Unlike the PL at short wavelengths, the analysis of the PL at long wavelengths 
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(λex∕em = 540 nm/600 nm) suggested that the linear model was the most appropriate among 
all polynomial regression models (Fig. 4.1B). The maximum PL for longer wavelength was 
observed at amine/acid ratio of 1.20. By using the statistical analysis, we determined that the 
PL at λex∕em = 540 nm/600 nm was mostly affected by the amine/acid ratio. Generally, the 
emission at 600 nm can be increased by increasing the amine/acid ratio (Eq. S2). The reaction 
time has a positive effect on the emission at high amine/acid ratio, while it has a negative 
effect when the amine/acid ratio is low. However, the overall effect of reaction time is much 
weaker than that of amine/acid ratio. We also determined that the concentration of CA did not 
have a significant effect.  
 
 
 
Figure 4.1 Schematic CCD-RSM design responses. (A) λex = 350 nm, λem = 460 nm. (B) λex = 540 nm, λem = 
600 nm.  
A) 
B) 
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The surface charge of nanoparticles has been shown to be associated with their PL 
performance (Zhai et al. 2012, Hu et al. 2013, Zhu et al. 2013). Hu et al. utilized a capillary 
electrophoretic method to characterize the surface charge of CDs synthesized from EDA and 
CA (Hu et al. 2013). They determined that the amine/acid ratio significantly affected the 
surface charge of nCDs. When the amine/acid ratio is within 0.25-0.8, positively, neutral, and 
negatively charged nCDs were generated. According to their results, at higher amine/acid 
ratio predominantly neutral and positively charged nCDs were formed. They concluded that 
species with a higher fraction of positively and neutrally charged nCDs exhibited stronger 
fluorescence than negatively charged nCDs when measured at a wavelength of λex∕em = 488 
nm/550 nm.  
Similar to Hu’s results, our findings also indicated that neutral and positively charged nCDs 
are more likely to be excited at a longer wavelength. The synthesis of nCDs with an 
amine/acid ratio of 1.20 yielded predominantly neutral and positive emitters, accounting for 
the strong wavelength emission of our product. The major contribution of our work is that we 
optimized the synthetic parameters for nCDs that we were able to obtain nCDs with deep-red 
to NIR emission without their isolation, i.e., by capillary electrophoresis as used by Hu and 
colleagues.  
4.3.2 Maximization of nCD red fluorescence intensity 
Since the PL at λex∕em = 540 nm/600 nm showed a linear increase when the amine/acid ratio 
was increased in the range of 0.48 to 1.20, we sought to further increase the PL at long 
wavelength by extending the range from 0.25 to 3.0. We synthesized another six batches of 
nCDs with amine/acid ratios of 0.25, 0.5, 1.0, 1.5, 2.0, and 3.0 while keeping the reaction time 
at 88 seconds and CA% at 10%. However, the batch with amine/acid = 3.0 formed an oily 
product, which was not completely soluble in water. Thus, amine/acid = 3.0 was eliminated 
from further study. We determined that the PL at λex∕em = 540 nm/600 nm showed a 
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significant increase with increasing amine/acid ratios in the range of 0.5 to 2.0 (Fig. 4.2). In 
addition, although the PL intensity showed a linear increase in the range of 0.5-1.0, as 
demonstrated in the DOE (Fig. 4.1), it approached to a maximum at an amine/acid ratio of 
1.20 (Fig. 4.1B). As we found that our synthesis of nCDs with amine/acid ratio of 2.0 yielded 
longer-wavelength excitable nCDs, which can be explained by the presence of predominantly 
neutral and positive nCDs,(Hu et al. 2013) accounting for the strong wavelength emission of 
our product. 
 
Figure 4.2 (A) Absorbance and (B) PL emission intensities of nCDs at different concentrations with varied 
amine to acid ratios. 
Fluorescence excitation-emission spectroscopy using excitation-emission matrix analysis 
showed that the nCDs demonstrate characteristic excitation-dependent fluorescence behavior 
(Fig. 4.3). Such method, in which a series of emission spectra are collected over a range of 
excitation energies is commonly used to resolve multicomponent fluorescent mixtures 
(Bachilo et al. 2002, Nevin et al. 2009). The 3D fluorescence spectra revealed the 
heterogeneity of the emitters at a low amine to acid ratio as indicated by the non-symmetrical 
and broad shape of the emission. This shape signifies the presence of multiple types of 
emissive species (i.e., neutral and positively charged) (Fig. 4.3, B-D). The heterogeneity 
disappears entirely at the high amine to acid ratio = 2.0 (Fig. 4.3E) indicating the formation of 
a single emitter (i.e., predominantly positively charged). It is worth noting that as the 
A) B) 
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amine/acid increased, the emission shifts towards NIR region reaching almost 750 nm (Fig. 
4.3E). The insets of the figures present nCDs in an aqueous suspension. Changing the 
NH2/COOH ratio exhibited different colors of nCDs in an aqueous suspension. The surface 
characteristics of nCDs have changed leading to a shift in emission as demonstrated by the 3D 
fluorescence spectra, and the observed colors of the final products are also consistent with this 
behavior. 
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Figure 4.3 Fluorescence excitation-emission spectroscopy of nCDs with amine/acid ratios of (A) 0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00. The peak for excitation and 
emission shifts towards near infrared region as the amine to acid ratio increases. All spectra were corrected for the lamp intensity. The insets of each figures represents 
synthesized nCDs in DI water, from left to right, the NH2/COOH ratio is increasing from 0.25 to 2.00. 
A) B) C) D) E) 
  
85 
 
4.3.3 Characterization of long wavelength nCDs 
The HR-TEM images display size distribution 4.05±0.46 nm, and the images reveal that the 
nCDs have a lattice spacing of 0.15 nm (Fig. 4.4A). This indicates that the nCDs are not 
amorphous but exhibit long-range ordering. The AFM analysis showed that the particle size 
of nCDs with amine/acid ratio of 2.0 was less than 5 nm (Fig. 4.4B). Both single carbon dots 
(marked with white circles) and aggregates of carbon dots were observed in AFM analysis.  
Fig. 4.4C presents the size distribution of carbon dots, which was determined by measuring 
the height of 50 single carbon dots observed under AFM. The size distribution suggests the 
average particle size of 2.99 ± 0.77 nm, with peak size between 2-2.5 nm. On the other hand, 
according to the DLS analysis, hydrodynamic sizes of the nCDs were found to be ranging 
from 0.87 ± 0.26 nm to 5.23 ± 1.25 nm in DI water with increasing amine to the acid ratio 
(Fig. 4.5 and Fig. S1). Furthermore, zeta potential analysis revealed that with increasing 
amine/acid ratio, the zeta potential of nCDs increased from -4.16 ± 7.76 mV to 45.15 ± 8.05 
mV (Fig. 4.5 and Fig. S2). The increase in zeta potential with increasing amine/acid ratio 
supports the hypothesis that nCDs with high amine/acid ratio yielded neutral and positive 
nCDs with strong red emission. 
 
A) 
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Figure 4.4 (A) HR-TEM image of nCDs with amine/acid ratio of 2.0. The particle size distribution is determined 
to be 4.05±0.46 nm. The lattice spacing is found to be 0.15 nm. (B) AFM images of nCDs with amine/acid ratio 
of 2.0. The diameter of nCDs is less than 5 nm. (C) Size distribution of nCDs which was determined by 
measuring the height of 50 single carbon dots observed under AFM 
        
Figure 4.5 Dynamic light scattering analysis of nCDs with NH2/COOH of 0.25, 0.75, 1.00, 1.50, and 2.00: (A) 
Hydrodynamic particle size measurement results. (B) Zeta potential measurement results. 
Next, we identified the mass of nCDs using MALDI-TOF mass spectroscopy. As shown in 
Fig. S3, the molecular ions with the highest intensities are m/z =799.6, 1215.0, and 1512.0 for 
the nCDs with amine/acid ratios of 0.5, 1.0, and 2.0 respectively. The nCD molecular weights 
determined with MALDI-TOF, increased with increasing amine/acid ratios of 0.5, 1.0, and 
2.0, were in accordance with the DLS findings.  
B) 
C) 
A) 
B) 
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The XPS analysis was performed to identify the bonds present on the surface of nCDs. The 
broad spectrum confirmed the presence of carbon, oxygen, and nitrogen (Fig. S4). Further, 
high-resolution XPS was performed to identify the type carbon and nitrogen bonds. The high-
resolution C1s figures of nCDs with different amine/acid ratio reveal that as the amine to acid 
ratio increased, different types of bonds were formed on CD surfaces (Fig. 4.6). As shown in 
Fig. 4.6, the C1s core level peak of the nCDs shows two main peaks at 284.0±0.3 eV (C=C) 
and 284.5±0.4 eV (C–C), aromatic and aliphatic carbons, respectively. The next peaks at 
higher binding energy indicate the existence of oxygen groups, including C–O (hydroxyl 
carbon) at 285.5±0.4 eV, C–O–C (epoxy carbon) at 286.5±0.5 eV, and C=O (carbonyl 
carbon) at 287.5±0.5 eV (Fig. 6). As the amine/acid was increased, C–O–C bonds (286.5 ±0.5 
eV) disappeared, and starting from amine/acid ratio of 1.00, C–O/C–N bonds (285.5±0.4 eV) 
were detected. The XPS results clearly indicate that there is a significant change in bonds 
formed on nCD surfaces as the amine to acid ratio changes. The high-resolution N1s results 
show that the pyrrolic nitrogen content in nCDs was increased significantly as the amine/acid 
ratio increased from 0.25 to 2.0 (Fig. S5). It has been shown that specifically cyclic 
polypyrroles such as pyrrolopyrole cyanines are fluorescent and emit light beyond 500 
nm.(Berezin et al. 2009) It is not possible to provide the exact mechanism of pyrolysis and an 
accurate molecular structure of the products since pyrolysis is essentially a burning process. 
However, based on the structure of citric acid, one of the most probable products (or moieties) 
contributing to deep-red-emissivity of nCDs could be N,N'-substituted-pyrrolo[2,3-b]pyrrole 
(Fig. 4.6F). It can be concluded that formation of C‒N (Fig. 4.6) and increasing pyrrolic N 
(Fig. S5) amounts are responsible for red-shifted fluorescence (Fig. 4.3).  
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Figure 4.6 High-resolution C1s XPS analysis results of nCDs with amine/acid ratios of (A) 0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00. Increasing NH2/COOH ratio resulted 
in an apparent C‒N bond formation. (F) Proposed formation mechanism for a possible product (N,N'-substituted-pyrrolo[2,3-b]pyrrole) contributing to red-emissivity of nCDs 
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Table S2. summarizes the effect of molar ratio of reactants to pyrrolic N content and MW of 
nCDs. Fig. S7A shows the linear relationship between the molar ratio of reactants to pyrrole 
content (R2=0.99) thereby underscoring that the chemical moieties responsible for red 
emission is associated with the pyrrole content. MW measurements, based on MALDI-TOF 
analysis, shows a second order correlation (R2=1) (Fig. S7B) which suggests that increasing 
the molar ratio of reactants further is not going to increase the MW of nCDs.  
The quantum yield of nCDs in the red emission range of 590-720 nm was determined using a 
comparative quantum yield measurement technique. The red-nCDs quantum yields were 
found to be in the range of 7%-15% in deionized water (Table S3).  
4.3.4 Cytotoxicity evaluation of nCDs 
For ocular clinical applications, when the nanoparticles are introduced intravenously, they will 
have to cross the blood-retinal barrier to reach the ocular tissues (Lavik et al. 2011). 
Dysfunction in retinal epithelial cells leads to vascular leakage that could potentially lead to 
vision-threatening conditions. Lens epithelial cells are associated with cataract formation, the 
most common visual impairment. We, therefore, investigated the toxicity of nCD to retinal 
(ARPE-19) and lens epithelial cells. Given the potential application of nCDs in cancer 
theranostics, we also evaluated the nCDs toxicity to Chinese hamster ovarian (CHO) cells.  
For the assessment of toxicity, three different independent end-point assays were used: 
viability based on enzymatic activity in mitochondria; the percent of apoptotic cells based on 
caspase 3/7 activity, and ROS generation, which is proportional to luciferase activity (see 
Methods). The results indicated that for retinal and lens epithelial cells, the lethal dose 
required to kill 50% of the cells (LD50) of nCDs was approximately 0.6 mg/mL (Fig. S8-9A). 
Up to this critical concentration, more than 50% of the retinal and lens epithelial cells did not 
initiate apoptotic cell death (Fig. S8-9B) but induced ROS generation (Fig. S8-9C). On the 
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other hand, interestingly, CHO cells generated more than twice ROS than ocular epithelial 
cells; however, their viability was not compromised up to 0.6 mg/ml exposure concentration 
of nCDs (Fig. S10). Cancer cells, in general, are shown to have increased ROS levels in 
comparison to normal cells to initiate cell death (Tafani et al. 2016). The increased ROS levels 
are partly due to an enhanced metabolism and mitochondrial dysfunction in cancer cells 
(Galadari et al. 2017).  
4.3.5 In-vitro imaging of nCDs 
To confirm the uptake of nCDs by the cells, we investigated the distribution of nCDs after 
incubation using a nano-plasmonic confocal laser scanning microscope (LEICA TCS-SP8) 
(see Methods). The above-mentioned cell lines were used for in vitro imaging analysis as 
well. According to the images presented in Fig. 4.7, nCDs have demonstrated successful use 
of fluorescence imaging in vitro, due to their excitability at multiple wavelengths in the 
visible spectrum. Furthermore, we showed that nCDs could also fluoresce when excited at 
635 nm thus minimizing the effect of autofluorescence and increasing the signal to 
background ratio.  
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Figure 4.7 Confocal microscopy images of nCDs excited at four different wavelengths: 405, 488, 532, 635 nm, 
exposed to (a) retinal pigment epithelial, (b) lens epithelial, (c) CHO cells.  
λex = 405 nm 
λem = 430-490 nm 
λex = 488 nm 
λem = 500-560 nm 
λex = 532 nm 
λem = 540-600 nm 
λex = 635 nm 
λem = 640-700 nm 
A) 
B) 
C) 
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4.4 Conclusions 
We developed and optimized a scalable isolation-free microwave pyrolysis method for 
synthesizing deep red-NIR emissive nitrogen-doped carbon dots from citric acid and 
ethylenediamine. MALDI-TOF and DLS results respectively showed that as the amine to acid 
ratio increased, both the MW and size of the nCDs increased. Based on the XPS analysis, the 
formation of C‒N and the presence of pyrrolic N content appear to be keys to creating red-
emissive nCDs. Both of these critical elements maximized at an amine/acid ratio of 2.0. 
Confocal images demonstrated that the nanoparticles could enter the cells, including cancer 
cells. Excellent biocompatibility results support the potential application of nCDs in 
nanomedicine. 
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Chapter 5: Hyaluronate Conjugated 
Nitrogen-doped Carbon Quantum Dots for 
Use in Bioimaging 
 
 
 
 
 
 
 
 
 
 
The results of this chapter have been compiled in Karakocak, B. B.; Liang, J..; Biswas, P.; 
Ravi, N. (2018). Hyaluronate Conjugated Nitrogen-doped Carbon Quantum Dots for Use in 
Bioimaging. In Preparation. 
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Abstract  
In this work, we demonstrate the application of hyaluronate conjugated nitrogen-doped 
carbon quantum dots (nCQDs) for bioimaging and their potential use for targeted drug 
delivery. nCQDs were synthesized by microwave-assisted pyrolysis of citric acid and 
aliphatic diamines. The time of pyrolysis, the molar ratio of acid to amine, and the 
concentration of reactants was optimized to yield high fluorescence in the red wavelength 
range (optimum excitation at 550 nm, emission up to 700 nm). The HA-nCQD conjugate was 
synthesized by a carbodiimide coupling of the amines on CQDs and the carboxylic acids on 
HAs. The nCQDs and their conjugates fluoresced variously depending upon the excitation 
wavelength. Three different cell lines were exposed to nCQDs and HA-nCQDs. Confocal 
microscopy images showed enhanced internalization of HA-nCQDs, which was facilitated by 
CD44 receptors. Further, ex-vivo (porcine eye globes) and post-mortem (mice) images were 
obtained. Observations demonstrate the use of HA as a carrier for targeted drug delivery into 
CD44 rich cells, and red emissive nCQDs can be used for both ex-vivo and in-vivo imaging.  
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5.1 Introduction 
Bioimaging, non-invasive visualization of a cell/tissue/organ is a crucial tool for diagnosis, 
treatment of various diseases, including cancer. In the last two decades, various nanomaterials 
were studied (Cherukula et al. 2016), and carbon dots have been shown to be promising for 
bioimaging applications (Hola et al. 2014, Choi et al. 2016, Zhang et al. 2016). Carbon 
quantum dots (CQDs) are one of the most promising bioimaging agents due to their unique 
intrinsic properties such as wavelength dependent excitation/emission (Jiang et al. 2015, Ding 
et al. 2016), long fluorescence lifetime (Dong et al. 2015), good stability (Zhang et al. 2015), 
and high biocompatibility (Tao et al. 2012).  
Various CQDs synthesis methods ranging from relatively simple to complex have been 
reported (Hola et al. 2014). For practical applications and mass production, it would be ideal 
to scale up the synthesis method (Wang and Hu 2014). Therefore, it is desirable to use a 
simple synthesis method involving commercially available and environmentally friendly 
reactants (Xu et al. 2014). Among the existing methods, the microwave method has distinct 
advantages for its shorter reaction times, milder reaction conditions, lower energy 
consumption, better stability, reproducibility, and higher product efficiency (Zhu et al. 2009, 
Hu et al. 2013). We have successfully used a domestic microwave oven to synthesize nitrogen 
doped CQDs (nCQDs) (Zhai et al. 2012, Hu et al. 2013, Xu et al. 2014). The reaction took 
less than two minutes using citric acid and aliphatic diamines in water as raw materials. This 
synthetic strategy is facile, fast, convenient, economical, and environmentally friendly. 
For CQDs to be used as bioimaging agents, fluorescence emission above 600 nm is desired 
(Hola et al. 2014, Ostadhossein and Pan 2017). In this study, we optimized a simple yet facile 
method of synthesizing CQDs to achieve highly efficient red emissive nCQDs. We 
synthesized nCQDs by microwave-assisted pyrolysis of citric acid and aliphatic diamines. 
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Time of pyrolysis, the molar ratio of acid to amine, and the concentration of reactants were 
optimized to yield high fluorescence, specifically above 600 nm. Moreover, we coated 
nCQDs with hyaluronic acid (HA) to demonstrate receptor-targeted delivery applications. In 
particular, the cells which express CD44 receptors, that are specific for hyaluronan, showed 
increased uptake efficiency of HA-coated nCQDs. Finally, the nCQDs were exposed to 
porcine eye globes and fresh post-mortem mice, respectively. The results showed that the 
highly efficient red emissive nCQDs could be potentially employed as bioimaging agents and 
can be functionalized to target cells which express CD44 receptors. 
5.2 Methods 
5.2.1 Materials 
All chemicals were used as received. Sodium hyaluronate (HA) (MW = 200 kDa, cat# HA-
200K-1) was purchased from Lifecore Biomedical. N-hydroxysuccinimide (98%, cat# 
130672), N-(3-dimethylaminopropyl)-N’-ethyl-carbodiimide hydrochloride (98%, cat# 
E1769), and ethylenediamine (99%, cat# E26266) were purchased from Sigma-Aldrich. Citric 
acid was purchased from J.T. Baker Chemical Co. Dulbecco’s modified Eagles’s 
medium/nutrient mixture F-12 Ham (DMEM/F12), trypsin-ethylenediaminetetraacetic acid 
(EDTA) solution 10x, and fetal calf serum (FCS), TritonTM X-100, phosphate buffer saline 
(PBS) were obtained from Sigma-Aldrich (St. Louis, MO). SlowFade® Gold Antifade 
Mountant with DAPI (cat# S36938) was purchased from Thermo Fisher Scientific (St. Peters, 
MO). ARPE-19 (Retinal pigment epithelial) (ATCC® CRL¬ 2302™), Lens epithelial cells 
(ATCC® CRL¬ 11421TM), and CHO (CCL¬ 61™) cells were purchased from American Type 
Culture Collection (Manassas, VA). ApoTox-Glo™ (cat# G6320) and ROS GloTM H2O2 (cat# 
G8820) assays were purchased from Promega Corporation (Madison, WI). All the chemicals 
were used as received. 
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5.2.2 Central-composite response surface design for synthesizing nCQDs 
with desired properties 
To investigate the effect of three factors – the molar ratio of amine to acid, the microwave 
time, and the concentration of the reactants – a Central-Composite Design Response Surface 
Methodology (CCD-RSM) design was utilized (Stat-Ease, Design-Expert® software, version 
9.0). Each factor was varied at five levels: amine/COOH = 0.30, 0.48, 0.75, 1.02, and 1.20; 
microwave time = 75s, 70s, 88s, 95s, and 100s; and concentration of citric acid=8.0%, 8.8%, 
10.0%, 11.2%, and 12.0%. There were twenty runs, as tabulated below (Table 5.1): 
Table 5.1 Experimental conditions (factors) of each synthesis of nCQDs using CCD-RSM design 
Runs CA wt% NH2/COOH Reaction Time 
1 10.0 0.75 88 
2 11.2 0.48 80 
3 10.0 0.75 100 
4 10.0 0.75 88 
5 8.8 1.02 95 
6 12.0 0.75 88 
7 8.8 0.48 80 
8 10.0 0.75 75 
9 10.0 0.75 88 
10 11.2 1.02 95 
11 10.0 0.75 88 
12 8.0 0.75 88 
13 8.8 0.48 95 
14 8.8 1.02 80 
15 10.0 0.75 88 
16 10.0 1.20 88 
17 10.0 0.30 88 
18 10.0 0.75 88 
19 11.2 0.48 95 
20 11.2 1.02 80 
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A stock 12 wt/v % solution of citric acid was made by dissolving 28.39 g of citric acid in 220 
mL of water. The desired amount (according to Table 5.1) of this stock solution was added to 
a 100-mL beaker, then DI water was added to make the volume up to 10 mL, and 
ethylenediamine was added. The mixture was shaken and heated in a microwave oven 
(General Electric, 1,100 watts) for one of the times listed in Table 5.1. The result was a solid 
was obtained, whose color varied from yellow to brown. This solid was dissolved in 3 mL of 
water and transferred to a 20 mL vial. The beaker was rinsed with another 2 mL of water, and 
the liquids were combined. The solution was dialyzed against water (Molecular weight cut-off 
(MWCO) = 500 Da). 
5.2.3 Conjugation of nCQDs with hyaluronic acid 
An aqueous solution of HA 1 w/v% was prepared by dissolving HA (0.10 g, 0.24 meq of 
COOH) in 10 mL of water. The pH of the HA solution was adjusted to 4.5. 1-Ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC: 0.45 g, 2.4 mmol), and N-hydroxysuccinimide 
(NHS: 0.14 g, 1.2 mmol) was added to the HA solution at 22 °C with stirring for 1 hour. CQD 
solution (0.10 g, 5 mL) was added to the HA solution, and the reaction mixture was 
continuously stirred for 18 hours. Thereafter, the reaction was terminated by adjusting the 
final pH to 8-9. The excess EDC, NHS, and any free CQDs were removed from the reaction 
mixture by dialysis (MWCO: 12,000-14,000) in H2O (three times). Then the solution was 
lyophilized, yielding a powder. 
5.2.4 Characterization of nCQDs and HA-CQDs   
UltraViolet-Visible (UV-Vis) absorption spectra were recorded on a Thermo Fisher Biomate 
3 UV-Vis spectrophotometer. Fluorescent spectra were measured on a SpectraMax Gemini 
EM fluorescence reader at ambient conditions. Nuclear magnetic resonance spectrum (1H 
NMR) spectra were obtained on a Varian Unity Inova 500 MHz (Palo Alto, CA) in D2O at 25 
°C. The PL emission was determined with a Varian Cary 5000 spectrophotometer.  
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5.2.5 Hydrodynamic size and zeta potential measurements with dynamic 
light scattering analysis 
A Malvern Zetasizer Nano ZS (Malvern Instruments, Westborough MA) equipped with a 
backscattering detector (173º) was used for hydrodynamic size measurements of synthesized 
carbon dots. Samples were dispersed in water, then sonicated for 15 min to homogeneously 
disperse them in the solution, after which they were filtered through a prerinsed 0.22 μm 
sterile filter, then equilibrated (typically for 5 min) at 25 °C. At least three measurements per 
sample were taken. The hydrodynamic diameter and zeta potential of nCQDs in solution 
before their exposure to cell culture medium was measured in batch mode using DLS.  
5.2.6 In-vitro cytotoxicity measurements on Retinal Pigment Epithelial 
(ARPE-19), NIH 3T3, and Chinese Hamster Ovary (CHO) cells with MTT, 
ApoTox-GloTM, and ROS-Glo™ H2O2 assays  
Cell metabolic activity, and hence the viability of cells in the presence of CQDs (0.01-0.6 
mg/ml), was assessed with 3-[4, 5 dimethyl-thiazoly-2-yl] 2-5 diphenyl tetrazolium bromide 
(MTT) assay. The relative amount of apoptotic cells and reactive oxygen species (ROS) 
generation were measured, respectively, by ApoTox-Glo™ and ROS GloTM H2O2 assays. In 
all biological and imaging tests, the cells without NP exposure served as a negative control.  
Each test result (viability measurements, the relative amount of apoptotic cells, and ROS 
generation) was compared with the corresponding negative (untreated cells) and positive (NPs 
without the cells) control groups with Student’s t-test. P* < 0.05, the significance level, was 
statistically acceptable.  
5.2.7 In-vitro imaging of nCQDs and HA-nCQDs. 
To confirm the presence of CQDs inside cells, we investigated the distribution of CQDs at 
0.01-0.6 mg/mL, using a nanoplasmonic confocal laser scanning microscope (Leica TCS-
SP8). Three laser wavelengths (405, 532, and 635 nm) were used during confocal imaging. 
The CQD detection range was 435-700 nm.  
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ARPE-19, NIH 3T3, and CHO cells were separately seeded in CELLviewTM plates at 5 × 104 
cells/well for 24 h. After 24 h of CQD exposure, the cells were fixed and washed with PBS 
three times before imaging. All cells were fixed by immersion in 4% paraformaldehyde (PFA) 
as the cross-linking solution for 10 min at room temperature. The cells were washed three 
times with ice-cold 1x phosphate buffered saline (PBS) for 3 min each time. The fixed cells 
were incubated in ice-cold 1x PBS buffer containing 0.1% Triton (permeabilization agent) for 
10 min at room temperature, then washed three times with ice-cold 1x PBS for 5 min each 
time. The CELLviewTM plates were then incubated with blocking buffer for 30 min at room 
temperature. The cells were subsequently washed three times with ice-cold 1x PBS for 3 min 
each. To stain the nuclei, SlowFade® Gold Antifade Mountant with DAPI (diluted 1:100 in 1x 
PBS) was used. The cells were kept at 4 oC overnight. The cells were again washed three 
times with ice-cold 1x PBS for 5 min each before being transferred to the confocal 
microscope for visual analyses. The laser wavelengths were 405, 532, and 635 nm for DAPI 
(nucleus staining) and for CQDs, respectively. During confocal imaging, several different 
images were taken through different optical sections by collecting Z-stacks with a thickness of 
35 nm. Based on the thickness of the cell, the number of images with the same Z-stack 
thickness varied. A negative control sample (untreated cells) was prepared with cells in the 
absence of CQDs.   
5.2.8 Ex-vivo and post-mortem imaging of nCQDs and HA-nCQDs. 
Fresh porcine ocular globes were obtained from Trenton Processing Center, Trenton, IL. The 
excessive mass and fat tissue around the eyeballs were cleaned, and the eyeballs were placed 
in 1% antibiotic-antimycotic in1x PBS. Intravitreal injections of nCQDs were performed at a 
dose of 10 mg/ml with an injection volume of 50 µl. Ex-vivo fluorescence imaging was 
performed on the same day on Bruker Multispectral FX 470/600 for 10 sec exposure, bin 2x2, 
the field of view (FOV) 50 cm. 
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Post-mortem mice were shaved prior to nCQD injection and imaging. The nCQDs and HA-
nCQDs were injected into dead mice subcutaneously on the left shoulder and upper back, 
respectively, at a dose of 0.40 mg∕kg. Animals (n = 3) were imaged at 2 minutes post-injection 
using the Pearl Small Animal NIR fluorescence imaging system (LICOR Biosciences, 
Nebraska), λex∕em 785∕820 nm 
5.3 Results and Discussion 
5.3.1 Conjugation of hyaluronic acid with carbon quantum dots 
In the second part of the study, we conjugated CQDs with HA to enable the CQDs to target 
cells with CD44 receptors. In addition, the HA conjugation was also expected to increase the 
biocompatibility of the CQDs.(Pomper and Fisher 2014) An EDC-coupling method was used 
to form amide bonds between the carboxyl groups of HA and the amine groups of CQDs 
(Figure 5.1). Since CQDs contain both amine and carboxyl groups, amide bonds may also be 
formed between two CQDs. To minimize crosslinking between CQDs, the carboxyl-activators 
EDC and NHS were reacted with HA for one hour before adding CQDs.  
  
Figure 5.1. HA-CQD conjugation chemistry 
NH
2
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We used 1H NMR spectra of CQDs, HA, and HA-CQD conjugates (Figure 5.2) to 
demonstrate the conjugation. The peaks at 1.88 ppm and 4.3-4.4 ppm (labeled with asterisks 
in Figure 5.2A) identify the presence of HA, and the peaks at 4.05 ppm and 5.7-5.9 ppm 
(marked with triangles in the Figure 5.2B) identify CQDs. In the 1H NMR spectrum of the 
HA-CQD conjugate (Figure 5.2C), we were able to detect all the peaks corresponding to HA 
and CQD. Thus, the 1H NMR spectra showed successful conjugation of HA and CQDs.  
 
 
 
Figure 5.2. A comparison of the 1H NMR spectra of (A) HA, (B) CQDs, and (C) HA-CQD conjugate confirms 
the presence of HA and CQD peaks in the HA-CQD conjugate. 
(A) 
(B) 
(C) 
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We also compared the fluorescence spectra of CQD and HA-CQD conjugates at an excitation 
wavelength of 540 nm (Figure 5.3). The emission peaks of the HA-CQD conjugates remained 
at the same wavelength as the CQDs before conjugation, which suggested that the chemical 
conjugation did not alter the fluorescence property of the CQDs.  In addition, the PL intensity 
of the HA-conjugates was about half of that the native CQDs at the same concentration, 
which is consistent with 1:1 conjugation ratio of HA and CQD. 
 
 
Figure 5.3 PL emission spectra of CQDs with an amine to acid ratio of (A) 0.5 and (B) 2.0 and their HA-CQD 
conjugates when excited at 540 nm. 
(A) 
(B) 
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5.3.2 In-vitro imaging of nCQDs and HA-nCQDs 
To confirm the presence of nCQDs inside cells, we investigated the distribution of nCQDs 
using a nano-plasmonic confocal laser scanning microscope (LEICA TCS-SP8) (see 
Methods). Three different cell lines were used for in-vitro imaging analysis as well: Retinal 
epithelial cells, NIH 3T3 cells, and CHO cells. According to the results, nCQDs have 
demonstrated successful use of fluorescence imaging in vitro, due to their excitability at 
multiple wavelengths in the visible spectrum (Figure 5.4B). Furthermore, we showed that 
nCQDs also fluoresce when excited at 635 nm, unlike previous reports where the exact same 
synthesis method was used but the nCQDs were excitable up to an excitation wavelength of 
488 nm (Zhai et al. 2012, Hu et al. 2013). On the other hand, the HA-CQDs were also 
excitable up to 635 nm, and no signal loss was observed (Figure 5.4C). The HA conjugation 
significantly increased the intracellular concentration of nCQDs (Figure 5.4C). Therefore, it 
can be inferred that HA does not only enable CD44 receptor-targeted delivery but also 
increased the amount of nCQDs which entered the cells.  
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Figure 5.4 Confocal microscopy images of retinal pigment epithelial cells exposed to 0.6 mg/ml CQDs with and 
without HA conjugation. 
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5.3.3 Cytotoxicity evaluation of nCQDs and HA-nCQDs 
We next studied the biocompatibility of nascent and HA-coated CQDs with retinal pigment 
epithelial (ARPE-19) cells. Three different independent end-point assays were used: viability 
based on enzymatic activity in mitochondria; the percent of apoptotic cells based on caspase 
3/7, and activity ROS generation, which is proportional to luciferase activity (see Methods). 
The results indicated that nCQDs were biocompatible up to 0.5 mg/ml (Fig. 5.5A), more than 
50% of the cells did not initiate apoptotic cell death (Fig. 5.5B), and induced ROS generation 
(Fig. 5.5C). However, at 0.6 mg/ml exposure dose, the critical LD50, the lethal dose required to 
kill 50% of the cells, the level was achieved, and same cells started to show an increased 
amount of ROS generation which may trigger apoptosis (Al Sulti et al. 2015, Karakocak et al. 
2018). Also, the viability results confirmed the increase in cell death. On the other hand, once 
the particles were conjugated with HA, their biocompatibility with retinal cells significantly 
increased. HA is known to be a natural antioxidant. When the carbon dots induce ROS 
generation, the HA acts as a ROS scavenger and reduces the intracellular ROS concentration 
(Balogh et al. 2003, Rinaudo et al. 2014, Karakocak et al. 2018). This phenomenon is also 
proven by our ROS measurement results, where HA-CQDs induced significantly less amount 
of ROS (Figure 5.5C).  
 
(A) 
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Figure 5.5 Biocompatibility results of nCQDs and HA-nCQDs with ARPE-19 cells. (A) % Viability (B) ROS 
generation (C) Apoptotic cell percentage measurement results after incubation with nCQDs for 24 h at 
concentrations up to 0.6 mg/mL. Data are expressed as mean ± SD from three independent experiments (*P < 
0.05). 
5.3.4 Ex-vivo and post-mortem imaging of nCQDs and HA-nCQDs 
Ex-vivo fluorescence imaging was performed on the days indicated on Bruker Multispectral 
FX 470/600 for 10 sec exposure, bin2x2. Post intravitreal injection images of 50 µl of nCQDs 
with the highest amine/acid ratio showed that the nCQDs were excitable at 470 nm and 
emitted light at 600 nm (Figure 5.6). This behavior proves that nCQDs are good candidates 
for ocular bioimaging applications.  
(B) 
(C) 
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Figure 5.6 Ex-vivo pig eyes images of 50 µl intravitreal injections of nascent and HA-coated CQDs. Excitation: 
470 nm, Emission: 600 nm. (A) Control, no particle injection. (B) Post-injection of nascent CQDs at 2 minutes. 
(C)  Post-injection of HA-CQDs at 2 minutes. 
Next, in-vivo fluorescence imaging was performed on Pearl Imager (LiCor), excitation: 685 
nm, emission: 720 nm for post-mortem imaging analysis of nCQDs, a local administration 
way (subcutaneous injection) was adopted, which is expected to avoid nCQDs entering into 
the bloodstream. For especially small animal imaging applications, imaging agents which are 
excitable at near-infrared region are desirable due to the possible interactions of the short-
wavelength light with tissue and capability of the light diffusing through multiple tissues. 100 
µl of nCQDs with the highest amine/acid ratio were injected subcutaneously into CD-ICR 
Nascent 
nCQDs 
(A) 
(B) 
(C) 
HA-nCQDs 
Nascent 
nCQDs 
  
112 
 
mice. It was observed that a fluorescence area was formed around the injection site (Figure 
5.7). The images proved that both unconjugated and HA-conjugated nCQDs were excitable at 
685 nm and gave an emission signal at 720 nm. Thus both nCQDs and HA-nCQDs can be 
used for whole animal imaging applications.  
           
Figure 5.7 Post-mortem mouse images of 100 µl subcutaneous injections of nascent and HA-coated CQDs. 
Excitation: 685 nm, Emission: 720 nm. (A) Control, no particle injection. (B) Post-injection of nascent CQDs at 
2 minutes. (C)  Post-injection of HA-CQDs at 2 minutes. 
5.4 Conclusions 
We optimized a very simple yet facile method of synthesizing nCQDs to obtain red emissive 
carbon dots using CCD-RSM. Further, we conjugated nCQDs with HA to target cancer cells 
and cells which overexpress CD44 receptors. Confocal images proved that the nCQDs could 
enter the cells, including cancer cells, and the HA conjugation enhanced the intracellular 
concentration significantly. Nascent nCQDs had fair compatibility up to 0.6 mg/ml; however, 
once they were conjugated with HA, they showed even better biocompatibility with the tested 
cells. Ex-vivo pig eye images showed that HA-nCQDs could effectively diffuse through 
injection 
site 
injection 
site 
(C) (B) (A) 
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vitreous and post-mortem whole-body mouse images also proved that the HA-nCQDs are 
suitable for bioimaging applications. The results imply the suitable application of HA-nCQDs 
in nanomedicine both for targeted drug delivery and imaging applications4.5  
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Abstract 
Rapid progress in nanotechnology has led to its implementation for in-vivo diagnosis and 
therapy. As an example, recent studies have shown that gold nanoparticles (Au NPs) can be 
used as both delivery and imaging agents. Carbon dots (CDs) also hold promise as potential 
imaging agents because they have much higher quantum yields than Au NPs. When 
nanoparticles are administered in-vivo, the systemic circulation distributes them to all body 
organs and to the targeted tissue. Precise characterization of nanoparticles’ distribution and 
accumulation in different body parts in preclinical models has been investigated; however, the 
eye remains an unexplored exception. For nanoparticles to be considered successful 
bioimaging and drug delivery agents in ophthalmology, an adequate dose must reach the 
target tissue. Coating nanoparticles with hyaluronic acid (HA), a biocompatible CD44 
receptor-ligand increases the delivered dose in the eye. In this work, HA was conjugated to 
both 20 nm Au NPs and to 5 nm carbon dots to enhance their delivered dose. This study tested 
intravitreal and intravenous injections of both nascent and HA-coated Au NPs (HA-S-Au 
NPs) and quantified their distribution in the retina and cornea. Next, nitrogen doped CDs 
(nCDs) were tested as imaging agents in ex vivo eye globes and a post-mortem whole-body 
mouse model. The results showed that following intravenous injections, Au NPs and HA-
coated Au NPs reached their maximum concentrations in the retina at 20 and 25 minutes, 
respectively. Twice as many HA-Au NPs reached the retina than nascent Au NPs. After 24 
hours, 8.55% of the Au NPs were left in the retina, whereas 12.06% of the HA-Au NPs 
remained. Finally, the ex-vivo imaging of porcine ocular globes and post-mortem imaging of a 
whole mouse demonstrated the utility of nCDs. 
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6.1 Introduction 
Gold nanoparticles (Au NPs) can deliver ocular drugs to specific target sites in the eye, where 
they can also be used as imaging agents due to their unique surface plasmon resonance 
(Boisselier and Astruc 2009, Jeong Hun et al. 2009, Yanai et al. 2012, Pan et al. 2013, Su et 
al. 2013, Zhou et al. 2013). Since Au NPs can be exploited as both imaging and drug delivery 
agents, they hold promise to revolutionize the detection and treatment of many eye diseases. 
With their capability to target a specific ocular region, Au NPs can more readily deliver the 
desired therapeutic dose (Bakri et al. 2008, Choonara et al. 2010, Christoforidis et al. 2012, 
Gabriele Sandrian et al. 2012, Gan et al. 2013, Ferenchak et al. 2014). Numerous recent 
studies have suggested that ocular medicine will benefit enormously from the use of 
nanoparticles, and gold nanoparticles are one of the most promising agents (Bakri et al. 2008, 
Hayashi et al. 2009, Jeong Hun et al. 2009, Jin Hyoung et al. 2011, Williams and Klebe 2012, 
Skala et al. 2013, Cho et al. 2015).  
Carbon dots (CDs), which measure less than 5 nm in diameter, are also the subject of several 
recent studies in bioimaging (Liu et al. 2017, Lin et al. 2018, Liu et al. 2018). As of May 
2018, well-known chemical suppliers can provide commercially available but expensive 
blue/green emissive CDs (Aldrich 2018). Despite their expense ($3/mg), these CDs are 
particularly interesting for their wavelength-dependent excitation/emission behavior (Gan et 
al. 2016), long fluorescence lifetime (Dong et al. 2015), good photostability (Miao et al. 
2017), and relatively high biocompatibility (Zhang et al. 2015) as discussed in previous 
chapters. With this unique combination of properties, CDs have demonstrated promise for 
bioimaging applications, where high quantum yield and red/near-infrared excitability are key 
properties. In this dissertation, we have optimized a facile method of synthesizing red-
emissive CDs. We have demonstrated their usefulness both in their nascent form (Chapter 4) 
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and HA-conjugated form (Chapter 5) for in-vitro imaging. However, it is also vital to 
demonstrate their usefulness in animal models as a prerequisite to clinical trials.  
Intravitreal injections are one of the most common methods to treat retinal diseases. 
Additionally, intravenous injections would be advantageous in ophthalmology if the NPs were 
designed to cross the blood-retinal barrier (BRB). It is worth noting that the BRB and the 
blood-brain barrier (BBB) have similar natures due to the similarity of their structure (Runkle 
and Antonetti 2011). Both barriers consist of an inner and outer barrier, which makes 
diffusion highly selective, due to the presence of tight junctions between the cells (London et 
al. 2013). However, if nanoparticles can cross the BRB, there is a high possibility of 
delivering a drug or gene to the brain as well.  
Intravenous injections are advantageous over intravitreal injections due to their reproducible 
results, ease of their application, and ready patient compliance (Bourges et al. 2003, Diebold 
and Calonge 2010, Cho et al. 2015). The entire administered dose reaches the systemic 
circulation immediately, and the delivered dose can be accurately calibrated against the 
response of the target organ.  
There have been several attempts to coat NPs with different conjugates to increase their 
delivered dose to the target organ/tissue. Many coating conjugates, ranging from synthetic 
ligands to natural biomolecules, have been used to improve the stability of particles and the 
efficiency of their delivery to specific cells or tissues (Manson et al. 2011, Lowe et al. 2015, 
Yilmaz et al. 2016, Lin et al. 2017). As discussed in Chapter 3, we chose hyaluronic acid 
(HA) as a coating material because it can prevent adsorption of proteins on the surfaces of 
biomaterials (Hans and Lowman 2002) and has an antifouling effect that arises from its 
hydrophilic and polyanionic characteristics (Lee et al. 2008, Santhanam et al. 2015). HA also 
scavenges free radicals and chelates pro-oxidant metals (Glucksam-Galnoy et al. 2012). It 
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exhibits many desirable physiological properties: For example, it can be either anti-
inflammatory or pro-inflammatory, depending on its molecular weight. On the other hand, as 
demonstrated in Chapter 3, HA coating can increase the intracellular concentration of NPs 
because specific cell membrane receptors, specific to HA, will recognize the HA coating and 
facilitate endocytosis.  
The main reason why intravenous injections are not preferred over other administration 
techniques is that the therapeutic agent has to cross at least two barriers (the BRB and BBB), 
which are very selective and do not allow the passage of large molecules. Thus, an effective 
concentration in the target organs (specifically the eye and the brain) is achievable. 
Intravenously injected nanoparticles must escape elimination through the reticuloendothelial 
system to maintain a prolonged effective concentration. In addition, for the delivery agent to 
reach the target tissues/cells in the brain and the retina, the agent should overcome both 
barriers. The BBB and inner BRB are composed of endothelial cells lining the brain and 
retinal vasculatures as illustrated in Figure 6.1 (Petros and DeSimone 2010, Jo et al. 2015). 
The inner BRB is a dynamic structure consisting of retinal endothelial cells, pericytes, and 
astrocytes, and the outer BRB consists of tight junctions between retinal pigment epithelium 
(RPE) cells (Kim et al. 2006, Runkle and Antonetti 2011). Similarly, the BBB consists of the 
same structures except for the presence of the basal lamina, which can be considered as an 
additional membrane inside the BBB. In addition to the fact that the BRB is critical in 
physiological and pathological processes in the retina, the structure of the BRB is the limiting 
factor in targeted drug and gene delivery applications when the target organ is the eye.  
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Figure 6.1 Structure of Blood Retina Barrier (BRB) and Blood Brain Barrier (BBB) (Adapted from (London et 
al. 2013)).  
Nanoparticles administered into the body are eventually cleared by organs in the mononuclear 
phagocyte system which contains phagocytic cells in reticular connective tissue, such as the 
liver and spleen. Nanoparticles remain in these organs for a long time after being taken up by 
the macrophages, which increases the likelihood of unintended acute or chronic toxicity. 
However, very few studies (Jeong Hun et al. 2009, Hirn et al. 2011) showed accumulation of 
Au NPs in the eye, despite the bio-distribution of gold nanoparticles being well studied 
(Sonavane et al. 2008, Terentyuk et al. 2009, Johnston et al. 2010, Khlebtsov and Dykman 
2011). Figure 6.2 illustrates the detailed structure of the blood-retinal barrier, with the 
absolute thicknesses of each section. The NP has to travel at least 11 µm to reach the rods and 
cones.  
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Figure 6.2 Detailed structure of the Blood Retina Barrier (BRB) and thicknesses of each section. The NP has to 
travel at least 11 µm while passing at least two layers of cells with tight junctions having an opening of 60 nm.  
So far, one study has reported that Au NPs can cross the BRB, depending on their size (Jeong 
Hun et al. 2009). The authors reported that intravenously administered 20 nm spherical Au 
NPs with an exposure concentration of 1g/kg could pass through the blood-retina barrier and 
did not cause ocular toxicity. However, only TEM images of the retina were presented, and 
quantification was presented from only one representative TEM image. The fate, location, and 
concentration of the Au NPs which crossed the blood-retina barrier are unknown, and just one 
bioassay was performed (TUNEL), in which the apoptotic cell death count was found to be 
only eight cells, seven days following the intravenous injection.  
It is clear that there is an urgent need for a comprehensive study reporting the quantification 
data on ocular locations of intravenously and intravitreally injected Au NPs. Further, for 
targeted drug and gene delivery applications, not only the fate of the NPs following 
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intravenous injection, but also the accumulated dose after a period of time (i.e., a minimum of 
24 hours post-injection) must be reported before suggesting Au NPs as potentially safe agents.  
In this Chapter, we aim to demonstrate that both nascent and HA-S-Au NPs cross the BRB 
while reporting the location and the accumulated amounts of Au NPs in different sections of 
the eye (cornea and retina). 
The final part of this chapter describes a demonstration of the potential usefulness of red-
emissive nCDs as bioimaging agents. The nCDs developed in Chapter 4 were injected 
intravitreally into ex-vivo porcine ocular globes and subcutaneously in euthanized mice, 
where they were readily detected. 
6.2 Materials and Methods 
6.2.1 Animals 
The mouse eye has a long-established history in ophthalmology, specifically in retinal 
research, and is an appropriate model for our short-term study. We utilized C57BL/6 male 
mice from Jackson Laboratory (Bar Harbor, ME, USA) 6-8 weeks old, with a weight of 20-25 
grams.  
Care, use, and treatment of all animals in this study were in strict agreement with the 
Association for Research in Vision and Ophthalmology (ARVO) statement for the Use of 
Animals in Ophthalmic and Vision Research. An animal protocol (20170241) was established 
accordingly and approved by the Washington University in St. Louis Institutional Animal 
Care and Use Committee in November of 2017.  
There were two main in-vivo studies. The first study demonstrated intravenous injections of 
both gold nanoparticles and carbon dots, and the second study consisted of intravitreal 
injections of the same nanoparticles.  
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6.2.2 Mimicking the blood-retinal barrier: Cell inserts 
Prior to the intravenous injections, a preliminary study was conducted to test the ability of Au 
NPs to cross the tight junctions between the retinal pigment epithelial cells. Transwell® 
permeable supports with 6.5 mm inserts were used. There are two chambers (bottom and top) 
present in one Transwell®, and they are separated by a Coster 3450-polyester membrane, 
which has pore openings of 0.4μm in diameter. The retinal pigment epithelial cells (ARPE-
19) are plated on these membranes at a concentration of 20,000 cells per transwell where the 
upper chamber volume is 200 μL, and the bottom chamber volume is 1000 μL. 
In our previous cell attachment study (Chapter 4), the electrical impedance (ECIS) 
measurements showed that the time required for the ARPE-19 cells to reach over 90% 
confluency is approximately 24 hours. To reach a nice monolayer of cells ensuring the 
formation of tight junctions between them, the cells were grown inside the transwells for 72 
hours, prior to the Au NP addition. We chose Au NPs with a diameter of 20 nm to observe 
NPs’ ability to cross the tight junctions. After 72 hours, aliquots were collected from the 
bottom plate for inductively coupled plasma mass spectrometry (ICP-MS) analysis. The 
presence of Au NPs in the bottom chamber will serve as the evidence that the Au NPs are able 
to pass through the ARPE-19 cells’ tight junctions. Cells attached to the transwell membrane 
will be fixed and examined with 3-D confocal microscopy to quantify the Au NP 
concentration within a cell.  
6.2.3 Intravitreal and intravenous injections of Au NPs and CDs 
The mice were anesthetized with Avertin (250 mg/kg), followed by intravenous and 
intravitreal injections of Au NPs or CDs. Au NPs with a diameter of approximately 20 nm 
were used either in end-thiolated hyaluronate coated (HS-HA) form or uncoated. The carbon 
dots (HA-conjugated and conjugated) were smaller than 5 nm. Information regarding 
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conjugation and a detailed physicochemical characterization was provided in Chapters 3 and 4 
for Au NPs and CDs, respectively. 
Intravitreal injections of Au NPs and CDs 
C57BL/6 male mice were obtained from Jackson Laboratory (Bar Harbor, ME, USA). The 
eye was proposed using forceps, and an incision was made at the limbus by inserting and 
withdrawing a 30-gauge needle. A second 30-gauge hypodermic needle fitted on a Hamilton 
700 series microsyringe (Hamilton, Reno, NV) was then inserted into the incision site to 
administer a 2 μl intravitreal injection of Au NPs (0.05 mg/ml). The procedure was performed 
under a surgical microscope on both eyes of each animal. Phosphate-buffered saline (PBS) 
was used for sham injections. 
Fresh porcine ocular globes were obtained from Trenton Processing Center, Trenton, IL. The 
excessive muscle and fat tissue around the eyes were excised, and the globes were placed in 
1% antibiotic-antimycotic in 1x PBS. Intravitreal injections of nCDs were performed at a dose 
of 5 mg/ml with an injection volume of 50 µL. The ocular globes (n=3) were imaged at the 6th 
and 30th minutes using the Multispectral FX Pro Imager (Bruker Biospin, Woodbridge, CT), λ 
ex∕em: 650 ∕ 700 nm. The contrast based on the signal of nCDs was quantified and compared 
among ocular globes with and without the injection of nCDs with NIH ImageJ software 
(National Institutes of Health, Bethesda, MD). 
Post-mortem imaging of nCDs 
The nCDs were injected subcutaneously on the dorsal side of fresh mice cadaver (n = 3) for 
small-animal whole-body imaging. Deceased mice were shaved prior to nCD injection and 
imaging. Injections of nCDs in water (100 µL solution per injection) were administered 
subcutaneously on left shoulder and right hip, at a dose of 33 µg/g. Animals were imaged at 
10 minutes post-injection using the Multispectral FX Pro Imager (Bruker Biospin, 
  
126 
 
Woodbridge, CT), λ ex∕em: 550-600 nm ∕ 600-750 nm. The contrast based on the signal of 
nCDs was quantified and compared versus the negative control with NIH ImageJ software 
(National Institutes of Health, Bethesda, MD).  
Intravenous injections of Au NPs to in-vivo mouse 
Both nascent and HA-coated Au NPs at a concentration of 0.05 mg/ml were injected 
intravenously through the lateral saphenous vein of C57BL/6 mice. The injected nanoparticles 
were allowed to circulate for up to a maximum of 24 hours to ensure crossing the blood-
retinal barrier. The mice were sacrificed at 5, 10, 15, 20, 25, 30, 60 minutes and finally at 24 
hours post-injection. Next, eyes were harvested for ex-vivo imaging following cervical 
dislocation of the animal. The enucleated eyes were transferred into 4% paraformaldehyde 
(PFA) in 1x PBS as the cross-linking solution overnight. The eyes were then embedded in 
paraffin and sectioned at a thickness of 4 µm.  
Histology staining and imaging of eye tissue sections with coated and uncoated Au NPs  
The 4 µm tissue sections were stained with Mayer’s hematoxylin and eosin Y (H&E; Richard-
Allan Scientific, Kalamazoo, MI). Bright-field imaging was performed using a research light 
microscope (Olympus BX51, Lombard, IL) equipped with a color camera (D5-Fi1, Nikon) 
and a 10/0.30 Plan Fluor objective lens (Nikon). 
Confocal microscopy imaging of eye tissue sections with coated and uncoated Au NPs  
The 4 µm tissue sections were incubated in ice-cold 1x PBS buffer containing 0.1% Triton 
(permeabilization agent) for 10 min at room temperature, then washed three times with ice-
cold 1X PBS for 5 min each time. The tissue sections were then incubated with blocking 
buffer for 30 min before the addition of Alexa Fluor® 633 phalloidin (diluted 1:200 in 
blocking buffer) to stain the tight junction proteins, cadherin. The cells were subsequently 
washed three times with ice-cold 1X PBS for 3 min each time. To stain the nuclei, 
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SlowFade® Gold Antifade Mountant with DAPI (diluted 1:100 in 1X PBS) was used. The 
slides containing tissue sections were incubated overnight at 4 oC.  
Electroretinogram analysis 
ERG was performed as previously described (Ban et al. 2017) using the UTAS-E3000 Visual 
Electrodiagnostic System running EM for Windows (LKC Technologies, Gaithersburg, MD, 
USA). In brief, we extracted quantitative measurements from the ERG waveforms using an 
existing Microsoft Excel macro that defines the a-wave amplitude as the difference between 
the average pre-trial baseline and the trough of the average trace and defines the b-wave 
amplitude as the difference between the trough to the peak, without subtracting oscillatory 
potentials. Statistical analyses were performed using the paired t-test to analyze variance and 
pattern electroretinographic variables. A P-value of 0.05 was considered statistically 
significant. Results were expressed as mean (SD). 
6.3 Results and Discussion 
6.3.1 Demonstration of 20 nm Au NPs crossing the tight junctions of retinal 
pigment epithelial (RPE) in-vitro 
We successfully demonstrated that 20 nm Au NPs were able to cross the tight junctions 
formed between the ARPE-19 cells. According to the results obtained (Figure 6.3), by the end 
of 24 hours, 70.3% of the Au NPs accumulated inside the cells. 7.2% of the Au NPs could 
cross the cell insert membrane and the tight junctions between the ARPE-19 cells. 22.4% of 
the NPs could not enter the cells and could not pass the membrane.  
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Figure 6.3 ICP-MS quantification results for the Au NPs that could cross both the tight junctions formed in 
between the RPE cells and the insert membrane. The amount that is detected in the bottom chamber of the inserts 
is denoted as % of NPs that can cross the BRB, as this in-vitro experimental design is a widely expected in-vitro 
model as proof of concept for the NPs crossing the BRB. 
A B 
C 
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6.3.2 Distribution of intravitreally injected HA-coated and uncoated Au 
NPs in the cornea 
Figure 6.4 displays optical images with H&E staining of a typical mouse eye section. All the 
sections of both the cornea and retina are labeled in Figures 6.4.A and 6.4.B, respectively.  
            
 
 
 
 
 
 
Figure 6.4 H&E stained optical microscopy images of the eye. (A) The whole cross-section. (B) 40X 
magnification of the front of the eye, where the cornea is present. (C) 40X magnification of the back of the eye, 
where the retina is located. The parts of the cornea and retina are labeled.  
Figure 6.5 displays an optical image of a paraffined section of an eye after an intravitreal 
injection of 2 µl Au NPs. As can be seen, there is retinal detachment, which can be due to the 
invasive nature of the intravitreal injection. The eye globe is small (3.4±0.2 mm in equatorial 
diameter, and 22±5 µl in volume) (Wisard et al. 2010) and the injection needle was a 
relatively large microsyringe.  
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Figure 6.5 Optical microscopy images of a paraffined section of an 8-week old C57BL/6 mouse eye. The main 
eye sections ‒ cornea, lens, retina, along with RPE cells are labeled. Following the intravitreal injection of Au 
NPs, the retina was detached.  
Next, the distributions of uncoated Au NPs and HA-S-Au NPs in the eye are displayed 
(Figure 6.6). Confocal microscopy detected the Au NPs because they are inherently 
fluorescent, and they absorb light in 480-600 nm region (Boisselier and Astruc 2009, Zhou et 
al. 2013, Linlin et al. 2015), depending on their size. 
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Figure 6.6 Confocal microscopy images of the cornea of an 8-week-old C57BL/6 mouse 24 hours post-injection 
of (A) nascent Au NPs, (B) HA-S-Au NPs. The nucleus is stained with DAPI and blue in color, and Au NPs are 
green. There are more HA-coated Au NPs detected in all sections of the cornea. (C) ImageJ analysis quantified 
the amounts of Au NPs in each section.  
DAPI Au NPs Merged (A) 
(B) DAPI HA-S-Au NPs Merged 
(C) 
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ImageJ analysis revealed that the HA coating consistently enabled significantly more Au NPs 
to enter the cornea (Figure 6.6C). In the stroma, approximately 850% more Au NPs were 
detected when they are coated with HA (0.019% vs. 0.18% of the NPs injected into the mouse 
eyes). Moreover, 360% more HA-coated Au NPs were detected in the corneal endothelium 
cells (0.039 vs. 0.18%), and finally, 700% (0.047 vs. 0.38%) more HA-Au NPs were detected 
in the corneal epithelial cells, where the maximum amount of NPs was detected. This 
consistent difference can be attributed to enhanced endocytosis of HA-coated Au NPs, 
because HA is recognized by the CD44 receptors expressed on the corneal epithelial cell 
membranes (Contreras-Ruiz et al. 2011, Karakocak et al. 2018). The distribution of Au NPs 
was not analyzed, because the retinal detachment would render results inaccurate.  
6.3.3 Distribution of intravenously injected uncoated and HA-coated Au 
NPs in the eye 
Several series of confocal images were taken for mouse tissue sections. As explained in the 
statistical analysis section, at least three replicas were used for each time point of sacrifice. 
There were eight time points (5, 10, 15, 20, 25, 30, and 60 minutes, and 24 hours), and both 
HA-coated and uncoated Au NPs were injected intravenously (30-50 µl, depending on the 
weight of the mouse). Sham injections were done with 1X PBS.  
Distribution analysis of Au NPs in the cornea 
Figure 6.7 displays confocal images of Au NPs post injection for all the time points tested. 
The signal from the second channel, where only the Au NPs can be detected (488 nm 
excitation λ, 500-550 nm emission λ) was the highest at the 15th minute.  
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Figure 6.7 The red staining corresponds to cadherin, a tight junction protein; the nucleus is stained with DAPI 
and blue, and Au NPs are green. The fourth image in each time point is a merged version of the previous three 
images. The amount of Au NPs that reached the cornea peaked at 15 minutes post injection, as can be seen. Scale 
bars are 50 µm. 
Next, the amount of Au NPs in each part of the cornea was quantified using ImageJ analysis, 
with the results shown in Figure 6.8. The NPs were most internalized by the endothelial cells, 
reaching a peak concentration at minute 15 post-injection. On the other hand, the least amount 
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of NPs was detected in the stroma, followed by the corneal epithelial cells. The corneal 
stroma, the nutrition source of the cornea, is composed of collagen fibril assemblies and 
maintains the corneal transparency where growth factors and cytokines are produced (Mohan 
et al. 2012, Williams and Klebe 2012, Zhang et al. 2017). The extracellular matrix is also 
mainly composed of collagen (Zhang et al. 2017). Unlike the corneal epithelium and corneal 
endothelium, the cell number concentration is relatively less in the stroma. Hence it can act as 
a void space where the transport of NPs is diffusion driven, is mainly by a concentration 
gradient. As a result, NPs may tend to move faster in the stroma than in the epithelium and 
endothelium. Thus, their residence time in the stroma will be much shorter than in the other 
parts of the cornea, which can explain the relatively less accumulation observed in the stroma.  
  
 
Figure 6.8 Au NP quantification results in the cornea. (A) The amount of Au NPs accumulated in each main 
section of the cornea: endothelium, stroma, and epithelium. (B) The results plotted as a function of time. (C) The 
cumulative amount of NPs found in the cornea as a function of time. It took more than 5 minutes, and less than 
10 minutes for NPs to reach the cornea. The delivered amount of NPs reaching the cornea peaks at minute 15. 
After minute 25, the amount remaining in the cornea significantly decreases. By the end of 24 hours, only 3.74% 
of the peak Au NP concentration remains in the cornea.  
(A) (B) 
(C) 
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Distribution analysis of HA-S-Au NPs in the cornea 
Figure 6.9 displays confocal images of HA-S-Au NPs post injection for all the time points 
tested. At 60 minutes post-injection, the signal from the second channel, where only the Au 
NPs can be detected (excitation λ: 488 nm, emission λ: 500-550 nm) was the highest. This 
finding means that HA coating slows down the NP transport significantly.  
   
   
   
DAPI DAPI 
DAPI DAPI 
DAPI DAPI 
Au NPs Au NPs 
Au NPs Au NPs 
Au NPs Au NPs 
Cadherin Cadherin 
Cadherin Cadherin 
Cadherin Cadherin 
25 minutes 30 minutes 
15 minutes 20 minutes 
10 minutes 5 minutes 
Merged Merged 
Merged Merged 
Merged Merged 
  
136 
 
   
Figure 6.9 The red staining corresponds to cadherin, a tight junction protein, the nucleus is stained with DAPI 
and blue; and Au NPs are green. The fourth image in each time point is the merged version of all three previous 
images. The intensity of the signal coming from the second channel is proportional to the amount Au NPs 
present. The amount of Au NPs that reached the cornea peaked at 60 minutes post injection, as it can be clearly 
seen. Scale bars are 50 µm. 
Next, the amount of HA-S-Au NPs in each part of the cornea was quantified using ImageJ 
analysis. Figures 6.10 summarizes the quantification analysis results. The HA-coated Au NPs 
were most internalized by the epithelial cells, unlike the nascent Au NPs, reaching a peak 
concentration at minute 60 post-injection. This behavior can be attributed to HA-CD44 
receptor interactions on the corneal epithelial cell membrane. This result is in accordance with 
our findings in Chapter 3, where we showed that CD44 receptors significantly increased the 
intracellular concentration of HA-Au NPs for cells that express CD44 receptors on their cell 
membrane. As before, the least amount of NPs was detected in the stroma, which can again be 
explained by the rate of the diffusion concentration gradient driven transport of NPs. Overall, 
the total amount of HA-S-Au NPs was approximately 14% more than the total uncoated Au 
NPs reaching the cornea. By the end of 24 hours, 17.10% of the peak Au NPs concentration 
remained in the cornea. These results prove that HA facilitated Au NP transport and was able 
to carry the Au NPs through the tight junctions more efficiently. 
DAPI DAPI Au NPs Au NPs 
Cadherin Cadherin 
60 minutes 24 hours 
Merged Merged 
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Figure 6.10 HA-S-Au NP quantification results in the cornea. (A) The amounts of Au NPs accumulated in each 
section of the cornea: endothelium, stroma, and epithelium. (B) The precise amounts in each section of the 
cornea are plotted as a function of time. (C) The cumulative amount of NPs found in the cornea as a function of 
time. It took the first NPs less than 5 minutes to reach the cornea. The amount of HA-S-Au NPs reaching the 
cornea peaks at minute 60. After minute 60, the amount left in the cornea significantly decreases. By the end of 
24 hours, 17.10 % of the peak HA-S-Au NP concentration remains in the cornea.  
 
Distribution analysis of Au NPs in the retina 
Figure 6.11 displays confocal images of Au NPs post injection for all the time points tested. 
25 minutes post injection, it was observed that the signal from the second channel, where only 
the Au NPs can be detected (488 nm excitation λ, 500-550 nm emission λ) was the highest, 
similar to the time point where the amount Au NPs accumulated in the cornea peaked.  
10 minutes 
(C) 
(A) (B) 
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Figure. 6.11 The red staining corresponds to cadherin, a tight junction protein, the nucleus is stained with DAPI 
and blue; and Au NPs are green. The fourth image in each time point is the merged version of all three previous 
images. The intensity of the signal coming from the second channel is proportional to the amount of Au NPs 
present. The amount of Au NPs that reached the retina was peaked at 20 minutes post injection, as it can be 
clearly distinguished from the images. Scale bars are 50 µm. 
Figures 6.12 summarizes the quantification analysis results of Au NPs accumulated in the 
retina. According to the results obtained, the NPs were internalized the most in the outer 
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retina where outer nuclear layer and outer plexiform layer are the regions of interest, reaching 
to a peak concentration at minute 20, post-injection. On the other hand, it was found that the 
least amount of NPs was detected in retinal epithelial cells, followed by inner retina where 
inner ocular layer, inner plexiform layer, and ganglion cells are present. This finding can be 
explained by the following behavior: As a result of the intravenous injections, the only way 
the NPs to enter the eye is via the blood flow and the first port of their entry is the choroid. As 
illustrated in Figure 6.2, the RPE is the second set of cells with tight junctions that NPs need 
to pass. As there is no flow present in the rest of the eye apart from the choroid, the NP 
transport is diffusion driven, where the concentration gradient is the main driving force. 
Therefore, the amount of NPs is expected to be less in RPE as they are prone to diffuse 
through the deep layers of the retina where the concentration is less.  
  
 
Figure 6.12 Au NP quantification results in the retina. (A) The amount of Au NPs accumulated in each main 
section of the retina: retinal epithelium, the outer retina, and the inner retina. The outer retina consists of the 
outer plexiform layer and outer nuclear layer, whereas the inner retina is composed of the inner plexiform layer, 
inner nuclear layer and the extension of the ganglion cells. (B) The results are plotted as a function of time for 
each central section of the retina. (C) The cumulative amount of NPs found in the retina as a function of time. 
(A) (B) 
(C) 
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The amount of Au NPs reaching the cornea peaks at minute 20. After the end of one hour, the amount remaining 
in the retina significantly decreases. By the end of 24 hours, 8.55% of the peak Au NP concentration remains in 
the retina. 
Distribution analysis of HA-S-Au NPs in the retina 
Figure 6.13 displays the confocal images of HA-S-Au NPs in the retina post injection for all 
the time points tested. 25 minutes post injection, it was observed that the signal from the 
second channel, where only the Au NPs can be detected (excitation λ: 488 nm, emission λ: 
500-550 nm) was the highest. Unlike the results for the cornea, the HA coating did not slow 
down the NP transport significantly (only by 5 minutes retardation for the NPs to reach their 
peak concentration).  
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Figure 6.13 The red staining corresponds to cadherin, a tight junction protein, the nucleus is stained with DAPI 
and blue; and Au NPs are green. The fourth image in each time point is the merged version of all three previous 
images. The intensity of the signal coming from the second channel is proportional to the NPs present. The 
amount of HA-S-Au NPs that reached the retina was peaked at 25 minutes post injection, as it can be clearly 
distinguished from the images. Scale bars are 50 µm. 
Figures 6.14 summarizes the quantification analysis results of HA-S-Au NPs accumulated in 
the retina. According to the results obtained, similar to the results of uncoated Au NPs, the 
NPs were most internalized in the outer retina where outer nuclear layer and outer plexiform 
layer are the regions of interest, reaching to a peak concentration at minute 25 post-injection. 
On the other hand, it was found that the least amount of NPs was detected in retinal epithelial 
cells, followed by inner retina where inner ocular layer, inner plexiform layer, and ganglion 
cells are present. Overall, the amount of HA-S-Au NPs that reached the retina was 
approximately twice as more than the uncoated Au NPs that reached the retina. This means 
that the HA coating can significantly enhance the amount of payload that can be delivered to 
the retina. The HA coating not only improved the delivery of Au NPs but also increased the 
amount that remained after a day by approximately 5% (8.55% vs. 12.06%).  
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Figure 6.14 HA-S-Au NP quantification results in the retina. (A) The amount of HA-S-Au NPs accumulated in 
each main section of the retina: retinal epithelium, the outer retina, and the inner retina. The outer retina consists 
of the outer plexiform layer and outer nuclear layer, whereas the inner retina is composed of the inner plexiform 
layer, inner nuclear layer and the extension of the ganglion cells. (B) The results are plotted as a function of time 
for each main section of the retina. (C) The cumulative amount of NPs found in the retina as a function of time. 
The amount reaches the retina peaks at minute 25. After 24 minutes, the amount remains in the retina 
significantly decreases. By the end of 24 hours, 12.06% of the peak Au NP concentration remains in the retina. 
Imaging of nitrogen-doped CDs in ex-vivo porcine ocular globes 
Clinically, the particles need to diffuse through the layers of the eye to reach the desired part 
within for specific ocular treatments and bioimaging (Kompella et al. 2013). On the other 
hand, systemic administration of nanoparticles as drug nanovesicles and bioimaging agents 
are also of interest due to enhanced tumor uptake (Huang and Hainfeld 2013, Wang et al. 
2013). For bioimaging applications, imaging agents, which optically active in the deep-red 
and NIR region are desirable due to their lower energy and reduced scattering interactions as 
compared to the short-wavelength light.  
(C) 
(A) (B) 
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Post intravitreal injection images of 50 µl of nCDs with the highest amine/acid ratio showed 
that the nCDs were excitable at a corresponding longer wavelength, for example, 650 nm with 
an emission at 700 nm (Figure 6.15).  
 
Figure 6.15. Ex-vivo ocular globe images obtained with a small animal imager (excitation λex = 650 nm, λem = 
700 nm). Porcine ocular globes with nCDs injections. (A) No injection of CDs, control. (B) Post-injection at 6 
minutes. (C) Post-injection at 30 minutes. 
Contrast based on the intensity density calculations conducted with ImageJ software showed 
that the normalized signal per region of interest (ROI) area was 1.63, 38.21, and 49.39 for 
Figs. 6.15A, 6.15B, and 6.15C, respectively. Also, it was observed that the nCDs diffused 
through the vitreous to cornea within half an hour (Fig. 6.15) suggesting that nCDs are 
suitable, low-toxicity (vide supra) candidates for ocular bioimaging applications. 
6.3.4 Post-mortem imaging of CDs 
The nCDs were injected subcutaneously into fresh mice cadaver (n = 3) for small-animal 
whole-body imaging. Deceased mice were shaved prior to nCD injection and imaging. 
Injections of nCDs in water (100 µL solution per injection) were administered subcutaneously 
on left shoulder and right hip, at a dose of 33 µg/g. Animals were imaged at 10 minutes post-
injection using the Multispectral FX Pro Imager (Bruker Biospin, Woodbridge, CT), λ ex∕em: 
550-600 nm ∕ 600-750 nm. The contrast based on the signal of nCDs was quantified and 
compared versus the negative control with NIH ImageJ software (National Institutes of 
Health, Bethesda, MD). 
A) B) C) 
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For post-mortem imaging analysis of the nitrogen-doped CDs (nCDs) developed in Chapter 4, 
a local administration route (subcutaneous injection) was adopted, which is expected to avoid 
nCDs entering the bloodstream. The nCDs with the highest amine/acid ratio (2.0) were 
injected subcutaneously (100 µL per injection) into post-mortem mice at two different 
locations. We observed that a fluorescence area was formed around both injection sites 
(Figure 6.16).  
                
Figure 6.16. Post-mortem images of mice with nCDs obtained with the small animal imager, Bruker spectral FX. 
(A) No injection of CDs, control. λex = 550 nm, λem = 600 nm. With nCD injections (B) After first injection, 
λex = 550 nm, λem = 600 nm. (C) After second injection, λex = 550 nm, λem = 600 nm. (D) λex = 550 nm, λem 
= 700 nm. (E) λex = 600 nm, λem = 750 nm. 
The images generated sufficient contrast to be quantified with ImageJ software based on 
intensity density calculations normalized with respect to the ROI (9.29, 35.00, 54.89, 33.33, 
and 31.02, for Figs. 6.16A, B, C, D, and E, respectively) at 550 and 600 nm excitation 
wavelengths. The images prove that the nCDs could be used for whole animal imaging 
applications.  
6.3.5 Electroretinogram analysis of intravenously injected uncoated and 
HA-coated Au NPs in the eye 
In-vivo studies are necessary to assess the ocular toxicity of nanoparticles since the response 
of the target cell/organ may be influenced by interactions between different types of cells; 
additionally, defense mechanisms might be different at the organ level. Electroretinogram 
B) C) D) E) 
Injection site 1 
Injection site 2 
A) 
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(ERG) analysis is a well-established technique that can record the electrical activity of the 
retina triggered by light and therefore is a suitable method for assessing the toxicity of the 
NPs. The ERG signal is generated mainly by voltage changes caused by radial currents (along 
the axis of photoreceptors and bipolar cells) flowing in the resistive extracellular space of the 
retina (Jaakko and Plonsey 1995). 
The first ERG signal was recorded in 1865 by Holmgren from the surface of a fish eye 
(Armington 1974). Einthoven and Jolly (Einthoven and Jolly 1908) divided the ERG response 
to the onset of light into three different waves, called a- (Penn and Hagins 1969), b- (Stockton 
and Slaughter 1989), and c- (Steinber.Rh et al. 1970) waves, that are now known to reflect 
mainly the activity of photoreceptors, bipolar cells, and pigment epithelium cells, 
respectively. The applied amplitude depends on the stimulating and physiological conditions, 
but ranges are in several hundred of a microvolt. 
We carried out ERG analysis for 8-weeks old mice both at Day 1 and Day 7 post injection of 
Au and HA-S-Au NPs (Figure 6.17). The results showed no significant difference between the 
signals among the control, nascent, and HA-S-Au NPs. This means neither Au NPs nor HA-
S-Au NPs caused toxicity at the injection doses tested.
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Figure 6.17. ERG analysis of nascent and HA-S-Au NPs: 1-day post-injection (A) scotopic a-wave (B) scotopic 
b-wave (C) phototopic b-wave and 1-week post-injection (D) scotopic a-wave (E) scotopic b-wave (F) 
phototopic b-wave. The results showed no significant difference among all the measurements obtained.  
C) 
D) E) 
F) 
A) B) 
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6.3.6 Histology staining and imaging of eye tissue sections with uncoated Au 
NPs and HA-S-Au NPs 
For concision, the results of this section are provided in Appendix V.  
6.4 Conclusions  
Intravitreal injections of Au NPs caused retinal detachment, and therefore, were not 
investigated further. The amount reaching the cornea was quantified for both coated and 
uncoated Au NPs. HA coating enabled significantly more Au NPs to enter and remain in the 
cornea. In the stroma, approximately 850% more Au NPs were detected when they are coated 
with HA (0.019% vs. 0.18% of the NPs injected to the mice). Similarly, approximately 360% 
more HA-coated Au NPs were detected in corneal endothelium cells (0.039 vs. 0.18%), and 
finally, 700% (0.047 vs. 0.38%) more HA-Au NPs were detected in the corneal epithelial 
cells. 
As a result of intravenous injections, 20 nm Au NPs not only reached the eye and crossed the 
blood-retinal barrier, but also were able to reach all the way to the cornea. By conjugating Au 
NPs with HS-HA, we were able to increase the delivered dose to the cornea and retina by 
approximately 14% and almost 100%, respectively. The amounts of uncoated and coated Au 
NPs that reached the retina peaked at 20 and 25 minutes, respectively. The amounts of 
uncoated and coated Au NPs remaining in the retina at the end of 24 hours were 8.55% and 
12.06%, respectively.  
Without and with HS-HA coating, the Au NP amounts reaching the cornea peaked at 15 
minutes and 60 minutes, respectively. For delivery to the cornea, the HA coating significantly 
retarded the time for the NPs to reach their maximum concentration; however, this effect was 
not apparent for the delivery of NPs to the retina. By the end of 24 hours, the amounts of 
nascent and HS-S-Au NPs remaining in the cornea were 3.74% and 17.10%, respectively.  
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Following intravenous injections, both the ERG analysis and histology analysis showed no 
apparent toxicity induced by either Au NPs or HA-S-Au NPs at this injection dose (0.05 
mg/ml).  
Ex vivo porcine eye images showed that intravitreally injected nCDs could effectively diffuse 
through the vitreous to the cornea, and post-mortem whole-body mouse images also 
demonstrated that the nCDs provide suitably strong signals for bioimaging applications. 
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Chapter 7: Conclusions and Suggestions for 
Future Work 
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7.1 Conclusions 
This section summarizes the major findings of this dissertation.  
7.1.1 Assessing the biocompatibility of Au NPs with retinal cells and 
providing a solution for their toxicity (Chapters 2 and 3) 
While Au NPs are widely explored in various biomedical fields, including ophthalmology, 
their toxicity to ocular cells has not been investigated. The first part of this dissertation 
(Chapter 2) assessed the in-vitro toxicity of different sizes and shapes of Au NPs with a 
retinal pigment epithelial cell line. The results showed that the toxicity is dependent on both 
the size and shape of the nanoparticles. Au nanocubes were not detected in the cells, so their 
toxicity, if any, could not be assessed. Au nanorods and nanospheres did enter the cells, 
although nanospheres larger than 50 nm could not enter. The critical observation, however, is 
that for particles small enough to enter, when the concentration is expressed as a function of 
surface area per unit volume, size has no effect on consequent toxicity. For similar surface 
area concentrations, spherical Au NPs in the range of 5-30 nm had almost the same 
biocompatibility. The observed toxicity was a result of surface interactions inside the cell, 
which are directly correlated to the surface area concentration of the NPs.  
The toxicity of Au NPs arises from ROS activity, which was shown to be correlated to the 
total available surface area (Pan et al. 2007, Jiang et al. 2008). Hyaluronic acid (HA), as 
discussed in Chapter 3, is a free radical quencher that is natural and consequently 
biocompatible (Balogh et al. 2003). We sought a way to mitigate the toxicity of Au NPs by 
coating them with end-thiolated hyaluronate (HS-HA). The homogenous coating was 
facilitated by the thiol group’s affinity to the Au surface. We successfully coated different 
sizes of Au NPs (5, 10, 20, 50, and 100 nm) with HS-HA and both verified and quantified the 
coating amount with thermal gravimetric and total organic carbon analysis. As expected, the 
HS-HA coating significantly enhanced the biocompatibility of Au NPs; unexpectedly, the 
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coating also considerably improved the internalization of larger Au NPs (50 and 100 nm), 
which in their nascent form could not enter the cell. HA acted as a Trojan horse to carry in 
larger Au NPs without triggering apoptosis and generating ROS. The outcomes of this study 
could be valuable in treating inflamed, proliferating, or cancer cells that express CD44 
receptors.  
7.1.2 Creating biocompatible red-emissive carbon dots for use in 
ophthalmology (Chapters 4 and 5) 
For the first time, we developed and optimized a facile and economical synthesis of deep red 
to near-infrared (600-700 nm) emissive nitrogen-doped CDs (nCDs) that uses simple dialysis to 
isolate the product (Chapter 4). A central-composite design response surface methodology 
(CCD-RSM) design was utilized (Stat-Ease, Design-Expert® software, version 9.0) to 
optimize the effect of three factors in the synthesis of nCDs – the molar ratio of amine to 
acid, the duration of pyrolysis (microwave exposure time), and the concentration of the 
reactants. The characterization results respectively showed that as the amine to acid ratio 
increased, both the MW and size of the nCDs increased. Based on high-resolution XPS 
analysis, the formation of C‒N bonds and the presence of pyrrolic N content appear to be 
keys to creating red-emissive nCDs. Both of these critical parameters reached a maximum at 
an amine/acid ratio of 2.0. We hypothesize that, based on the structure of citric acid, one of 
the most probable products (or moieties) contributing to deep-red-emissivity of nCDs could 
be N,N'-substituted-pyrrolo[2,3-b]pyrrole. The quantum yield of the nCDs was found to be 
15% in DI water. Next, a detailed cytotoxicity analysis found that up to 0.6 mg/ml exposure 
concentration, the nCDs induced no apparent toxicity. However, there is still motivation for 
enhancing their biocompatibility because repetitive injections may be required for high-
resolution imaging.  
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Using the HA conjugation technique for enhancing the biocompatibility and intracellular 
concentration of Au NPs, we conjugated CDs with HA by a carbodiimide coupling of the 
amines on CDs and the carboxylic acids on HAs (Chapter 5). Confocal imaging analysis 
revealed that the nCDs and their conjugates fluoresced at different wavelengths, depending 
upon the excitation wavelength without a loss in the emitted signal. Three different cell lines 
were exposed to nCDs and HA-nCDs. Confocal microscopy images showed enhanced 
internalization of HA-nCDs, which was facilitated by CD44 receptors. Although the 
intracellular concentration was increased, a biocompatibility assessment revealed that ROS 
production was reduced by a factor of two, while apoptosis initiation was decreased by more 
than an order of magnitude. HA is known to be a natural antioxidant. When carbon dots 
induce ROS generation, the HA acts as a ROS scavenger and reduces the intracellular ROS 
concentration, thus reducing the incidence of apoptosis. These observations suggest the use of 
HA as a conjugate carrier for CDs into CD44 rich cells. 
The formation of C‒N bonds and presence of pyrrolic nitrogen on the surface of the nCDs are 
critical parameters in creating red-emissive carbon dots. In the complementary work, we 
found that HA conjugation not only enhances the payload delivered to the cells but also 
significantly decreases the signs of toxicity. This work also yielded a recipe for creating 
biocompatible red-emissive CDs, ruling out the effects of pyrolysis time and citric acid 
concentration and emphasizing the amount of nitrogen.  
7.1.3 Demonstration of the usefulness of gold nanoparticles and carbon dots 
in-vivo (Chapter 6) 
Upon completing the in-vitro toxicity assessment of both nanomaterial products, we 
conducted in-vivo studies (Chapter 6). In-vivo studies are necessary to assess the ocular 
toxicity of nanoparticles, since the response of the target cell/organ may be influenced by 
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interactions between different types of cells; additionally, defense mechanisms might be 
different at the organ level.  
Prior to any in-vivo tests, a preliminary in-vitro study tested the ability of Au NPs to cross the 
tight junctions between retinal pigment epithelial cells. Transwell® permeable supports were 
used to simulate the blood-retinal barrier (BRB). The results showed that 20 nm Au 
nanospheres successfully crossed the permeable supports covered with confluent retinal 
pigment epithelial cells. Based on this finding, we used 20 nm Au nanospheres in the 
following experiments and coated them with HS-HA. We used intravitreal and intravenous 
injections to deliver Au NPs in a C57BL/6 mouse model.  
Following the intravitreal injections, histology and confocal imaging analysis revealed retinal 
detachment. Therefore, we quantified the amount of Au NPs with and without the HA coating 
only in the cornea. The HA coating revealed a almost one-fold increase in the amount of Au 
NPs detected in all three layers of the cornea: the corneal endothelium, stroma, and 
epithelium. For both nascent and coated Au NPs, no sign of toxicity was observed in the 
entire cornea. Next, we injected both nascent and coated Au NPs intravenously through the 
lateral saphenous vein of C57BL/6 mice. Using confocal imaging, we quantified the amount 
of Au NPs as a function of time in all layers of the retina and cornea. The Au NPs reached the 
eye in less than 5 minutes and achieved a maximum concentration within approximately 20 
minutes in the retina. On the other hand, the amount of HA-S-Au NPs in the retina peaked at 
25th minute. Due to the enhanced permeabilization and retention (EPT) effect of NPs, 8.55 
and 12.06% of the uncoated and HA-coated Au NPs that reached the retina remained after 24 
hours. The thicknesses of the inner and outer retina were measured and compared among the 
control animals. Although the thicknesses of the inner and outer retina were highly variable 
from animal to animal, there were no signs of toxicity for both uncoated and coated Au NPs.  
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For nitrogen-doped carbon dots (nCDs), we used the best performing nCDs with the highest 
amine to acid ratio, 2.0. The nitrogen-coated carbon dots, whose sizes are typically below 5 
nm, were injected into porcine eye globes and post-mortem C57BL/6 mice. Ex-vivo porcine 
eye images showed that 50 µL of intravitreally injected nCDs could efficiently diffuse 
through the vitreous to the cornea. Post-mortem whole-body mouse images also demonstrated 
that 100 µL of nCDs which were injected subcutaneously on the dorsal side of the mice, was 
sufficient to generate a strong signal upon excitation by Bruker spectral FX small animal 
imager built-in laser at a wavelength of 600 nm. This result proved that the nCDs created in 
this study are suitable for bioimaging applications.  
7.2 Suggestions for Future Work 
7.2.1 Selecting a disease model to demonstrate the usefulness of the Au NPs 
as targeted drug delivery agents 
Angiogenesis, the growth of new capillaries from blood vessels, and vascular maintenance 
are essential for proper organ development and functioning, particularly in the metabolically 
demanding eye, a part of the CNS. The mouse retina is a direct extension of the brain and 
serves as a useful model system for studying angiogenesis in the CNS because the mouse 
retina vascularizes after birth within a couple months.  
Neovascularization, the natural formation of new blood vessels in response to pathological 
stimuli, is a typical characteristic of vision-threatening retinal diseases. Examples include 
proliferative diabetic retinopathy (PDR) and neovascular AMD, which are the leading causes 
of blindness in the Western world (Farjo and Ma 2010, Honda et al. 2013, Kompella et al. 
2013). Other examples include retinopathy of prematurity (ROP), retinal vein obstruction 
(RVO), pathogenic myopia, uveitis, and neovascular glaucoma (Williams and Klebe 2012, 
Monika et al. 2013). In these diseases, intraretinal or choroidal neovascularization is initiated 
by ischemia, a potent trigger for the local production of angiogenic factors, which induce the 
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growth of new capillaries from an existing vessel (Folkman and Shing 1992, Carmeliet 2003, 
Usui et al. 2015). As stated in this dissertation, Au NPs are inherently anti-angiogenic, which 
makes them potential treatment agents for angiogenesis-related ocular diseases, even without 
carrying an additional drug. On the other hand, it has been shown that Au NPs can also be 
used to image blood vessels with optical tomography (OCT), because certain shapes, such as 
Au nanorods, depending on their aspect ratio, can be excited in the near-infrared region 
(Lapierre-Landry et al. 2017). Hence, it would be valuable to study how inherently anti-
angiogenic Au NPs could effectively eliminate new blood vessel formation. Specifically, Au 
nanorods with high aspect ratios, along with Au nanospheres, could be used to image the 
angiogenic progress in real-time, if they can be excited in the near-infrared region. A 
fundamental study of the inhibition mechanism, using at least two sizes and shapes of Au 
nanoparticles, could be conducted in a similar manner to that described in Chapter 6, such a 
fundamental study would be a prerequisite to a clinical trial.  
7.2.2 Controlled dose-dependent in-vivo studies 
In our in vivo work, we found that the dose delivered to the retina via intravenous injections 
was less than 5%, and thus a design to increase the delivered dose is needed. In chapter 5, the 
transport through the retinal layers was studied; however, only one injected dose was tested. 
A dose-dependent study would help to identify the critical dose for different disease models 
without causing toxicity. The levels of administered and delivered doses during the 
experiments in Chapter 5 suggest that the administered dose can be increased further, because 
both coated and uncoated Au NPs did not induce toxicity at 0.05 mg/ml. Furthermore, it was 
observed that the NPs peak in the retina at the 20th minute and then gradually decrease. By 
the end of 24 hours, the amount remained was still low (8.55% of the peak concentration in 
the retina), therefore a controlled release methodology could also be proposed to prevent 
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repetitive invasive injections. For example, engineered nanoparticles could be designed to 
maximize the delivered dose in the eye.  
7.2.3 Long-term toxicity analysis of engineered gold nanoparticles as a 
prerequisite to clinical trials 
The safety profile of Au NPs remains largely undefined. Gold, a chemically inert material, is 
generally considered biocompatible at low doses and has been used in some routine clinical 
practices, such as in treating rheumatoid arthritis, for many years (Ellman et al. 1940). Also, 
there is an ongoing clinical trial on using PEG-coated silica-gold nanoshells for near-infrared 
facilitated thermal ablation (Anselmo and Mitragotri 2016). Several studies have reported no 
significant short-term toxicity of Au NPs (1 day to 3 months) (Connor et al. 2005, Chen et al. 
2013, Axiak-Bechtel et al. 2014, You et al. 2014). On the other hand, other studies have 
reported that at the cellular level, Au NPs induce toxicity by causing actin stress (Pernodet et 
al. 2006) and initiating apoptosis (Cho et al. 2009). At the organ level, Au NPs were shown to 
cause inflammation in the liver (Sadauskas et al. 2009). To better understand the combined 
cellular responses to NP exposure, systematic long-term in-vivo studies are required. In-vitro 
studies and short-term in-vivo studies are necessary to provide data for a proof of concept. 
Subsequently, in order to take it to the next level, clinical trials, long-term in-vivo tests are 
mandatory.  
Based on their anatomical and physiological similarities with humans, domestic pigs (Sus 
scrofa) and various minipig breeds are considered important animal species in translational 
research (Gutierrez et al. 2015). For example, the Göttingen minipig (Bode et al. 2010), the 
most widely used experimental minipig breed, shares physiological similarities with humans, 
in particular with regards to the cardiovascular, urinary, integumentary, and digestive 
systems, as well as the size of the eye (3/4 scale compared to human eye) (Vezina 2018). 
These features, along with the lower mature body weight of minipigs and their earlier sexual 
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maturity compared to other nonrodent species, have led to the increasing use of minipigs as 
species in preclinical safety testing. Across various marketed drug products, safety studies 
with minipigs have shown good accordance between the effects seen in this non-clinical 
model and clinical outcomes in patients (Ganderup 2012). Future work could focus on 
developing systematic long-term (6 months and beyond) in-vivo studies using Göttingen 
minipigs to ensure the safe use of Au NPs. 
7.2.4 Synthesis of red-emissive carbon dots with ultrahigh quantum yield 
Quantum yield, the ratio of the photons absorbed to photons emitted, is an essential parameter 
in determining the usefulness of a fluorescent material. As discussed earlier, fluorescent 
carbon dots with high quantum yields have emerged as a new class of phosphors for various 
applications. Specifically, for bioimaging applications, synthesis of red-emissive, thermally 
and photocatalytically stable, biocompatible carbon dots with high quantum yield is highly 
desired. Although blue and green emissive CDs with high QYs have been obtained 
(Bourlinos et al. 2008, Zhu et al. 2009, Wang et al. 2010, Bourlinos et al. 2012, Sun et al. 
2012, Zhu et al. 2013, Hola et al. 2014, Sun et al. 2014, Xu et al. 2014, Yang et al. 2015), the 
synthesis of red emissive CDs with high QYs still stands as a significant challenge. The 
larger size of the sp2 π-conjugation domains makes them more susceptible to defect formation 
and more vulnerable to environmental perturbation. According to the literature (Sun et al. 
2012, Sun et al. 2016, Wang et al. 2017) and our own study, the intense absorption band of 
the red-CDs could be tentatively ascribed to the n → π* transition of π systems containing C‒
N/C=N or C‒O structures. However, the obtained quantum yields are relatively lower than 
the theoretical maximum, so a more in-depth study is still required to clarify this issue and 
increase the quantum yield further. Parameters that may contribute to the quantum yield have 
not been thoroughly evaluated, specially for creating red fluorescence emission. Additionally, 
concerns have been raised regarding the validity of the quantum yield measurements for red 
  
162 
 
fluorescence, especially in such a minuscule size range (3-5 nm), where the dots 
photoresponse may be very unstable.  
Reduction with NaBH4 has been introduced as one strategy to increase the QY of CDs 
(Zheng et al. 2011, Zhang et al. 2015). Reducing the carbon dots led to a decrease in the 
number of carbonyl groups but increased hydroxyl related defects, and hydroxy carbon has 
been shown to increase the quantum yield of CDs in other studies (Liu et al. 2017, Liu et al. 
2018). Zn conjugation can also potentially increase the fluorescence intensity of carbon dots, 
but the excitation wavelength is shifted towards the blue region (Miao et al. 2017). Taken 
together, a method to promote hydroxy carbon and, as we identified in this thesis, to increase 
the pyrrolic nitrogen amount on the surface of the CDs could create highly efficient red-
emissive carbon dots.  
Future work could focus on the design and evaluation of methods for creating red-emissive 
carbon dots with high quantum yield. Zn involvement, the use of different nitrogen sources to 
promote C‒N bonding and hydroxy carbon formation on the surface of CDs, and the use of 
reducing methods could all be further investigated. Some preliminary work on evaluating 
quantum yield measurements of red emissive carbon dots is discussed in Appendix V.  
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(A) Materials and Methods 
Table S1. Summary of experiments performed 
Section Description 
Details of the 
measurement 
performed 
Instruments/methodology 
used 
Objective 
1 Synthesis of NPs Au NPs Seed-mediated approach 
Comparative toxicity study of  different shape 
and size of the Au NP 
2 
Characterization of Au 
NPs and exposure to 
ARPE-19 cell line 
Morphological study 
and Optical absorption 
of Au NPs 
TEM and UV-Vis 
Confirmation of the shape and physical 
dimension of NPs by TEM and supporting 
information on morphology using UV-Vis 
measurements was collected 
Hydrodynamic 
diameter 
measurements 
DLS 
Confirmation of the size of NPs in DI water and 
DMEM and 31.6 μM HCl. 
Surface chemistry, 
zeta potential 
measurements 
DLS 
Determination of the ionic strength effects on 
dispersion characteristics 
Plating the cells and 
NP exposure study 
Determination of the 
concentration in the media 
using ICP-MS 
Determination of the exposure concentration of 
the NPs for ARPE 19 
Microbial growth on basal 
nutrient medium 
Test the sterile (free from microbial 
contamination) nature of the synthesized NPs 
3 
Toxicity assessment of 
the ARPE-19 cell line 
MTT assay 
Colorimetric cell viability 
measurement 
Studying the viability of the cells after different 
NP exposure concentrations 
Studying the role of size of the Au nanoparticles 
Detecting the effect of shape of the Au 
nanoparticles 
Confirmation of the presence of NPs inside 
ARPE-19 cells 
ECIS measurements Cell attachment measurement 
Monitoring the cell attachment behavior as the 
cells are exposed to Au NPs 
4 
Investigation for the 
internalization of NPs 
Confocal Microscopy 
Confocal Microscopy, 
nanoplasmonic imaging 
To confirm the internalization of the Au NPs 
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1. Synthesis of Au Nanoparticles 
Gold (Au) nanoparticles were synthesized using seed-mediated approach. Details of the synthesis 
method for each nanoparticle are given below. 
Au nanospheres were synthesized in two steps by seed-mediated approach (Wu et al. 2010) using 
cetyl trimethyl ammonium chloride (CTAC) as a surfactant.  In the first step, seed solution was 
prepared by vigorous mixing (500 rpm for 1h at 30°C) of 10 mL of HAuCl4 (2.5 × 10
-4M) 
aqueous CTAC (0.1 M) solution with 0.45 mL of ice cold NaBH4 (0.02 M). The seed solution 
was aged for 60 minutes (at 30°C) to decompose the excess of NaBH4.  In the second step, the 
growth solution was prepared by adding 514 µL of HAuCl4 (4.86 mM), 10 µL of NaBr (0.01 M) 
and 90 µL of ascorbic acid (0.04M) to 5 mL of aqueous CTAC (0.1 M) solution.  To this 
colorless solution, 25 μL of seed solution was added under vigorous agitation and left 
undisturbed overnight at room temperature. The size of the sphere was controlled by varying the 
molar ratio of ascorbic acid to seed solution.  
Gold nanocubes were synthesized in three steps. In the first step, the seed solution was prepared 
similarly to the gold nanospheres.  Two growth solutions were prepared by adding of 5 ml of 
aqueous CTAC (0.1 M), 514 µL of HAuCl4 (4.86 mM), 10 µL of NaBr (0.01 M), 4625 μL of 
ultrapure water and 90 µL of ascorbic acid (0.04M). The total solution volume of each growth 
solution was 10 mL. The 25 μL of prepared seed solution was added to the first growth solution 
with immediate vortex for a few seconds from this 25 μL of solution was added to the second 
growth solution and kept overnight at room temperature without disturbing.   
Gold nanorods were synthesized using a seed-mediated approach (Jana et al. 2001) in which seed 
solution was prepared by adding 0.6 mL of an ice-cold solution of 10 mM sodium borohydride 
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into 10 mL of magnetically stirred 0.1M CTAB and 2.5×10−4 M HAuCl4 aqueous solution at 
room temperature.  The color of the seed solution changed from yellow to brown as an indicator 
of Au nanoparticle formation. Simultaneously, growth solution was prepared by mixing 10 mL 
of 0.1M CTAB, 0.8 mL of 10 mM AgNO3, 5 mL of 10 mM HAuCl4, and 0.11 mL of 0.1M 
ascorbic acid in the same order. The solution was homogenized by gentle stirring. To the 
resulting colorless solution 0.024 mL of freshly prepared seed solution was added, and the 
mixture was set aside in dark for 14 h at room temperature.  
2. Characterization of nanoparticles and exposure to ARPE-19 cell line 
2.1.Morphological study by transmission electron microscopy (TEM) and UV-Vis 
analysis 
TEM micrographs were obtained using an FEI Spirit TEM (Hillsboro, OR, USA) operated at 120 
kV.  A 400-mesh Formvar® carbon-coated copper grid was glow-discharged in a vacuum 
evaporator (Denton, Moorestown, NJ, USA) for 30 seconds to make the grid hydrophilic and, 
thus, attractive to particles.  The sample was prepared by placing 2 μL of sonicated colloidal NP 
solution onto the grid and wicking off the excess sample with filter paper after 30 seconds.  To 
further confirm the size, UV-Vis measurements were performed.  Cary 50 Bio UV-Vis 
spectrophotometer (Varian, Palo Alto, CA) was used for recording of absorption spectra of NPs. 
2.2.Hydrodynamic diameter, agglomeration, and sedimentation profile 
Malvern Zetasizer Nano ZS (Malvern Instruments, Westborough MA, and USA) equipped with a 
backscattering detector (173º) was used for hydrodynamic size measurements of the synthesized 
nanoparticles.  Samples were dispersed in water, followed by sonication for 15 minutes to 
homogeneously disperse them in the solution; they were then filtered through a pre-rinsed 0.2 
  
170 
 
μm filter followed by equilibration (typically 5 minutes) at 25 °C.  A minimum of three 
measurements per sample was taken.  The NP sedimentation rate was visually quantified up to 
72 hours in both dispersant solvents, i.e., water and cell culture media.  
2.3.Surface chemistry: zeta potential measurements 
A Malvern Zetasizer Nano ZS was used to measure the zeta potential at 25 °C for all samples.  
Samples were loaded into a pre-rinsed folded capillary cell for the zeta potential measurements.  
An applied voltage of 100 V was used for the NP colloids, and a minimum of three 
measurements was performed per sample.  The surface zeta potential of NPs dispersed in 
deionized (DI) water as well as in the cell culture medium, i.e., Dulbecco’s modified Eagle’s 
medium (DMEM), and in 8.3mM Hydrochloric acid solution was measured.  Zeta potential of 
the cell culture media (C-DMEM/F12) was measured as − 8.09 mV. Thus, it was confirmed that 
changing the solvent (from DI water to C-DMEM/F12) plays a critical role in zeta potential of 
the NPs.   
2.4.Validation of NP concentration  
Quantitative determination of Au (Gold) concentrations in stock solutions were performed by an 
inductively coupled plasma-mass spectrophotometer, also referred to as an ICP-
MS (Elan DRC II, PerkinElmer, Norwalk, CT).  Synthesized NPs were dispersed in water as a 
stock solution for the preparation of ICP-MS analysis.  Then, 100 μL of stock solution was 
digested in triplicates using an equal volume of aquaregia (3 mL of HCl: 1 mL of HNO3).  
Aqueous dilutions of the stock suspension were subjected to analysis using direct nebulization 
into the ICP-MS and were quantified against external calibration curves.  
3. Toxicity assessment of the ARPE-19 cell line  
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3.1.Establishment of ARPE-19 cell line 
ARPE-19 cells were maintained at 37 °C in a humidified atmosphere of 5% CO2.  Cells were 
grown in 75 mm flasks and maintained with DMEM, composed of a nutrient mixture F12 (1:1) 
supplemented with 10% FBS, 2 mL-1 glutamine, 100 UmL-1 penicillin, and 100 UmL-1 
streptomycins.  Cell media were changed every 3 days.  Cultures were passaged by dissociation 
in 0.25% (w/v) trypsin-EDTA in Hanks’ balanced salt solution (HBSS).  Cells were seeded in 
100 mm x 20 mm plates.  All the cells in the same passages were grown to 70–90% confluence 
before seeding on a 96-well plate for assay. 
3.2.Cell attachment study: ECIS measurements 
In this technique, cells were plated in wells containing gold electrodes connected to an ECIS 
system.  As the cell morphology and attachment to the electrodes present in the bottom of the 
well changed, the resistance across the electrodes also changed.  The change in resistance at 
different frequencies from 400 to 64,000 Hz can be measured over time.  At high frequencies, 
current couples through the insulating cell membrane with minimal current passing through the 
solution channel under and between adjacent cells.  The impedance (capacitive reactance) of the 
membrane is relatively small and, hence, can be used to monitor the establishment of a confluent 
cell layer.  On the other hand, at low frequencies, current predominantly flows through the 
solution channel under and between adjacent cells, and the membrane impedance is high.  As a 
result, low-frequency impedance can be used to monitor the solution paths around the cells and, 
hence, the layer’s cell to cell barrier functions (Arndt et al. 2004).  The addition of Au NPs 
further complicates the impedance of the system.  However, at a frequency of 4000 Hz, the 
contribution of resistance from cells was dominant over the contribution of resistance from Au 
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NPs with media (Kandasamy et al. 2010).  Hence, a frequency of 4000 Hz was chosen to monitor 
cell growth and biocompatibility.  The time required for retinal cells (bot primary RPE and 
ARPE-19 cells) was determined via impedance measurements.  As can be seen in Figure S1., by 
the end of the first day, the ARPE-19 cells did reach confluency; however, pRPE cells required 
more time to become confluent.   
 
Figure S1. ARPE-19 and primary retinal (pRPE) cells attachment behavior for more than six 
weeks were monitored real time via ECIS measurements.  By the end of the 24th hour, the 
ARPE-19 cells reached confluency; however pRPE required more than 26 hours to transition 
from logarithmic growth phase to stationary phase (become confluent).  
4. Investigation for the internalization of NPs  
4.1.Nucleus staining and sample preparation for confocal imaging 
ARPE-19 cells were fixed by immersion in a 4% paraformaldehyde (PFA), as the cross-linking 
solution, for 10 minutes at room temperature.  The cells were then washed three times by 
immersion in ice-cold 1X PBS (phosphate buffer saline) for five minutes each time.  The fixed 
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cells were incubated in ice-cold 1X PBS buffer containing 0.1% Triton (permeabilization agent) 
for 10 minutes at room temperature.  After that, the cells were washed three times again with ice-
cold 1x PBS for five minutes each.  The cell slides were then incubated with blocking buffer for 
30 minutes before addition of slow fade.  The cells were subsequently washed three times with 
ice-cold 1X PBS for five minutes each.  For the staining of the nucleus, SlowFade® Gold 
Antifade Mountant with DAPI (diluted 1:100 in 1X PBS) was used, and the cells were incubated 
with the above cell slides overnight at 4 0C.  Then the cells were again washed three times with 
ice-cold 1X PBS for five minutes each.  Finally, the cell slides were transferred to a confocal 
microscope for optical analyzes.  The used laser wavelengths were 488 and 533 nm for DAPI 
(nucleus staining) and for Au NP detection respectively. 
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(B) Results 
1. UV-Vis characterization of synthesized ENP 
Nanoparticles were also characterized by UV-Vis absorption spectroscopy.  The distinct band 
maxima for Au spheres (5, 10, 20, and 30 nm) were measured at 510-540 nm.  For Au cube (50 
nm) and Au spheres (50 and 100 nm), peaks were detected at 556, 536, and 573 nm, respectively.  
Au nanorods showed two absorption peaks at 517 and 761 nm due to their morphological aspect 
ratio. 
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Figure S2. UV-Vis absorption spectra of synthesized Au NPs 
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Table S2. Influence of exposure media on physicochemical properties of NPs 
 
NP type 
pH Zeta Potential (mV) Hydrodynamic Diameter (nm) 
Sedimentation %              
(after 72 hours)* 
DI water DMEM DI water DMEM DI water DMEM DI Water DMEM 
Au S 5 3.2 7.5 37.5 (±0.38) 0.12 (±0.46) 4.83 (±1.52)# 8.27 (±2.66) NO NO* 
Au S 10 3.3 7.6 33.5 (±0.14) 0.18 (±0.28) 8.89 (±2.80) 17.81 (±5.77) NO NO* 
Au S 20 3.2 7.8 24.8 (±0.08) 1.72 (±0.52) 14.57 (±4.54) 29.11 (±9.16) NO NO 
Au S30 3.2 7.6 21.4 (±0.50) 1.58 (±0.46) 29.39 (±7.55) 42.62 (±13.34) NO NO 
Au S 50 3.4 7.6 42.1(±1.72) -11.9 (±1.27) 45.57 (±14.27) 66.83 (±22.37) NO <33 
Au S 100 3.3 7.8 28.1(±1.60) -12 (±0.58) 98.25 (±31.38) 120.15 (±39.85) NO <33 
Au cube 7.6 7.7 40.6 (±0.72) -6.33 (±0.16) 50.25 (±16.74) 60.12 (±21.26) ~33 ~33 
Au rods 3.8 7.7 36.9 (±0.21) -7.40 (±0.09) 120.25 (±44.99) 130.45 (±51.85) ~33 ~33 
DMEM 7.7 7.7 -8.09 (±0.06) -8.09 (±0.06) NM NM NO NO 
                    # Standard deviation  
             *values presented in %, based on visual appearance; NO: Not observed; NM: Not measured 
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Figure S3. 3D Confocal microscopic images of nanoparticles inside cells after 72 h of exposure.  All figures are from the same stack 
of cells, in which nuclei are present.  Included are (a) cells without nanoparticle exposure, (b) ARPE-19 cells exposed to 5-nm Au 
spheres (LD50: 0.030 mg/ml) with green dots representing Au NPs inside cells in the vicinity of the nucleus and voids (exact areas are 
shown with white arrows) representing loss of cytoplasm on the observed layer.  (c) Void like structures can be seen at ARPE-19 cells 
exposed to 5-nm Au spheres (LD50: 0.030 mg/ml)  (d) ARPE-19 cells exposed to 10-nm Au spheres (LD50: 0.057 mg/ml, with 
particles inside cells and nuclei. (e) ARPE-19 cells exposed to 20 nm Au spheres at a critical concentration of LD50: 0.113 mg/ml; the 
presence of particles inside cells and nuclei is confirmed.  (f) ARPE-19 cells exposed to 0.129 mg/ml of 30-nm Au spheres.  (g) 
LD50:0.050 mg/ml of 10×90 nm Au nanorods inside cells and nuclei.  (h) 0.129 mg/ml of 50- nm Au spheres.  (i) 0.129 mg/ml of 100-
nm Au spheres.  Internalization of 50- and 100-nm Au spheres may be hindered by their large size.  The available surface area, the key 
metric for biocompatibility, is much less for 50- and 100-nm Au spheres compared than for ARPE-19 cells exposed to smaller Au 
nanospheres.  (j) 0.129 mg/ml of Au nanocubes. 
 
(i) (j) 
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Figure S4. Inductively coupled plasma mass spectrometer (ICP-MS) measurement results for 
the aliquots collected after the washing procedure prior to Confocal microscopy imaging.  
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1H NMR, FTIR, and GPC analysis of end-thiol modified HA (HS-HA). The HS-HA was 
characterized using 1H NMR spectroscopy. 1H NMR spectrum was obtained on a Varian 
Unity Inova 500 (Palo Alto, CA). HS-HA samples were dissolved in D2O (8 mg/mL) with 
NaOD (20 mol). Each sample was scanned for 128 times at 25 oC. The infrared spectra of 
HS-HA was obtained using a fourier transsform spectroscopy (Spectrum GX, PerkinElmer, 
USA). The infrared spectra of the samples were measured over a wavelength range of 4000 - 
500 cm−1. Transmission spectra was taken in the spectral range by the accumulation of at 
least 64 scans with a resolution of 4 cm−1. The GPC system used a VE 1122 pump with a VE 
7510 degasser (Viscotek/Malvern, Houston, TX) equipped with a TDA302 triple detector 
system that measured the refractive index (RI), multi-angle laser light scattering, and 
viscosity. The column used was a G5000PWXL (Tosoh Biosep, Montgomeryville, PA). 
Viscotek Omnisec software was used to calculate the RI area, weight-averaged molecular 
weight, intrinsic viscosity, and hydrodynamic radius. Samples (100 μL) were injected at a 
concentration of 2 mg/mL. The column buffer (pH 7.6) contained 20 mM of sodium 
phosphate and 100 mM of NaCl. The flow rate was 0.8 mL/min. Measurements were 
conducted at 37 °C. 
Particle size measurements.  The morphologies and the size of the synthesized uncoated Au 
NPs were examined by high-resolution transmission electron microscopy (HR-TEM, Tecnai 
TM Spirit, FEI Co.), operated at 200 kV accelerating voltage. A 400 mesh TEM grid (CF400-
Cu-UL, Electron Microscopy Sciences, PA) was used. A Malvern Zetasizer Nano ZS 
(Malvern Instruments, Westborough MA) equipped with a backscattering detector (173º) was 
used for hydrodynamic size measurements of synthesized nanoparticles. Samples were 
dispersed in water, then sonicated for 15 min to homogeneously disperse them in the solution, 
after which they were filtered through a prerinsed 0.22 μm sterile filter, then equilibrated 
(typically for 5 min) at 25 °C. At least three measurements per sample were taken. The 
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hydrodynamic diameter and zeta potential of NPs in solution before and after their exposure 
to cell culture medium was measured in batch mode using DLS. 
Ellman’s reaction. The amount of thiol content of end-thiolated hyaluronate (HS-HA) was 
also determined spectrophotometrically, using an Ellman’s reagent as described by Ellman 
(Ellman 1959). Briefly, 10 mg of lyophilized sample was diluted with 2 mL of N2-bubbled 
water. To 100 mL of this sample, 500 mL of 0.1 M phosphate buffer (pH 8), 400 mL of water, 
and 50 mL of Ellman’s reagent were added. Samples were incubated for 15 min at room 
temperature in dark and their absorbance measured at λ = 412 nm in a Varian Cary 5000 
spectrophotometer. Thiol content was calculated as per the equation: 
                    SH (moles) / HA (g) = (Ab/13,600) × (Vtotal / Vsample) × (1/HAconc)                    (1) 
where Ab is the absorbance and Vtotal is the total volume, whereas Vsample is the sample 
volume and 13,600 is the extinction coefficient. The concentration of the HA (HA conc) is in 
mg/mL. 
Total organic carbon (TOC) measurements. We used a Shimadzu TOC-VWP to determine 
the carbon content of HS-HA-Au NPs in the solid phase. Lyophilized samples were weighed 
before pretreatment with acid to remove and measure all inorganic carbon. During the TOC 
analysis, the sample underwent combustion heating to 680 oC. During decomposition, the 
CO2 generation was recorded. The inorganic carbon (IC) was measured by acid digestion of 
the sample, followed by nitrogen sparging (CO2 isolation). Subtracting the inorganic carbon 
from the total carbon yield the total organic carbon, corresponding to the HA content of the 
sample.  
Thermal gravimetric analysis (TGA). A TA Q5000 thermal gravimetric analyzer was used. 
Any change in sample mass, a function of increasing temperature and time, was measured. 
HA is known to decompose at 220-280 oC (Jiang et al. 2015, Ahire et al. 2016). On the other 
hand, Au NPs under 150 nm in diameter possess lower melting temperature (above 426-976 
  
183 
 
 
oC) compared to bulk gold (1027 oC) (Buffat and Borel 1976). Taking bound water content 
into account from the TGA curves, the explicit Au content was determined by calculating the 
difference between the total mass of the sample and the HA content.  
In-vitro cytotoxicity measurements on ARPE-19 MTT, ApoTox-GloTM, and ROS-Glo™ 
H2O2 assays.  For all three assays, the cells were distributed in a flat-bottom 96-well plate 
with a 150 μL volume (1.5 × 106 cells per 20 ml). After plating, cells were incubated for 48 h 
(37 °C, 5% CO2), then exposed to different concentrations of NPs. Physically characterized 
particles were dispersed in DMEM to be used for cell exposure. For each size of Au NPs, 
concentrations of the exposed solutions were 0.01, 0.05, 0.1, and 0.5 mg/ml. The upper limit 
of exposure concentration was determined by the toxic potential of the NPs as reported in the 
literature (Karakocak et al. 2016). NP exposure was maintained for 24 h before assay 
measurements. In all biological and imaging tests, the cells without NP exposure served as a 
negative control 
For the MTT assay, following the exposure of NPs, 100 µL of MTT (1 mg/l in growth media) 
were added to each well, and the plate was incubated for an additional 5 h at 37 °C in 5% 
CO2. The resulting blue component, produced by the reduction of tetrazolium salt of MTT by 
mitochondrial dehydrogenase enzyme, was dissolved in 100 µL dimethyl sulfoxide (DMSO). 
The optical density of the colored product was read photometrically using a 
spectrophotometer at 540 nm with a microplate reader (Molecular Devices Spectra Max 190). 
The absorbance of untreated cells was used as a negative control. The percentage viability of 
the cells was calculated from the ratio of the mean optical density of the sample to the optical 
density of the negative control. 
For all three assays, the cells were distributed in a flat-bottom 96-well plate with a 150 μL 
volume (1.5 × 106 cells per 20 ml). After plating, cells were incubated for 48 h (37 °C, 5% 
CO2), then exposed to different concentrations of NPs. Physically characterized particles 
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were dispersed in DMEM to be used for cell exposure. For each size of Au NPs, 
concentrations of the exposed solutions were 0.01, 0.05, 0.1, and 0.5 mg/ml. The upper limit 
of exposure concentration was determined by the toxic potential of the NPs as reported in the 
literature.44, 45 NP exposure was maintained for 24 h before assay measurements. 
For the MTT assay, following the exposure of NPs, 100 µL of MTT (1 mg/l in growth media) 
were added to each well, and the plate was incubated for an additional 5 h at 37 °C in 5% 
CO2. The resulting blue component, produced by the reduction of tetrazolium salt of MTT by 
mitochondrial dehydrogenase enzyme, was dissolved in 100 µL dimethyl sulfoxide (DMSO). 
The optical density of the colored product was read photometrically using a 
spectrophotometer at 540 nm with a microplate reader (Molecular Devices Spectra Max 190). 
The absorbance of untreated cells was used as a negative control. The percentage viability of 
the cells was calculated from the ratio of the mean optical density of the sample to the optical 
density of the negative control. 
The cells were cultured and treated with NPs in 96-well, clear-bottomed white plates for the 
apoptosis and ROS detection experiments. Caspase 3/7 activity, the key indicator for 
apoptosis, was evaluated using the ApoTox-Glo™ Triplex assay according to the 
manufacturer’s protocol. The light output, measured with a luminometer, correlates with 
Caspase-3/7 activation, and luminescence was measured using a microplate reader 
(Molecular Devices Spectra Max 190).  
ROS generation was evaluated with the ROS-Glo™ H2O2 assay according to the 
manufacturer’s protocol. The light signal produced by recombinant Luciferase is proportional 
to the level of H2O2 in the cells. The luminescence was measured using a microplate reader 
(Molecular Devices Spectra Max 190). 
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Confocal Microscopy.  ARPE-19, NIH 3T3, and CHO cells were seeded in CELLviewTM 
plates at 5 × 104 cells/well for 24 h. After 24 h of NP exposure, the cells were fixed and 
washed with PBS three times before imaging. All cells were fixed by immersion in 4% 
paraformaldehyde (PFA) as the cross-linking solution for 10 min at room temperature. The 
cells were then washed three times with ice-cold 1x PBS for 3 min each time. The fixed cells 
were incubated in ice-cold 1x PBS buffer containing 0.1% Triton (permeabilization agent) for 
10 min at room temperature, then washed three times with ice-cold 1x PBS for 5 min each 
time. The CELLviewTM plates were then incubated with blocking buffer for 30 min before the 
addition of Alexa Fluor® 633 phalloidin (diluted 1:200 in blocking buffer). The cells were 
subsequently washed three times with ice-cold 1x PBS for 3 min each time. To stain the 
nuclei, SlowFade® Gold Antifade Mountant with DAPI (diluted 1:100 in 1x PBS) was used. 
The cells were incubated overnight at 4 oC.  
During confocal microscopy analysis, the laser wavelengths were 405, 525, and 633 nm for 
DAPI (nucleus staining), for Au NP detection, and for actin visualization, respectively. 
Several different images (based on the thickness of the cell, the number of images with the 
same Z-stack thickness vary) were taken through different optical sections by collecting Z-
stacks with a thickness of 35 nm. A negative control sample (untreated cells) was prepared 
with cells in the absence of nanoparticles.   
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Fig. S1. NMR spectrum of end-thiolated hyaluronate. Typical hyaluronate peaks are 
presented in the spectrum. Extremely low level of the chain-end thiols caused its signals to be 
buried among other peaks or noise. 
  
Fig. S2. FTIR transmittance spectrum of end-thiolated hyaluronate. For hyaluronic acid, -OH 
group is found at 3200-3700 cm-1. Stretching vibration of C-H and CH stretching can be seen 
at 2915 cm-1 and 2845 cm-1, respectively. Carboxylic groups and C-O-C bonds can be 
detected at 1660 cm-1 and 1045 cm-1, respectively. Typical the -SH signal (2560 cm-1) is 
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buried in the noise due to the low amount of SH in the HA sample as quantified with 
Ellman’s assay ([-SH]/[HA repeating units] = 0.025).  
 
Fig. S3. HR-TEM images of different sizes of uncoated gold nanoparticles. Facets are 
detected with the thicknesses of 0.21 nm and 0.23 nm. 
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Table S1. The amount of HA molecules per unit Au surface area was calculated based on TGA and TOC analysis, respectively. 
TGA          
Au dp 
(nm) 
Amount 
of HA  
(g) 
Amount of 
Au  
(g) 
Total mass 
of the 
sample (g) 
 Mass of one 
Au NP (g) 
# of Au NPs 
in the sample  
 Mass of one HA 
molecule (mg), MW: 
19.69 kDa 
# of HA 
molecules in the 
sample  
Total surface area 
of Au NPs in the 
sample 
# of HA molecules 
per unit surface 
area (nm2) 
5 2.15E-02 6.32E-02 8.47E-02 1.08919E-18 5.80E+16 3.26E-20 6.59E+17 4.13E+18 0.16 
10 7.27E-03 6.29E-02 7.02E-02 6.85845E-18 9.17E+15 3.26E-20 2.23E+17 2.22E+18 0.10 
20 3.17E-03 1.10E-01 1.13E-01 9.21237E-17 1.20E+15 3.26E-20 9.74E+16 1.64E+18 0.06 
50 1.71E-03 2.57E-01 2.58E-01 1.49173E-15 1.72E+14 3.26E-20 5.25E+16 1.51E+18 0.03 
100 2.30E-04 7.80E-02 7.82E-02 1.34871E-14 5.78E+12 3.26E-20 7.06E+15 2.20E+17 0.03 
          
TOC          
Au dp 
(nm) 
Amont of 
HA  
(g) 
Amount of 
Au  
(g) 
Total mass 
of the 
sample (g) 
 Mass of one 
Au NP (g) 
# of Au NPs 
in the sample  
 Mass of one HA 
molecule (mg), MW: 
19.69 kDa 
# of HA 
molecules in the 
sample  
Total surface area 
of Au NPs in the 
sample 
# of HA molecules 
per unit surface 
area (nm2) 
5 1.82E-02 4.880E-02 6.700E-02 1.08919E-18 4.48E+16 3.26E-20 5.58E+17 3.19E+18 0.18 
10 8.95E-03 8.605E-02 9.500E-02 6.85845E-18 1.25E+16 3.26E-20 2.75E+17 3.04E+18 0.09 
20 2.05E-03 7.695E-02 7.900E-02 9.21237E-17 8.35E+14 3.26E-20 6.29E+16 1.15E+18 0.05 
50 5.02E-04 7.850E-02 7.900E-02 1.49173E-15 5.26E+13 3.26E-20 1.54E+16 4.62E+17 0.03 
100 1.72E-04 6.283E-02 6.300E-02 1.34871E-14 4.66E+12 3.26E-20 5.28E+15 1.77E+17 0.03 
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Fig. S4. Particle size distributions for nascent and coated Au NPs obtained with DLS 
measurements. (A) 5nm, (B) 10 nm, (C) 20 nm, (D) 50 nm, (E) 100 nm. 
A B 
C D 
E 
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Fig. S5. Physical characterization of nascent and coated Au NPs by DLS measurements in DI 
water (A) particle size (B) zeta potential measurement results. The same particles exposed to 
DMEM (C) particle size (D) zeta potential measurement results. When the HA-HA-Au NPs 
are exposed to DMEM, the increase in particle size is much less compared to the nascent Au 
NPs, due to HS-HA coating, which prevents protein adsorption on the NP surface.   
         Nascent 5 nm,           Coated 5 nm,           Nascent 10 nm,           Coated 10 nm,              
         Nascent 20 nm,            Coated 20 nm,          Nascent 50 nm,            Coated 50 nm,  
         Nascent 100 nm,           Coated 100 nm.
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Fig. S6. The red staining corresponds to actin, the nucleus is blue, and Au NPs are green. 2D 
confocal images for uncoated and HS-HA-coated Au NPs. (A) ARPE-19 cells without Au NP 
addition, the control. The cells were exposed to (B) 5-nm nascent Au NPs, (C) HA-coated Au 
NPs, (D) 10-nm nascent Au NPs, (E) HA-coated Au NPs, (F) 20-nm nascent Au NPs, and (G) 
HA-coated Au NPs.  The last six images indicate that the coating slightly affects the 
internalized number of Au NPs. (H) 50-nm nascent Au NPs, (I) HA coated Au NPs, (J) 100-
nm nascent Au NPs, and (K) HA coated Au NPs. All the exposure experiments were 
conducted at the lethal dose (LD50) of the nanoparticle of interest. The difference in the 
H I 
J K 
L 
Nascent 100 nm Coated 100 nm 
Pretreated with 10x 
HS-HA, and then 
exposed to 50 nm 
HS-HA Au NPs 
Nascent 50 nm Coated 50 nm 
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number of internalized NPs (indicated with arrows) increased significantly with the presence 
of HA coating for the larger particles. Also, when the cells are exposed to coated NPs, the 
actin density is not hindered, unlike the cells which are exposed to nascent NPs. (L) ARPE-19 
cells were treated with 10x HS-HA prior to the addition of 0.5 mg/ml HS-HA coated 50-nm 
Au NPs. The internalization of HS-HA-Au NPs was significantly more than for the cells 
which were not pretreated with HA. This finding confirms the role of CD44 receptors on 
receptor-mediated endocytosis of HA-Au NPs in retinal cells. 
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Fig. S7. The red staining corresponds to actin, the nucleus is blue, and Au NPs are green. (A) 
ARPE-19 cells without Au NP addition, the control.  The ARPE-19 cells were exposed to (B) 
5-nm nascent Au NPs, (C) 5-nm HS-HA Au NPs, (D) 10-nm nascent Au NPs, (E) 10-nm HS-
HA Au NPs, (F) 20-nm nascent Au NPs, (G) 20-nm HS-HA Au NPs, (H) Cells exposed to 50-
nm nascent Au NPs, (I) ARPE-19 cells with HS-HA Au NPs, where the size increased to 
95.07±25.98, as shown by DLS results, (J) Cells exposed to 100-nm nascent Au NPs, (K) 
ARPE-19 cells with HS-HA-coated Au NPs, where the size increased to 127.5±42.21, as 
shown by DLS. Although the nascent and relatively smaller nanoparticles did not enter the 
cells, when coated with SH-HA, the NPs presence in the cells was drastically increased. Also, 
when the cells are exposed to coated NPs, the actin density is not hindered, unlike the cells 
which are exposed to nascent NPs. (L) ARPE-19 cells treated with 10x SH-HA prior to the 
addition of 0.5 mg/ml HS-HA Au NPs. The internalization of HA-Au NPs was significantly 
less than for cells which were not pretreated with HA. This finding confirms the role of CD44 
receptors on receptor-mediated endocytosis of HS-HA Au NPs. Scale bars are 20µm. 
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Fig. S8. The red staining corresponds to actin, the nucleus is blue, and Au NPs are green. (A) 
3T3cells without Au NP addition, the control, (B) 3T3 cells exposed to HA-Au NPs (dp=50 
nm), (C) 3T3 cells treated with 10x end-thiolated HA prior to the exposure to 0.5 mg/ml HA 
coated 50-nm Au NPs. The internalization of 50-nm Au NPs was not affected by the presence 
of HA coating because 3T3 cells are known to have a fewer number of CD44 receptors which 
is the analog for the CD44 receptor. Scale bars are 20µm.
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Fig. S9. The CHO cells were not stained for actin. The nucleus is blue and Au NPs are green. 
CHO cells (A) without Au NP addition, the control. (B) cells exposed to nascent Au NPs 
(dp=50 nm). (C) cells exposed to 50- nm HS-HA-Au NPs. (D) cells treated with 10x end-
thiolated HA prior to exposure to 50- nm HS-HA coated Au NPs. The internalization of 50- 
nm Au NPs was affected drastically by the presence of HA coating because CHO cells are 
known have CD44 receptors, and since they are cancer cells, the number of receptors 
expressed is higher than normal cells. Scale bars are 20µm. 
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Table S1.  Experimental conditions (factors) of each nCDs synthesis using CCD-RSM design 
Runs CA wt% NH2/COOH Reaction Time (s) 
1 10.0 0.75 88 
2 11.2 0.48 80 
3 10.0 0.75 100 
4 10.0 0.75 88 
5 8.8 1.02 95 
6 12.0 0.75 88 
7 8.8 0.48 80 
8 10.0 0.75 75 
9 10.0 0.75 88 
10 11.2 1.02 95 
11 10.0 0.75 88 
12 8.0 0.75 88 
13 8.8 0.48 95 
14 8.8 1.02 80 
15 10.0 0.75 88 
16 10.0 1.20 88 
17 10.0 0.30 88 
18 10.0 0.75 88 
19 11.2 0.48 95 
20 11.2 1.02 80 
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Table S2.  The effect of molar ratio of reactants to pyrrolic N content and MW of nCDs. 
Molar ratio of  
EA/CA 
XPS results (intensity, au) Maldi-TOFF results 
Pyrrole content m/z 
0.5 413.0 799.6 
1.0 778.0 1215.0 
2.0 1663.0 1512.0 
 
 
Table S3.  Quantum yield measurements of nCDs. 
NH2/COOH Quantum Yield, Φ (%) 
0.25 7.0 
0.50 15.0 
1.00 10.7 
1.50 13.9 
2.00 10.3 
 
1.1. Statistical Analysis.   
For PL results at the short wavelength, the analysis of variance suggested that the quadratic 
regression model was most appropriate among all polynomial regression models. First, the 
sequential model sum of squares indicated that the quadratic regression was the highest order, 
with the sequentially added terms being significant, and the model was not aliased (F-value = 
14.06 and P-value = 0.001, when comparing the quadratic regression to the 2FI regression). 
Second, the lack of fit F-value = 0.62, and the P-value = 0.67, which jointly imply that the 
quadratic model fits well, while lower order models all indicated a significant lack of fit. 
Thus, quadratic regression was used in this analysis, as below:  
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PL (Ex 350 nm, Em 460 nm) = -2.21 × 106 + 4.38 × 105 × (amine/acid) + 4.89 × 104 × 
Time ‒ 815 × (amine/acid) × Time ‒ 2.27 × 105 × (amine/acid2) ‒ 277 × Time2         (Eq. S1)                                                                                                         
This quadratic model is graphically represented in Fig. 1 by a three-dimensional response 
surface. The model is statistically significant, with a model F-value = 13.23 and P-value = 
0.0001. The coefficient of determination R2 = 0.84, and the adjusted R2 = 0.77, indicating a 
good fit; further, the predicted R2 = 0.63 is in reasonable agreement with the adjusted R2, 
suggesting the quadratic regression model also has high predictive ability for new 
observations.  
The normal probability plot in Fig. 1A shows points close to the diagonal, which means a 
normal pattern was observed for the regression residuals. The residual plot shows no outlier 
or special pattern for the data. Thus, there were no problems detected from the model 
diagnostics. 
As predicted by the model, CDs with the highest intensity of PL at λex∕em = 350 nm/460 nm 
were produced with an amine/acid ratio of 0.75 and a reaction time 88.0 seconds. 
The sequential model sum of squares indicates that the linear regression is the suggested 
highest order, with the sequentially added terms being significant, and again the model is not 
aliased (F-value = 63.07 and P-value < 0.0001 when comparing the linear regression to the 
mean regression). Second, the lack of fit F-value = 1.42 and the P-value = 0.37, which jointly 
imply no significant lack of fit relative to the pure error. Thus, the linear regression was used 
in this analysis. The linear equation is listed below:  
PL (Ex 540 nm, Em 600 nm) = -822 + 1.48 × 103 × (amine/acid) + 9.42 × Time ‒ 12.3 × 
(amine/acid) × Time                                                                                                       (Eq. S2) 
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This linear model is graphically presented in Fig. 1B by a three-dimensional response 
surface. The model is statistically significant, and again the model F-value = 93.45 and P-
value < 0.0001. The coefficient of determination R2 = 0.95, and the adjusted R2 = 0.94, 
indicating a good fit; the predicted R2 = 0.91 is in reasonable agreement with the adjusted R2, 
suggesting the linear model also has high predictive ability for new observations. The normal 
probability plot in Fig. 1B shows points close to the diagonal, which means a normal pattern 
was observed for the regression residuals. The residual plot shows no outlier or special 
pattern for the data. Thus, there were no problems detected from the model diagnostics. 
In vitro Cytotoxicity Measurements on Retinal Pigment Epithelial (ARPE-19), Lens 
Epithelial, and Chinese Hamster Ovary (CHO) cells with MTT, ApoTox-GloTM, and 
ROS-Glo™ H2O2 assays.   
For all three assays, the cells were distributed in a flat-bottom 96-well plate with a 150 μL 
volume (1.5 × 106 cells per 20 ml). After plating, cells were incubated for 48 h (37 °C, 5% 
CO2), then exposed to different concentrations of nCDs. nCDs exposure was maintained for 
24 h before assay measurements. In all biological and imaging tests, the cells without NP 
exposure served as a negative control 
For the MTT assay, following the exposure of nCDs, 100 µL of MTT (1 mg/l in growth 
media) were added to each well, and the plate was incubated for an additional 5 h at 37 °C in 
5% CO2. The resulting blue component, produced by the reduction of tetrazolium salt of 
MTT by mitochondrial dehydrogenase enzyme, was dissolved in 100 µL dimethyl sulfoxide 
(DMSO). The optical density of the colored product was read photometrically using a 
spectrophotometer at 540 nm with a microplate reader (Molecular Devices Spectra Max 190). 
The absorbance of untreated cells was used as a negative control. The percentage viability of 
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the cells was calculated from the ratio of the mean optical density of the sample to the optical 
density of the negative control. 
The cells were cultured and treated with nCDs in 96-well, clear-bottomed white plates for the 
apoptosis and ROS detection experiments. Caspase 3/7 activity, the key indicator for 
apoptosis, was evaluated using the ApoTox-Glo™ Triplex assay according to the 
manufacturer’s protocol. The light output, measured with a luminometer, correlates with 
Caspase-3/7 activation, and luminescence was measured using a microplate reader 
(Molecular Devices Spectra Max 190).  
ROS generation was evaluated with the ROS-Glo™ H2O2 assay according to the 
manufacturer’s protocol. The light signal (luminescence) produced by recombinant 
Luciferase is proportional to the level of H2O2 in the cells. The luminescence was measured 
using a microplate reader (Molecular Devices Spectra Max 190). 
1.3. In vitro imaging of nCDs  
All cells were fixed by immersion in 4% paraformaldehyde (PFA) as the cross-linking 
solution for 10 min at room temperature. The cells were washed three times with ice-cold 1x 
PBS, for 3 min each time. The fixed cells were incubated in ice-cold 1x PBS buffer 
containing 0.1% Triton (permeabilization agent) for 10 min at room temperature, then washed 
three times with ice-cold 1x PBS, for 5 min each time. The CELLviewTM plates were then 
incubated with blocking buffer for 30 min at room temperature. The cells were subsequently 
washed three times with ice-cold 1x PBS for 3 min each time. To stain the nuclei, 
SlowFade® Gold Antifade Mountant with DAPI (diluted 1:100 in 1x PBS) was used. The 
cells were then kept at 4 oC overnight. The cells were again washed three times with ice-cold 
1x PBS for 5 min each time before being transferred to the confocal microscope for visual 
analyses. 
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Figure S1. Hydrodynamic size measurement raw results of nCDs with amine/acid ratio of 
(A) 0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00. 
D) 
E) 
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Figure S2. Zeta potential measurement raw results of nCDs with amine/acid ratio of (A) 
0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00. 
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Figure S3. MALDI-TOF mass spectra of CDs with NH2/COOH ratios of (A) 0.5, (B) 1.0, 
and (C) 2.0. 
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Figure S4. Broad spectrum XPS analysis results of nCDs 
 
 
Figure S5. High resolution N1s XPS analysis results of nCDs with amine/acid ratio of (A) 
0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00. 
C1s 
N1s 
O1s 
A) B) C) 
D) E) 
  
228 
 
 
Figure S6. High resolution O1s XPS analysis results of nCDs with amine/acid ratio of (A) 
0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00. 
 
  
Figure S7. Correlation of the molar ratio of reactants to (A) pyrrole content and (B) MW of 
nCDs.  
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Figure S8. Biocompatibility results of retinal pigment epithelial (ARPE-19) (a) cell 
viabilities ((b) apoptotic cell percentage (c) ROS generation after incubation with nCDs for 
24 h at concentrations up to 0.6 mg/mL. Data are expressed as mean ± SD from three 
independent experiments (*P < 0.05).  
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Figure S9. Biocompatibility results of lens epithelial (a) cell viabilities (b) apoptotic cell 
percentage (c) ROS generation after incubation with nCDs for 24 h at concentrations up to 
0.6 mg/mL. Data are expressed as mean ± SD from three independent experiments (*P < 
0.05). 
 
 
 
 
 
 
C) 
A
) 
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Figure S10. Biocompatibility results of CHO (a) cell viabilities (b) apoptotic cell 
percentage (c) ROS generation after incubation with nCDs for 24 h at concentrations up to 
0.6 mg/mL. Data are expressed as mean ± SD from three independent experiments (*P < 
0.05) 
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B) A) 
  
232 
 
 
 
 
 
 
Appendix IV.  
Post Intravenous Injection Histology 
Analysis for Uncoated and Coated Au NPs 
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Post Intravenous Injection Histology Analysis for Uncoated and Coated Au NPs 
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Figure 1. Histology analysis after intravenously administered Au NPs. (A) 5 minutes (B) 10 
minutes (C) 15 minutes (D) 20 minutes (E) 25 minutes post injection.  
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Figure 2. Histology analysis after intravenously administered HA-S-Au NPs. (A) 5 minutes 
(B) 10 minutes (C) 15 minutes (D) 20 minutes (E) 25 minutes post injection. All the sections 
of both cornea and retina are intact.  
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Appendix V.  
A Highly Sensitive Non-enzymatic Glucose 
Sensor based on Cu/Cu2O/CuO Ternary 
Composite Hollow Spheres Prepared in a 
Furnace Aerosol Reactor 
 
 
 
 
 
 
 
 
The results of this appendix have been reprinted with permission from Lin L. Y*., 
Karakoçak B. B*., Kavadiya S., Biswas P. A Highly Sensitive Non-enzymatic Glucose 
Sensor Based on Cu/Cu2O/CuO Ternary Composite Hollow Spheres Prepared in a Furnace 
Aerosol Reactor. 2018. Sens. Actuators B. Chem. 259: 745-752. Copyright 2018 Elsevier 
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Abstract 
A novel ternary composite, Cu/Cu2O/CuO hollow spheres (HSs), synthesized using an 
aerosol furnace reactor (FuAR) was investigated for the first time as a non-enzymatic 
electrochemical biosensor for glucose detection. The composite HSs were synthesized by 
aerosolizing a mixture of copper nitrate, citric acid, and ammonia through a FuAR. 
Interestingly, the addition of ammonia played a crucial role in the in-situ formation of hollow 
Cu/Cu2O/CuO ternary composites. The HSs modified electrode was employed for non-
enzymatic glucose detection where it exhibited a detection limit of 0.39 µM and an 
outstanding sensitivity of 8726 μA cm-2 mM-1 which is superior to existing Cu/Cu2O HSs and 
CuO HSs modified electrodes. The high sensitivity was attributed to the synergy arising from 
the ternary composition’s interfacing with multiple Cu redox couples. The Cu/Cu2O/CuO 
HSs modified electrode also showed excellent selectivity in detecting glucose in the presence 
of interfering species, including chloride salts of Na+, K+, Ca2+, and anions of ascorbic acid 
(AA), dopamine (DA), and uric acid (UA). This simple and scalable FuAR technique will 
attract interest and enable in designing other high-performance metal/metal oxide composites 
for commercial glucose sensing applications.  
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1. Introduction  
In the last few decades, the development of highly sensitive and selective glucose sensors 
with wide detection ranges has received considerable attention in clinical diagnosis and the 
food industry [1]. Currently, glucose oxidase (GOD)-based glucose biosensors comprise 
more than 85% of the sensor market, owing to their simplicity, high sensitivity, good 
selectivity, and reliability [2]. Nevertheless, the enzymes involved are quite sensitive to 
temperature, pH, and humidity, which significantly impede further development of enzyme-
based biosensors. Given the inherent drawbacks of enzymes, non-enzymatic glucose 
sensors based on the electrocatalytic oxidation of glucose by a variety of electrocatalysts 
have been attracting much interest as promising alternatives. 
Nanostructured metal/metal oxides are good candidates for electrocatalysts because of their 
low cost, high stability, and excellent redox behaviors across various potential ranges under 
a wide variety of reaction conditions [3]. Among the electrocatalysts for glucose sensors, 
copper oxides (Cu2O and CuO) are of particular interest for their high activity in electro-
oxidation of glucose, and low overpotential for electron-transfer reactions [4,5]. Various 
Cu-based metal oxides have been demonstrated as non-enzymatic glucose sensors and 
showed varying sensitivity, selectivity, and stability during electro-oxidation of glucose 
[4,6–8]. It has been demonstrated that the morphological characteristics of metal oxides 
affect the electrochemical sensitivity of glucose biosensors [9,10]. In particular, hollow 
structures can be an effective morphological alternative to designing high-performance 
electrode materials. Their unique properties – a high exposed surface area, hollow interior, 
thin walls, and excellent permeability could enable electrodes to be exposed to a larger 
electrode-glucose contact area and reduce the electron diffusion path, resulting in improved 
electrochemical activity [4,11]. 
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The redox activation of the electrode materials in electrocatalytic processes is another 
major factor contributing to the sensitivity of electrochemical glucose detections. A 
composite material with multiple redox couples promotes redox reactions and enhances 
electrocatalytic activity [12,13]. For example, compared with pure CuO, a CuO/Cu2O 
composite showed superior electrocatalytic activity in glucose oxidation [14]. This 
superiority is primarily attributed to the presence of a mixed-valence Cu2+/Cu+ system that 
promotes redox reactions between electrode materials and glucose, thus improves the 
performance of CuO/Cu2O. Also, the incorporation of metallic Cu into the Cu-oxide (e.g., 
Cu2O) has also been reported to be beneficial for enhancing electro-conductivity and 
electrocatalytic activity toward glucose oxidation [15,16]. More recent studies emphasized 
the synergistic effect of multiple oxidation species in improving the glucose detection 
performance [17–20]. Therefore, designing a Cu-based composite material consisting of 
mixed valences of Cu, Cu2O [Cu
+], and CuO [Cu2+] may be a good strategy to improve the 
sensitivity of the electrochemical glucose sensor further.  
In this work, a single-step synthesis of Cu/Cu2O/CuO composite hollow spheres (HSs) as 
non-enzymatic glucose sensors using an aerosol furnace reactor (FuAR) is presented for the 
first time. A triple oxidation state system of the Cu/Cu2O/CuO composite HSs was 
synthesized to promote redox reactions and improve electrochemical sensitivity. To the best 
of our knowledge, this is the first study demonstrating the use of Cu/Cu2O/CuO composite 
HSs as a non-enzymatic glucose sensor. The formation mechanism of the Cu/Cu2O/CuO 
HSs was investigated in detail, and electrochemical studies to demonstrate the selectivity 
and sensitivity to glucose were established. This sensitivity was compared to those of 
Cu/Cu2O HSs and CuO HSs prepared using the same FuAR method, and the reasons for the 
differences are elucidated. 
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2. Experimental  
2.1. Reagents and Materials 
All materials were of analytical grade and used as received without further purification. 
Copper nitrate hemipentahydrate, citric acid, ammonia (NH3), glucose, ascorbic acid (AA),  
uric acid (UA), dopamine (DA), sodium hydroxide (NaOH), potassium chloride (KCl), 
sodium chloride (NaCl), calcium chloride (CaCl2), fetal calf serum (FCS) were obtained 
from Sigma-Aldrich (St. Louis, MO). LIQUION™ Nafion™ containing solution was 
purchased from Ion Power Nafion™ Store (Newcastle, DE). Alumina micropolish powder 
(0.05 µm) was obtained from Buehler (Lake Bluff, IL). 
2.2. Preparation of Cu/Cu2O/CuO HSs 
The Cu/Cu2O/CuO composite HSs were synthesized in a lab-built furnace aerosol reactor, 
depicted in Fig. S1. To prepare the precursor solution, 1.86 g of copper nitrate 
hemipentahydrate (8 mmol) and 0.845 g of citric acid (4.4 mmol) were dissolved in 40 ml 
of DI water, followed by the addition of 1.9 ml of ammonia solution (28-30 wt. %) under 
constant stirring. The precursor mixture was then nebulized into aerosol droplets by using a 
collision nebulizer (BGI Incorporated) and delivered by a nitrogen flow (14 psi) through a 1 
mm ID quartz tube 25 mm long surrounded by a furnace thermostatically controlled at 850 
°C. The particle residence time inside the furnace aerosol reactor was calculated to be 1.2 
seconds. The products were collected downstream of the reactor on a membrane filter, 
washed thoroughly with DI water, and finally dried in an oven at 110 oC for 6 hours. 
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2.3. Material characterization  
The morphologies of the synthesized hollow spheres were examined by field emission 
scanning electron microscopy (FE-SEM, Nova NanoSEM 230, FEI Co.), and transmission 
electron microscopy (TEM, Tecnai TM Spirit, FEI Co.). The crystal phase of the material 
was determined by X-ray diffraction (XRD, D8 Advance, Bruker, USA) with Cu Kα 
radiation (λ = 1.548 Å). The chemical composition of the material was determined with X-
ray photoelectron spectroscopy (XPS) analysis, performed on a PHI 5000 VersaProbe II 
equipped with monochromatic Al Kα (1486.6 eV) X-ray source. The XPS peak fitting was 
done in OriginLab, OriginPro (Northampton, MA) software using Lorentz distribution. The 
surface area and pore size distribution were analyzed using the nitrogen physisorption 
method (Autosorb-1, Quantachrome Instruments, Boynton Beach, FL). In total, 79 
adsorption and desorption points were analyzed using the nitrogen physisorption method. 
The surface area was calculated using the Brunauer–Emmett–Teller (BET) method, and the 
pore size distribution was obtained from the desorption isotherm, which is more appropriate 
than the adsorption isotherm for evaluating the pore size distribution of an adsorbent. For 
the same volume of gas, the desorption isotherm exhibits a lower relative pressure, 
resulting in a lower free energy state, i.e., one closer to true thermodynamic stability. 
2.4. Electrode fabrication and electrochemical measurement 
An enzyme-free amperometric electrochemical sensor was prepared with a modified glassy 
carbon electrode (GCE, 3 mm diameter) at room temperature. Before modification, the bare 
GCE was polished to a mirror-like surface with 0.05 µm alumina slurry and then washed 
ultrasonically in deionized water for at least two minutes. Electrochemical measurements 
were performed with a lab-built three-electrode cell setup. For the working electrode, 10 
mg of the material powder was dispersed in 5 ml of deionized water, followed by the 
addition of 1 ml of Nafion solution (0.05 wt. %). After approximately 30 min of 
  
245 
 
ultrasonication, 20 μl of the suspension, which contained 33 μg of the powdered material, 
was dropped onto the pretreated GCE and dried at 60 oC for 20 min. A Pt wire was used as 
the counter electrode and Ag/AgCl as the reference electrode. Cyclic voltammetry (CV) 
measurements and chronoamperometry (CA) were performed using a CHI 760E 
electrochemical workstation. For glucose detection experiments, the workstation was 
operated at +0.55 V with continuous stirring to ensure efficient convective mass transport. 
In the experiment, 200 µl of glucose was added incrementally to 2 ml of 0.1 M NaOH 
aqueous solution. Then, interfering anion and cation experiments were conducted. Finally, 
the short-term (1000 s) and long-term (21 days) stability of the electrode was tested. All the 
measurements were carried out at room temperature in a normal atmosphere. 
Electrochemical impedance spectroscopy (EIS) was performed using the same three-
electrode system in 100 mM KCl electrolyte solution containing equimolar (0.01 M/0.01 
M) [Fe(CN)6]4-/3- at a bias potential of 0.55 V by applying an AC voltage with 5 mV 
amplitude in a frequency range from 0.1 Hz to 1 MHz.  
3. Results and Discussion 
3.1. Synthesis and characterization of Cu/Cu2O/CuO HSs 
The formation of Cu/Cu2O/CuO HSs is illustrated in Fig. 1. The formation of mixed-
phased copper oxide HSs is based on an in-situ gas release mechanism in a single aerosol 
droplet, where citric acid acts as a blowing agent. Further information regarding the 
formation mechanism can be found in the Supporting Information (SI-2). The phase 
composition of the aerosol-made materials was investigated by XRD, with the results 
displayed in Fig. 2a. When using nitrogen as a carrier gas in the FuAR process, the powder 
prepared from the precursor solution containing copper nitrate–citric acid is identified as 
Cu/Cu2O [13]. The addition of ammonia in the precursor solution (copper nitrate–citric 
acid–ammonia) results in the formation of Cu/Cu2O/CuO hybrids [21]. The peaks are 
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identified with standard pdf card for Cu (pdf # 01-071-4611), Cu2O (pdf # 04-016-6875) 
and CuO (pdf # 04-007-0518). It can be seen that the intensities of the Cu2O crystalline 
phases decrease with corresponding increases in the intensities of the CuO peaks, implying 
a growing amount of CuO at the expense of Cu2O. On the other hand, the pure CuO phase 
is clearly identified in the CuO HSs sample obtained in airflow during the FuAR process. 
The phase composition of Cu/Cu2O/CuO is determined by XPS analysis. High-resolution 
XPS was performed to identify Cu peaks. The binding energy for Cu and Cu+1 peaks are 
very close and therefore difficult to distinguish. There are satellite peaks corresponding to 
electronic shake-up that are present for CuO. The ratio of Cu(II)/(Cu(0)+Cu(I)) present in 
the composite HSs is calculated to be 2.47 based on the ratio of their XPS peak areas.  
 
Fig. 1. The formation mechanism of Cu/Cu2O/CuO HSs. The aerosol droplet consisting 
copper nitrate, and citric acid in ammonia enters the reactor. The increase in temperature 
inside the reactor leads to evaporation of water and decomposition of the precursors. The 
final product is the copper oxide particles in powdered form, which are collected on a 
membrane filter.  
 
The morphology of the synthesized Cu/Cu2O/CuO was investigated by SEM and TEM. 
Most of the Cu/Cu2O/CuO particles are spherical with diameters ranging from 0.05 to 3 
μm. Also, hollow as well as fractured particles are observed (Fig. 2b). The hollow structure 
of the Cu/Cu2O/CuO spheres was further verified by the bright contour at the center of the 
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sphere in the TEM image (Fig. 2c), and the shell thickness is estimated to be ~30 nm (Fig. 
2d). Similar hollow morphologies are also found in both Cu/Cu2O HSs and CuO HSs 
samples (Fig. S4). The Brunauer–Emmett–Teller specific surface area (SBET) and pore 
volume (Vp) of Cu/Cu2O/CuO HSs measured using the nitrogen physisorption method were 
determined to be 11.3 m2/g and 0.12 cm3/g, respectively. In comparison, the SBET and Vp 
values of Cu/Cu2O and CuO HSs were 13.2 and 0.10 cm
3/g, and 5.3 m2/g and 0.078 cm3/g, 
respectively.  
 
Fig. 2. (a) Powder XRD patterns of CuO, Cu/Cu2O, and Cu/Cu2O/CuO HSs samples, (b) 
SEM (scale bar 1 µm), and (c) TEM image (1 µm) of Cu/Cu2O/CuO HSs, (d) high-resolution 
TEM image (100 nm) of Cu/Cu2O/CuO HSs showing the wall thickness of approximately 30 
nm. 
3.2. Electrochemical performance analysis 
All three aerosol-made HSs composites – Cu/Cu2O/CuO, Cu/Cu2O, and CuO – were 
applied as a non-enzymatic glucose sensor by depositing an aqueous solution containing 
powdered composite and Nafion on a glassy carbon electrode (GCE) surface. Cyclic 
(a)
1 μm
(b)
(c)
1 μm 100 nm
(d)
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voltammetry measurements were performed to investigate the modified electrode’s 
electrocatalytic activity toward glucose oxidation. As shown in Fig. 3a, in the presence of 
10 µM glucose, the oxidation of glucose started at an onset potential of 0.40 V for both the 
Cu/Cu2O-GCE and the CuO-GCE. In comparison, an increasing current signal was 
observed for the Cu/Cu2O/CuO-GCE starting at a lower positive onset potential of 0.30 V. 
The current signal was 5.9 and 3.9 times higher than for the Cu/Cu2O-GCE and CuO-GCE, 
respectively. Most notably, the combination of Cu, Cu2O, and CuO in a composite 
significantly enhanced the electrochemical performance of the electrode, which may result 
from the synergistic effect of improved electron transfer between the ternary compositions. 
To prove this, we performed electrical impedance spectroscopy (EIS) measurement on 
these electrodes (Fig. 3b). After modification of the GCE electrode with the composites, 
the semicircle diameter, which represents the resistance to electron transfer of the modified 
layer increases, indicating the attachment of material on the conductive GCE electrode 
surface. It is observed that the order of electron transfer resistance is Cu/Cu2O/CuO < CuO 
< Cu/Cu2O, with Cu/Cu2O having a very high resistance. EIS results show that the electron 
transfer ability of the ternary composite (Cu/Cu2O/CuO) is very rapid.  
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Fig. 3. (a) Cyclic Voltammetry (CV) curves at 50 mV/s of Cu/Cu2O/CuO, CuO, and 
Cu/Cu2O-modified GCEs in 0.1 M NaOH with a glucose concentration of 10 µM. (b) 
Electrical impedance spectroscopy (EIS) data recorded on bare GCE, Cu/Cu2O/CuO, CuO, 
and Cu/Cu2O-modified GCEs. EIS parameters: frequency range of 0.1–106 Hz, and 5 mV 
amplitude of sine voltage signal. 
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Fig. 4a displays the CV curves of the Cu/Cu2O/CuO-GCE in a 0.1 M NaOH solution in the 
presence of various concentrations of glucose at 50 mV/s. The electrode’s response was 
very weak in the absence of glucose (black curve), but the electro-oxidation current 
increases steadily with an increase of glucose concentration up to 100 µM. Furthermore, 
CVs of the Cu/Cu2O/CuO-GCE were recorded in 100 µM glucose solution at different scan 
rates (5 mV/s to 200 mV/s) (Fig. S5). It was found that anodic peak current increases with 
the increasing scan rate potential. The inset shows anodic peak current is linearly correlated 
to the square root of the scan rate, implying that the electrode surface oxidation reaction is 
not electrocatalyst kinetics limited, but instead, a typical diffusion-controlled process. 
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Fig. 4. (a) CV curves at 50 mV/s of Cu/Cu2O/CuO modified GCE in 0.1 M NaOH with 
glucose concentrations from 0 to 100 µM. (b) Amperometric response at 0.55 V of the 
Cu/Cu2O/CuO modified GCE to successive ~10 s additions of glucose to 0.1 M NaOH. The 
inset is the corresponding calibration curve. (c) Calibration plot derived from the 
amperometric responses at 0.55 V versus an Ag/AgCl reference electrode for all three 
composites: Cu/Cu2O/CuO, Cu/Cu2O, and CuO. Cu/Cu2O/CuO-modified GCE showed 
outstanding sensitivity. 
 
For a healthy individual, the body’s homeostatic mechanism restores the blood glucose 
level at 4.4-6.6 mM; whereas diabetic blood sugar can increase up to 15.0 mM [22,23]. In 
light of this information, the amperometric response of the Cu/Cu2O/CuO-GCE to 0.5 µM – 
30 mM glucose was tested. The amperometric responses of the modified electrode to 0 µM 
– 100 µM glucose addition is presented in Fig. 4b and responses to higher concentrations 
of glucose additions (1 mM – 30 mM) are plotted in Fig. S6. The responses of three 
independent experiments were used to calculate the standard error. The results indicated a 
sensitive amperometric response for the entire glucose concentration range tested. The 
insets in Fig. 4b and Fig. S6 show the calibration curve of the modified electrode based on 
the amperometric results. The clear stepwise linear increments over the entire concentration 
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range indicate that the Cu/Cu2O/CuO-GCE can monitor glucose sensitively. The fitting 
equation was I (mA/cm2) = 0.0087 C (µM) + 0.29, with a correlation coefficient of 0.99 for 
the concentration up to 100 μM (Fig. 4b). The detection limit was found to be 0.39 µM, as 
calculated by 3σ/S, where σ and S respectively denote the standard deviation of the 
background current (1.1×10-3 mA/cm2) and the slope of the calibration curve (8.7×10-3).  
Based on the amperometric results, the current density calibration curve results for the 
modified GCE with all three composites – Cu/Cu2O/CuO, Cu/Cu2O, and CuO – in 0.1 M 
NaOH with a glucose concentration of 1-100 µM at a scan rate of 50 mV/s was created 
(Fig. 4c). For comparison, Table 1 lists the analytical performances of other existing Cu-
based composite modified GCE sensors along with our findings. The sensitivity of the 
CuO-modified GCE was found to be 1234 µA mM-1 cm-2, similar to the values reported 
previously on the CuO-modified electrodes [11,24]. Furthermore, similar to the results 
reported for the Cu/Cu2O modified GCE [12], the sensitivity of the Cu/Cu2O modified GCE 
was determined to be 1104 µA mM-1 cm-2. Although compared with previously reported 
values, our results showed a slight enhancement in the sensitivity of GCEs modified with 
either Cu/Cu2O or CuO, we wanted to take the modification composition recipe one step 
further, and created the Cu/Cu2O/CuO composite. An outstanding sensitivity of 8726 µA 
mM-1 cm-2 was achieved by the Cu/Cu2O/CuO-GCE, which is 7-fold higher than those of 
the Cu/Cu2O and CuO modified GCEs (Fig. 4c). 
The glucose sensing performance in this study and that of other non-enzymatic sensors 
available in the literature are summarized in Table 1. Clearly, the Cu/Cu2O/CuO modified 
GCE developed in this study had the highest sensitivity among all non-enzymatic glucose 
sensors under comparable conditions, except for Ag-carboxylate functionalized SiO2. The 
sensitivity of Ag-carboxylate functionalized SiO2 (potential, 0.62 V; electrolyte, 0.1 M 
NaOH; sensitivity, 9091 µA mM-1 cm-2) is slightly higher than that of the Cu/Cu2O/CuO 
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ternary composite HSs (potential, 0.55 V; electrolyte, 0.1 M NaOH; sensitivity, 8726 µA 
mM-1 cm-2). Nevertheless, the need for an expensive noble metal precursor as well as the 
multi-step synthesis procedures (thermal treatment, refluxing, filtration, and washing) and 
long reaction time (100 h) of Ag-carboxylate functionalized SiO2 might limit its potential 
use for practical applications. As a result, our sensor is successful in detecting the glucose 
concentration for the entire range tested (0.5 µM to 30 mM) with a detection limit of 0.39 
µM. 
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Table 1. Analytical performance comparison of non-enzymatic electrochemical sensors for glucose detection. 
Electrodes 
Applied 
potential 
(V) 
Electrolyte 
Sensitivity    (µA 
mM-1 cm-2) 
Linear range 
Detection 
limit 
Reference 
Cu/Cu2O/CuO HSs/GCE 0.55 NaOH 8726 0.5 µM - 30 mM 0.39 µM Current work 
Cu/Cu2O nanohybrids 0.55 
CuSO4+Lactic 
Acid+NaOH/KOH 
1434 Up to 40 mM 1.6 µM [18] 
Cu/CuxO 0.5 NaOH 1620 0 - 6 mM 49 µM [12] 
Hollow Cu2O nanospheres 0.6 NaOH 2038 1.25 - 37.5 µM 0.41 µM [4] 
Cu2O nanourchin 0.5 KOH 2682 0.1 - 3 mM 1.52 µM [32] 
Cu2O/Cu 0.5 NaOH 6681 1 µM - 1.8 mM 0.67 µM [33] 
Anneal shrinked Cu2O 
dendrites 
0.45 NaOH 5040 0.001 - 1.4 mM 0.13 µM [8] 
Cu/CuO 0.6 NaOH 1887 2 µM -3.56 mM 0.05 µM [34] 
CuO nanowires/carbon cloths 0.55 NaOH 2973 Up to 1.12 mM 1 µM [35] 
CuO nanospheres/carbon 0.55 NaOH 4902 Up to 1 mM 1 µM [35] 
Sandwich structured CuO 0.6 NaOH 5343 Up to 3.2 mM ~1 µM [36] 
Ag-carboxylate functionalized 
SiO2 
0.62 NaOH 9091 0.004 - 5.5 mM 0.33 µM [37] 
Nano Ni/Ti electrode 0.5 NaOH 7320 0.05 - 0.6 mM 1.2 µM [38] 
Cu-Ag/nanofiber 0.55 NaOH 7746 0.005 - 3.5 mM 0.08 µM [28] 
Cu-Cu2O/TiO2 0.65 NaOH 4895 0.1 - 2.5 mM 8.6 µM [17] 
3D graphene-Co3O4 0.58 NaOH 3390 Up to 0.08 mM < 0.025 µM [39] 
Pd-CuO/reduced graphene 
oxide/screen printed electrode 
0.6 NaOH 3355 0.006 - 22 mM 0.03 µM [40] 
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Currently, the mechanism for glucose electrooxidation on the Cu-based electrodes in an 
alkaline medium is not entirely clear; nevertheless, it is believed that a Cu3+ species, rather 
than Cu+ or Cu2+, serve as the electron-transfer mediator [25]. Also, it was demonstrated 
that the electro-oxidation of glucose in an alkaline medium requires the presence of oxide, 
hydroxide, and/or oxyhydroxide groups [26]. That is, the electro-oxidation of glucose on 
the Cu or Cu composite occurs through reaction with CuOOH to form Cu(OH)2. Based on 
this assumption, a possible mechanism for glucose detection on the Cu/Cu2O/CuO modified 
GCE is proposed in Fig. 5. During electrochemical measurements, Cu(0), Cu(I) and Cu(II) 
would be oxidized to Cu(III), which could catalyze glucose oxidation to generate 
gluconolactone.  
 
 
Fig. 5. The schematic representation of the mechanism of glucose sensing with 
Cu/Cu2O/CuO composite HSs. 
Recent studies showed that improved electrocatalytic activity could be achieved by the 
synergistic effect of binary composition interfaces, in which the electrons are rapidly 
transferred between the redox couples [27,28]. Hassan and Hamis [29] found that the 
electrocatalytic activity toward glucose oxidation of a Cu electrode can be significantly 
enhanced by the co-deposition of CuO. The same study also mentioned that CuO facilitates 
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the transformation of the Cu3+/Cu2+ redox couple. In the case of the Cu/Cu2O/CuO-
modified GCE, CuO may facilitate the conversion of Cu3+/Cu2+ redox pairs, so, rapid 
electron transfer occurs between the Cu, Cu2O, and CuO species. The highest electron 
transfer ability of the Cu/Cu2O/CuO composite was also verified by the EIS results (Fig. 
3b). Moreover, the high surface area of the Cu/Cu2O/CuO (Section 3.1) could also play 
another crucial role in its superior electrocatalytic activity. It is widely accepted that highly 
efficient electrocatalysis often results from a large active surface area [13–15]. Hence, even 
though the electron transfer resistance of Cu/Cu2O/CuO and CuO are similar, the high 
surface area and large pore volume of the Cu/Cu2O/CuO provide more active sites and 
facilitates the glucose oxidation process. The surface area of Cu/Cu2O is the highest, which 
might allow the glucose molecules access to the active sites more easily. However, 
Cu/Cu2O’s highest electron transfer resistance resulted in poor electrocatalytic 
performance. Overall, to achieve a remarkable sensing performance, the material should 
have not only low electron transfer resistance but also a high surface area, as achieved in 
the case of Cu/Cu2O/CuO.  
3.3.  Interference and Stability Studies  
To evaluate the selectivity of the Cu/Cu2O/CuO-modified GCE sensor, we examined the 
effects of possibly interfering ions such as anions of chloride, uric acid (UA), ascorbic acid 
(AA), and dopamine (DA) which typically coexist with glucose in human blood. To test the 
Cl- ion interference, chloride was added in the form of NaCl, KCl, and CaCl2. According to 
blood test reference charts [22], for a healthy individual, the relative ratios of glucose to 
Na+, K+, Ca2+ are 1:26, 1:1, 1:2. The ratios of AA, DA, and UA to glucose are 1:69, 1:13, 
1:423, respectively [22]. As a result, for the interference study, the ratio of glucose to 
possibly interfering Cl salts was conservatively selected to be 1:30, higher than the highest 
healthy ratio; whereas the proportion of potentially interfering anions to glucose was 
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chosen to be 1:10, lower than the lowest healthy ratio. According to the amperometry 
results (Fig. 6), current signals from interfering ions is insignificant, and a clear response 
from glucose is obtained in the presence of these ions. The observations confirm that the 
Cu/Cu2O/CuO modified GCE demonstrates excellent detection specificity for glucose in 
the presence of selected anions, which may hinder glucose selectivity. The high selectivity 
of the sensor towards glucose may be attributed to the negative sulfonate groups present on 
the Nafion that hinder the attachment of the interfering anions on the electrode surface and 
secure the surface for glucose attachment [16,30]. 
 
Fig. 6. Amperometric response of the Cu/Cu2O/CuO-modified GCE to the successive 
additions of 50 and 100 µM of glucose in the presence of (a) 3 mM Na+, K+, and Ca2+, 
respectively. (b) 10 µM of UA, AA, and DA, respectively. 
The stability of the hollow Cu/Cu2O/CuO-GCE was investigated by measuring its 
amperometric response to 50 µM glucose for an extended period, for this case, 21 days. The 
electrode was exposed to air, and the amperometric response was measured at Day 1, Day 
7, Day 14 and Day 21 (Fig. S7 and Table S1). The efficiency dropped by ~24% by the 14th 
day and then remained stable until the end of the 21st day. Ultimately, the Cu/Cu2O/CuO-
GCE preserved a high sensitivity of 6545 µA mM-1 cm-2 until the end of the 21st day. 
Cu/Cu2O/CuO was further characterized following the glucose sensing test by both TEM 
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and XRD analyses. As shown in Fig. S8(a), the hollow spherical structure was still well 
retained over the used Cu/Cu2O/CuO sample. However, the used Cu/Cu2O/CuO sample 
shows a different phase composition compared to the fresh Cu/Cu2O/CuO (Fig. S8(b)). The 
intensity of the Cu2O phases decreases to a certain extent with corresponding increase in 
the intensity of the CuO peaks, implying a growing amount of CuO at the expense of Cu2O. 
As explained earlier, the sensing performance also diminishes with time and number of 
measurements. A simultaneous decrease in the sensing performance and change in the 
material composition indicate that the electrocatalytic performance of the Cu/Cu2O/CuO is 
affected by the ratio of each component. Accordingly, it is expected that engineering the 
phase composition of the Cu/Cu2O/CuO composite could further enhance its 
electrocatalytic performance and stability. Based on the formation mechanism of these HSs 
described in the Supporting Information, we have also briefly discussed the synthesis 
parameters that can be used to control the composition, but the synthesis of material 
(Cu/Cu2O/CuO) with exact controlled composition is out of the scope of this paper.  
Next, we studied the short-term stability of the Cu/Cu2O/CuO-modified GCE. As shown in 
Fig. S9, there is nearly no loss in the current signal over a period of 17 minutes for 100 µM 
glucose on 0.1 M NaOH at 0.55 V, showing the excellent stability of the electrode. 
Moreover, the inset displays that it takes approximately 3 seconds to achieve a steady-state 
current, indicating the relatively rapid response of our sensor to glucose. Furthermore, to 
verify its workability with blood, we have tested our sensor’s response to glucose in fetal 
calf serum (FCS), which is the blood fraction remaining after the natural coagulation of 
blood, followed by centrifugation to remove the remaining red blood cells. The serum 
perfectly mimics real blood due to its composition [29]. Fig. S10 displays the results of the 
response to 5 mM glucose addition. The current response at 0.55 V from the proposed 
glucose sensor is in good agreement with the value obtained at pH 7, which indicates a 
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potential application in practice. Finally, we compared the sensing responses of electrode 
materials, specifically Cu/Cu2O/CuO, synthesized in two different batches and the 
performance of modified GCEs were compared (Fig. S11). Both amperometric responses 
and CV analysis showed consistent sensing performance for detection of glucose.  
4. Conclusions   
Cu/Cu2O/CuO ternary composite HSs were successfully synthesized by a facile FuAR 
method and were used as a non-enzymatic sensor for electrochemical detection of glucose. 
The performance of a Cu/Cu2O/CuO-modified glassy carbon electrode (GCE) for the 
detection of glucose over a concentration range of 0.5 µM - 30 mM was established. The 
results showed that the modified electrode had an outstanding sensitivity of 8726 µA cm-2 
mM-1, with a low detection limit of 0.39 µM. The Cu/Cu2O/CuO hollow spheres (HSs) 
modified GCE exhibited not only remarkable selectivity but also showed strong short-term 
stability and a fast and excellent selective response for glucose detection. We hypothesize 
that the outstanding sensing performance of the Cu/Cu2O/CuO HSs modified electrodes 
originate from minimum resistance in the electron conduction between the electrode 
materials and availability of high surface area.  
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Experimental  
 
Fig. S1. The furnace aerosol reactor (FuAR) experimental setup. The setup consists of a 
controlled gas supply, a precursor solution, a collision nebulizer, an electric furnace, and a 
membrane filter for particle collection.  
 
SI-1. Preparation of Cu/Cu2O HSs and CuO HSs 
Cu/Cu2O HSs were synthesized using copper nitrate and citric acid (dissolved in DI water) 
as the precursors using nitrogen (14 psi) as the carrier gas. The preparation of CuO HSs 
was performed using copper nitrate, citric acid and ammonia (dissolved in DI water) as the 
precursors, while compressed air (14 psi) was the carrier gas in the FuAR process. The 
subsequent aerosol process for the preparations of Cu/Cu2O HSs and CuO HSs was the 
same as that for Cu/Cu2O/CuO HSs. Detailed synthetic parameters of the aerosol-made 
materials are summarized in Table S1. 
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Table S1. Detailed synthetic parameters of Cu/Cu2O/CuO, Cu/Cu2O, and CuO. 
Sample Precursor Carrier gas (14 psi) 
Cu/Cu2O/CuO Copper nitrate, citric acid and ammonia Nitrogen  
Cu/Cu2O Copper nitrate and citric acid  Nitrogen 
CuO Copper nitrate, citric acid and ammonia Air 
 
Results and Discussion 
SI-2. Formation mechanism of Cu/Cu2O/CuO HSs 
The formation of mixed-phased copper oxide HSs is based on an in situ gas release 
mechanism in a single aerosol droplet, where citric acid acts as a blowing agent [1]. As the 
droplet containing the precursors enters the heated zone, the rapid water evaporation results 
in a temperature gradient within the aerosol droplet. The surface of the aerosol droplets is 
heated first, and then heat is transferred to the core. Further, the decomposition of citric 
acid results into hot gasses including CH4, H2, CO, CO2, NH3, NO2, and H2O[2,3], which 
then creates an outward “blowing force,” leading to the formation of a hollow sphere. The 
gasses heating of the droplet proceeds, a CuO shell forms as a result of supersaturation, 
precipitation, and decomposition of copper nitrate at the droplet surface. It is important to 
note that the hollow sphere formation does not occur with only copper nitrate precursor 
(Fig. S2), but with the presence of citric acid.  
Recently, Trusov et al. [4] demonstrated the synthesis of metallic Cu and Cu/Cu2O hollow 
microspheres, using copper nitrate and glycine as precursors in a spray solution combustion 
method under an argon atmosphere. Their study showed that at a high temperature (600-
750 oC), the decomposition of glycine resulted in the evolution of NH3 gas that further 
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reduced the pre-formed CuO nano-grains to produce metallic Cu and Cu/Cu2O particles. 
We believe the formation of Cu/Cu2O HSs in our work occurred by a similar mechanism 
where pre-formed CuO is reduced to Cu/Cu2O from the decomposition of citric acid. The 
decomposition of citric acid produced a large amount of gas including CH4, H2, CO, CO2, 
NH3, NO2, and H2O [2,3], which acted as in situ gas releasing agents inside the particles. 
These agents induced a high pressure inside the particles and promoted the formation of 
hollow structures. Therefore, the in-situ reduction of CuO particles by strong reducing 
gasses (e.g., CH4 and H2) under a nitrogen atmosphere led to the formation of Cu/Cu2O 
HSs. 
Interestingly, we found that the addition of ammonia in the precursor solution facilitated the 
formation of a Cu/Cu2O/CuO system under a nitrogen atmosphere. During the preparation 
of the precursor solution of copper nitrate, citric acid, and ammonia, soluble NH4NO3 
crystallites formed, as revealed by the XRD results (Fig. S3). NH4NO3 is a strong oxidizer 
[5], and the decomposition products from NH4NO3, including O2, N2O, and NO2, are also 
strong oxidizers. In the presence of these strong gaseous oxidizers, the reduction of CuO by 
the decomposition products of citric acid may, therefore, be hindered. As a result, not all 
CuO is reduced, and this can lead to the formation of Cu/Cu2O/CuO composite during the 
FuAR process. Overall, the formation of Cu/Cu2O/CuO ternary composite is a result of a 
trade-off between reduction and oxidation reactions involving copper nitrate, citric acid, 
and ammonia. On the basis of the above formation mechanism, the phase composition of 
Cu, Cu2O, and CuO in the Cu/Cu2O/CuO ternary composite can, therefore, be controlled by 
tuning the following parameters: (i) furnace temperature, (ii) citric acid/Cu ratio, and (iii) 
the concentration of ammonia in the precursor mixture.   
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Crystalline CuO was also identified in the copper nitrate–citric acid–ammonia precursor in 
a strong oxidizing atmosphere (air and NH4NO3) during the FuAR process. To the best of 
our knowledge, this is the first study demonstrating the preparation of Cu/Cu2O/CuO 
composite HSs using an aerosol-based synthesis method.  
Previous studies on preparing Cu-based electrode materials were typically performed in an 
aqueous batch system (e.g., a hydrothermal method, electrospinning, and electrodeposition) 
in which multiple synthetic steps and tens of hours of processing time are required [6–9]. In 
contrast, the FuAR is a scalable method which ensures an easy, rapid and highly 
reproducible synthesis; more importantly, it can be operated continuously, with a residence 
time of only several seconds [10,11]. Also, the Cu/Cu2O/CuO composite HSs were 
produced from an aqueous solution of copper nitrate, citric acid, and ammonia, all of which 
are low-cost and readily available for mass production of HSs.  
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Fig. S2. TEM image of CuO microspheres synthesized with copper nitrate only through 
FuAR. 
 
 
Fig. S3. XRD patterns of dried copper nitrate–citric acid and copper nitrate–citric acid–
ammonia precursors.   
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Fig. S4. TEM images of (a) Cu/Cu2O HSs and (b) CuO HS 
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Fig. S5. CV curves of Cu/Cu2O/CuO-modified electrode in 0.1 mM glucose and 100 mM 
KCl electrolyte solution containing equimolar (0.01 M/0.01 M) [Fe(CN)6]4-/3- solution at 
different scan rates. The inset is the corresponding calibration curve. 
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Fig. S6. Amperometric response at 0.55 V of the Cu/Cu2O/CuO modified GCE to successive 
~10 s additions of different concentrations of glucose to 0.1 M NaOH.   
. 
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Fig. S7. The long-term stability of the hollow Cu/Cu2O/CuO-modified GCE, measured by 
its current response to 50 µM glucose. The measurements were taken at Day 1, 7, 14, and 21. 
The left y-axis denotes the percentage of the measured current response to the initial current 
at Day 1. The right y-axis displays the value of the measured current.  
 
Table S2. The current responses to 50 µM glucose at 0.55V of Cu/Cu2O/CuO-modified GCE 
on day 1, 7, 14 and 21. 
Day Current (A) I/I0 
1 74.2 100.0 
7 62.3 83.9 
14 55.1 74.2 
21 55.0 74.2 
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Fig. S8. (a) TEM image of the Cu/Cu2O/CuO sample after glucose detection. (b) 
Comparative XRD patterns of Cu/Cu2O/CuO composite samples before and after reactions. 
(a) 
(b) 
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Fig. S9. The short-term stability of the hollow Cu/Cu2O/CuO-modified GC electrode, 
measured by its amperometric response 0.55 V to 100 µM glucose for more than 1000 
seconds. The inset shows the response time of the electrode to reach a steady-state current. It 
takes approximately 3 seconds for the electrode to respond to glucose addition.  
 
.
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Fig. S10. CV curves at 50 mV/s of Cu/Cu2O/CuO modified GCE with glucose concentrations 
of 5 mM in fetal calf serum (FCS), pH 7.4 and DI water, pH 7.0. The blank represents the CV 
curve without the addition of glucose.  
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Fig. S11. Two different batches of Cu/Cu2O/CuO HSs were synthesized, and the performance 
of Cu/Cu2O/CuO-modified GC electrodes were compared. (a) Amperometric responses 
measured at 0.55 V to 5 mM glucose for more than 120 seconds. (b) CV curves at 50 mV/s of 
two different batches of synthesized Cu/Cu2O/CuO modified GCE with glucose concentrations 
of 5 mM in 0.1 M NaOH.  
(a) 
(b) 
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Appendix VI.  
Investigating the Effects of Stove Emissions 
on Ocular and Cancer Cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The results of this appendix have been compiled as a full paper and submitted to Scientific 
Reports. Karakoçak B. B., Patel S., Ravi N., Biswas P. Investigating the Effects of Cookstove 
Emissions on Ocular Cells. 2018. 
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Abstract 
More than a third of world’s population relies on solid fuels for cooking and heating, with 
major health consequences. Although solid fuel combustion emissions are known to increase 
the prevalence of illnesses such as chronic obstructive pulmonary disease and lung cancer, 
however, their effect on the eyes is underexplored. This study assesses the acute toxicity of 
solid fuel combustion emissions on healthy ocular cells and a cancer cell line. Three healthy 
ocular cell lines (corneal, lens, and retinal epithelial cells) and a cancer cell line (Chinese 
hamster ovary cells) were exposed to liquid and gas phase emissions from applewood and coal 
combustion. Following the exposure, real-time cell attachment behavior was monitored for at 
least 120 hours with electrical cell impedance spectroscopy. The viability of the cells, amount 
of apoptotic cells, and generation of reactive oxygen species (ROS) were quantified with MTT, 
ApoTox-GloTM, and ROS-GloTM H2O2 assays, respectively. The results showed that coal 
emissions compromised the viability of ocular cells more than applewood emissions. 
Interestingly, the cancer cells, although their viability was not compromised, generated 1.7 to 
2.7 times more ROS than healthy cells. This acute exposure study provides compelling proof 
that biomass combustion emissions compromise the viability of ocular cells and increase ROS 
generation. The increased ROS generation was fatal for ocular cells, but it promoted the growth 
of cancer cells. 
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3. Introduction  
Nearly three billion people still use solid fuels, such as biomass, coal, and cow dung cakes, in 
inefficient stoves for cooking and heating. These stoves generate pollutants such as 
particulate matter (PM), CO, and CH4. The resultant exposure to household air pollution 
(HAP) has been associated with respiratory (Noonan et al. 2010) and cardiovascular diseases 
(Pena et al. 2017), as well as formation of cataracts (Pokhrel et al. 2005, Pokhrel et al. 2013). 
The World Health Organization (WHO) recognizes HAP as the single most significant health 
risk, accounting for 4.3 million premature deaths in 2012 (World Health 2015).  
Epidemiological studies have investigated associations between stove emissions and different 
health indicators, such as cardiovascular risk, hypertension, and lung function (Pokhrel et al. 
2005, Silva et al. 2009, Dutta et al. 2013, Pokhrel et al. 2013, Dutta and Ray 2014). However, 
epidemiological associations between indoor air pollutants and morbidity and mortality are 
often hindered by relatively small sample sizes, which are frequently not considered 
representative, and by the logistical difficulties of fieldwork in developing countries. A truly 
fundamental approach to understand and characterize the human health burden related to 
indoor stove exposure would be to investigate effects both in-vitro and in-vivo. 
Both in-vitro and in-vivo studies centered on the respiratory system have shown that 
emissions from biomass fuels have carcinogenic and mutagenic properties (Danielsen et al. 
2011, Mauderly et al. 2011, Corsini et al. 2013, Liberda and Chen 2013, Muala et al. 2015, 
Dilger et al. 2016). However, on the cellular level, no study has investigated the possible 
adverse effects of exposure to solid fuel combustion emissions on the eye, a part of the 
central nervous system (Figure 1). Only a few in-vivo studies have explored the effects of 
combustion smoke on the eye (Zou et al. 2009, Kunchithapautham et al. 2014). One in-vivo 
study showed that combustion smoke inhalation injury is caused by hypoxia and particulate 
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matter acting alone or in combination (Zou et al. 2009). How inhaling stove emissions causes 
secondary injury to the eye has not been fully explored; however, there is evidence that in 
response to smoke exposure from cotton burning, the permeability of the ocular blood vessels 
increased, which resulted in edema in the retina (Zou et al. 2009).  
 
 
 
Figure. 1. Daily activities like cooking and heating pose a threat, especially to women and 
children whose eyes are in direct contact with combustion smoke 
Exposure to stove emissions can induce oxidative stress because it depletes the antioxidant 
protection against cataract formation (Pokhrel et al. 2013). On the cellular level, oxidative 
stress can lead to the subsequent release of reactive oxygen species (ROS), which damages 
both nuclear DNA and mitochondrial DNA (Barrett et al. 1999, Elder et al. 2000, Guo et al. 
Retina 
Lens 
Cornea 
Combustion 
aerosols 
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2013). Thus, biochemical and molecular changes occur which may lead to apoptosis (cell 
death) or tumor initiation (Galadari et al. 2017). The ROS handling capacities of healthy cells 
and cancer cells are different, and cancer cells are known to adapt well to oxidative stress 
(Liou and Storz 2010). On the other hand, healthy ocular cells handle oxidative stress 
differently. For example, unlike corneal and lens epithelial cells, retinal cells can cope well 
with oxidative stress due to their unique ROS handling capacity, an evolutionary mechanism 
for tolerating light exposure (Zou et al. 2009). In view of this information, and because 
biomass and coal combustion is a repetitive daily activity for women, especially in 
developing countries (Joshi et al. 2010, Hosgood et al. 2011, Anenberg 2012, Kumar 2012, 
Hodnebrog et al. 2016), there are clear motives to investigate the effect of biomass and coal 
combustion smoke at the cellular level first. The present study sought to determine whether 
ocular cells, as well as cancer cells, would be affected by exposure to emissions from 
applewood and coal combustion in a stove. To our knowledge, this is the first evaluation of 
the in-vitro toxicity of biomass and coal combustion emissions on the eye. 
Experimental Methods 
Particulate matter collection and characterization. An improved gasifier cookstove, 
described in a previous study (Patel et al. 2016), was used to burn applewood and coal. 
Detailed physical and chemical characteristics of the cookstove emissions from applewood 
and coal have also been reported in previous work (Patel et al. 2016), and therefore are not 
repeated here. A forced-draft gasifier cookstove (Phillips, Model HD4012 LS) was used. 
Applewood chips with no additives were purchased locally (St. Louis, MO) and bituminous 
coal was procured from Brilliant, Alabama. 
For gas phase exposure, cell culture plates were placed inside a chamber as illustrated in 
Figure 2A. A minimum amount of medium was left in the wells to prevent the cells from 
drying out and to create an air-liquid interface for the exposure experiment (inset of Figure 
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2A). The humidity of the chamber was maintained at 67% by placing wet towels inside the 
box. Air, either alone (as the control) or containing cookstove emissions, was passed through 
the chamber for one hour at the same flow rate of 3 LPM as used for PM collection via a 
filter (Figure 2). At the end of the exposure, the cell plates were removed from the chamber, 
and the cell culture medium was replenished.  
 
     
Figure. 2. Schematic illustration of the experimental setup (A) Gas phase exposure. The inset 
represents the air-liquid interface created for the gas phase exposure. (B) Liquid phase 
exposure.  
(A) Gas phase 
(B) Liquid phase 
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For liquid phase exposure, the particulate matter (PM) emissions were first collected on a 47 
mm Teflon filter (Sigma-Aldrich, St. Louis, MO) as illustrated in Figure 2B. To extract the 
collected PM, the filter was submerged in 100 ml of deionized water and sonicated for 30 
minutes. This extract was then further diluted to different strengths with Dulbecco’s modified 
Eagle’s medium (DMEM F-12) (Sigma-Aldrich, St. Louis, MO) with 10% fetal calf serum 
(Sigma-Aldrich, St. Louis, MO) and 1% antibiotic-antimitotic solution (Sigma-Aldrich, St. 
Louis, MO). Particle suspensions (1000-200-50-20-10 µg/ml, denoted in the rest of the study 
as dilution ratios of 1:1, 1:5, 1:20, 1:50, 1:100, respectively) were sonicated with a Branson 
sonicator bath (Hach, Loveland, CO) for 30 seconds immediately before being added to cell 
cultures. The cell media was removed prior to the applewood extract exposure in the liquid 
phase. The volume of applewood extracts was verified to be 150 μl in each well.  
Cell models. The selection criterion for cell lines was the likelihood of the cells being in 
direct environmental contact with the biomass emission. As illustrated in Figure 1, biomass 
smoke is expected to hit the cornea first. Epidemiological studies have reported a direct 
correlation between cataract formation and biomass smoke exposure (Shalini et al. 1994, 
Pokhrel et al. 2005, Pokhrel et al. 2013, Ravilla et al. 2016), so lens epithelial cells were also 
included in this study. Further, retinal pigment epithelial cells have been reported to be 
adversely affected by cigarette smoke exposure (Alcazar et al. 2007, Jia et al. 2007, Bertram 
et al. 2009), so they were included in this study as the last healthy ocular cell line. On the 
other hand, the in-vitro toxicity of biomass smoke to lung cancer cell lines is well 
documented (Dogan et al. 2011, Dilger et al. 2016); therefore, lung cancer cells were not 
assessed in this study. Instead, we chose an ovarian cancer cell line which has been shown to 
have a high mitotic index (Tobey et al. 1967, Harada and Morris 1981) and also has not been 
studied before for in-vitro toxicity assessment of biomass smoke emissions.  
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Corneal epithelial cells (ATCC® PCS¬ 700-010TM), lens epithelial cells (ATCC® CRL¬ 
11421TM), retinal pigment epithelial cells (ATCC® CRL¬ 2302™), and Chinese hamster 
ovary (CCL¬ 61™) cells were purchased from American Type Culture Collection (Manassas, 
VA).  
Cell culture conditions. In flat-bottom 96-well plates, 150 μl volumes of cells (2.0 × 104 cells 
per well) were incubated at 37 °C in 5% CO2 until confluent, then exposed to biomass 
emissions. For gas phase experiments, a minimum amount of cell medium was kept in each 
well to prevent cells from drying, while also ensuring direct contact with the biomass 
emission. For liquid phase experiments, biomass emission extracts were dispersed in cell 
culture medium (DMEM/F12) to be used for cell exposure. 
Assessment of cytotoxicity measurements with MTT, ApoTox-GloTM, and ROS-GloTMH2O2 
assays. Cell metabolic activity, and hence the viability of cells in the presence of biomass 
smoke, was assessed with MTT (3-[4, 5 dimethyl-thiazoly-2-yl] 2-5 diphenyl tetrazolium 
bromide).  
The apoptotic cell amount and ROS generation, respectively, were measured by ApoTox-
Glo™ and ROS GloTM H2O2 assays. In all biological and imaging tests, cells exposed to 
filtered air alone served as a negative control. For the MTT assay, following the gas and 
liquid phase exposures, 100 µL of MTT (1 mg/l in growth media) was added to each well, 
and the plate was incubated for an additional 5 h at 37 °C in 5% CO2. The resulting blue 
component, produced by the reduction of the tetrazolium salt of MTT by mitochondrial 
dehydrogenase enzyme, was dissolved in 100 µL dimethyl sulfoxide (DMSO). The optical 
density of the colored product was read photometrically, using a spectrophotometer at 540 nm 
with a microplate reader (Molecular Devices Spectra Max 190). The absorbance of untreated 
cells was used as the negative control. The percentage viability of the cells was calculated 
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from the ratio of the mean optical density of the sample to the optical density of the negative 
control (Karakocak et al. 2016). 
For the apoptosis and ROS detection experiments, the cells were cultured and exposed to 
liquid and gas phase biomass emissions in 96-well, clear-bottomed white plates. Caspase 3/7 
activity, the key indicator for apoptosis, was evaluated using the ApoTox-Glo™ Triplex assay 
according to the manufacturer’s protocol (Promega Biosciences San Luis Obispo, CA). The 
light output, measured with a luminometer, correlates with Caspase-3/7 activation, and 
luminescence was measured using a microplate reader (Molecular Devices SpectraMax 190).  
ROS generation was evaluated with the ROS-Glo™ H2O2 assay according to the 
manufacturer’s protocol (Promega Biosciences San Luis Obispo, CA). The light signal 
produced by recombinant Luciferase enzyme is proportional to the level of H2O2 in the cells. 
The luminescence was measured using a microplate reader (Molecular Devices SpectraMax 
190). 
Electrical Impedance Spectroscopy. The cell attachment behavior of the cells was analyzed 
real-time using electrical impedance spectroscopy (ECIS), a noninvasive technique that 
measures the impedance across gold electrodes at the bottom of tissue culture wells, using 
frequencies of alternating current (Wegener et al. 2000, Arndt et al. 2004). Cells were plated 
in a 96-well ECIS array (Applied Biophysics, 96W20idf PET, Troy, NY) similar to those 
plated for the endpoint toxicity assays. The change in resistance at frequencies ranging from 
400 to 64,000 Hz was measured over time. Low-frequency impedance can be used to monitor 
the solution paths around the cells, and hence the layer’s cell-to-cell barrier functions 
(Wegener et al. 2000). The addition of particles may complicate the impedance of the system. 
However, at a frequency of 4,000 Hz, the contribution to resistance from cells was dominant 
over the contribution to resistance from biomass extracts with the medium (Kandasamy et al. 
  
288 
 
2010). Therefore, we chose a frequency of 4,000 Hz to monitor cell growth and 
biocompatibility. 
Statistical Analysis. Analysis of variance (ANOVA) was used to statistically compare ECIS 
results with the negative control (untreated cells) and positive control (medium only). A 
significance level of **P < 0.001 was deemed statistically acceptable.  
ANOVA was also used to statistically evaluate endpoint biocompatibility testing results with 
a negative control. A significance level of *P < 0.05 was deemed statistically acceptable. All 
tissue culture data (MTT, ApoTox-GloTM, and ROS-GloTM H2O2) were expressed as the mean 
± standard error of the mean (SEM) values of at least three independent culture experiments. 
Eight replicates were performed for each separate cell culture experiment.  
Data Availability 
All data generated or analyzed during this study are included in this article.  
Results  
We conducted laboratory experiments to investigate the effects of stove emissions on ocular 
and cancer cells exposed via two pathways: (1) gas phase and (2) liquid phase. In-vitro 
models can be designed to closely mimic real exposure conditions; i.e., creating an air-liquid 
interface (Mulhopt et al. 2016). When used with a direct particle-to-cell deposition system, 
in-vitro models provide more physiologically relevant conditions for evaluating the cellular 
reactions, i.e., apoptosis initiation and ROS generation, in response to environmental 
pollutants (Seagrave et al. 2005, Hawley and Volckens 2013, Mulhopt et al. 2016). In the first 
part of our study, to closely simulate ocular cell exposure to air pollutants, we performed gas 
phase exposure to cells maintained in ‘‘air-liquid interface’’ conditions, where only a thin 
layer of fluid separates the cells from the aerosols (Figure 2A). Unlike the liquid phase 
exposure experiments, these conditions expose the target cells to both particulate and non-
particulate constituents of the exhaust in naturally occurring proportions. In the second part of 
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the study, liquid phase exposure experiments were conducted where particulate matter 
extracts were exposed to submerged cell cultures (Figure 2B). 
Coal and applewood were the two fuels used in this study. A laboratory hood setup (Figure 2) 
with an aspiration-based dilution system was used to capture the emissions from fuel burned 
in a micro-gasifier stove. Comprehensive details about the stove, fuel properties, and their 
combustion and emissions characteristics were reported in previous studies (Patel et al. 2016, 
Leavey et al. 2017).  
Acute toxicity: Gas phase exposure 
To assess the cellular responses to gas phase exposure, at approximately the 47th hour of cell 
growth the viability, apoptotic cell amount, and ROS production were measured before and 
after exposing the cells to applewood and coal combustion emissions for one hour. The cell 
attachment behavior, however, was monitored in real time for more than 120 hours.  
Figure 3A compares the viability, amount of apoptotic cells, and the amount of ROS 
generation for the four cells types exposed (gas phase) to emissions from applewood and coal 
combustion. No significant difference was observed for the biocompatibility of corneal and 
lens epithelial cells exposed to the emissions from the two fuels (Figure 3A). Both retinal and 
CHO cells were more biocompatible with applewood emissions than coal emissions. The 
viability of the CHO cells was not compromised; instead, when exposed to applewood 
emissions, their biocompatibility was measured to be greater than 100%. However, coal 
emissions adversely affected the CHO cells’ viability (89%). The apoptotic cell 
measurements showed statistically significant differences in the responses to applewood and 
coal combustion emissions (Figure 3B). Lens epithelial cells showed the highest apoptosis 
signal, followed by corneal and retinal cells. The apoptotic signals recorded from retinal and 
CHO cells were significantly less strong than the signals from corneal and lens epithelial 
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cells. Similar to the apoptotic signal results, corneal and lens epithelial cells produced 
significantly higher amounts of ROS (Figure 3C) than retinal and CHO cells.  
 
 
  
Figure. 3. Comparative biocompatibility of applewood and biomass combustion emissions 
with corneal epithelial cells, lens epithelial cells, retinal pigment epithelial (RPE-19) cells, 
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and Chinese hamster ovary (CHO) cells. (A) Viability results. (B) Amount of apoptotic cells. 
(C) ROS. Values are expressed in mean ± SEM, with each condition tested (n = 4). *P < 0.05 
ECIS allows monitoring the changes in cell morphology that are essentially evoked by 
alterations in the architecture of the cell’s structural components, such as the cytoskeleton and 
cell-cell and cell-substrate junctions (Stolwijk et al. 2015). Figure 4 illustrates the real-time 
(120 hours) impedance measurements of all cell lines tested. Figure 4A shows the results for 
the negative control group, the cells exposed to air only. All the cell types grew and reached 
confluency without showing any disruption in the impedance measures. Figure 4B 
demonstrates the cells’ response to applewood combustion emissions. Except for the cancer 
cells, all the ocular cells were adversely affected by the exposure. Similarly, all the ocular cell 
lines exposed to coal combustion emissions detached from the plate, resulting in a decrease in 
impedance. On the other hand, CHO cells maintained their confluency, although their growth 
rate was significantly less than that of the negative control group.  
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Figure. 4. Real-time impedance measurements of corneal epithelial cells, lens epithelial cells, 
retinal pigment epithelial cells, and Chinese hamster ovary (CHO) cells. Cells were plated at 
20,000 cells/well and exposed to stove emissions for one hour. (A) Control (B) Cells exposed 
to applewood combustion emissions. (C) Cells exposed to coal combustion emissions. Values 
are expressed in mean ± SEM, with each condition tested (n = 8). Black vertical lines 
represent the timing and the duration of exposure **P < 0.001. 
Exposure 
Control 
Applewood 
Coal 
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Acute toxicity: Liquid phase exposure 
Our previous study showed that emissions from coal combustion exceeded those from 
applewood on almost all characterization metrics, such as mass concentration, number 
concertation, particle size, surface area concentration, organics concentration, and 
carcinogenic polycyclic aromatic hydrocarbons (PAH) concentration (Patel et al. 2016). 
Consistent with the above-mentioned results, the gas phase exposure study revealed that coal 
combustion emissions were more toxic to all cell lines tested. Therefore, for the liquid phase 
exposure study, only the effect of applewood combustion emission was investigated.  
As shown in Figure 5A, overall viability declined with increasing emission exposure levels 
(decreasing dilution ratio) for all healthy ocular cell types, but the viability of retinal 
epithelial cells demonstrated the least sensitivity to the exposure levels. Conversely, cancer 
cells were not affected until the exposure concentration was increased to a dilution of 1:1. 
Interestingly, except for the 1:1 dilution, the cancer cells showed more than 100% viability, 
i.e., their growth was promoted. Unlike the overall viability results, retinal cells sent the 
strongest signals of impeding apoptosis until the exposure concentration was increased to a 
dilution of 1:20 (Figure 5B). On the other hand, the amount of ROS generation in healthy 
ocular cells increased with increasing exposure concentration (until a dilution of 1:20), and 
similar to the apoptosis signaling results, retinal cells generated relatively more ROS than 
corneal and lens epithelial cells (Figure 5C).  
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Figure. 5. Biocompatibility measures of applewood emission extracts in contact with corneal 
epithelial cells, lens epithelial cells, retinal pigment epithelial (RPE) cells, and Chinese 
hamster ovary (CHO) cells. (A) Viability results. (B) Amount of apoptotic cells. (C) ROS 
generation. Values are expressed in mean ± SEM, with each condition tested (n = 8). *P < 
0.05. 
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In addition to the experimental endpoint toxicity evaluations of viability, apoptosis, and ROS 
generation, electrical impedance spectroscopy (ECIS), a sensing technique for monitoring 
cell motion and morphological changes real-time, was also used (Xiao et al. 2002, Karakocak 
et al. 2018). Upon plating, cells start to attach to and spread out over the gold electrodes. As a 
result, the impedance increases because the insulating cell membranes form tight junctions 
that block the electrical current’s flow. Conversely, when cells are stressed and dying, cell-to-
cell junctions are disrupted. Moreover, changes in cell morphology, such as contractile 
rounding of membranes and detachment of cells from the gold electrode, result in higher 
electrical current passage, which leads to a decrease in impedance over time (Pennington and 
Van de Walle 2017). 
Figure 6 presents electrical impedance measurements for all cell types tested. Cells were 
allowed to reach confluency (~97 hr) and then exposed to emission extracts twice, once at the 
97th hour and again at 168th hour, when then had recovered and again reached confluency. 
The real-time response behavior for corneal epithelial (Figure 6A) and lens epithelial cells 
(Figure 6B) was similar. For both cell types, after the initial response to exposure, a sharp 
decline was recorded in impedance during the first 20 hours post-exposure for all exposure 
levels tested. The impedance level recovered following both the first and second exposures; 
however, eventually, it dropped gradually. After the second exposure, the decline was 
irreversible. The impedance levels of both cell types (Figures 6A and 6B) continuously 
declined irreversibly below the initial impedance level, based on the data collected up to the 
265th hour, the end of the experiment. It was also observed that the rate of the final decline in 
impedance was higher for higher exposure levels. With higher exposure concentrations, it is 
likely that the cells reacted more drastically. In what follows, it is evident that there is a 
complex pattern of growth followed by retardation and resumption as a result of exposure to 
biomass smoke. Most notably, however, the retinal cells were markedly less affected (Figure 
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6C). The growth rate of the retinal cells was significantly affected; however, the cells still 
maintained a confluent layer by the end of the experiment. Finally, for the cancer cells, 
except at the highest exposure concentration, the impedance levels were higher than for the 
control cells (Figure 6D). Interestingly, when the cells were exposed to the extracts with the 
lowest dilution ratio, the impedance level of the cells was recorded to be 53% more than the 
impedance level of the unexposed cells (the negative control) by the end of the experiment 
(265th hour). 
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Figure. 6. Impedance measurements of (A) corneal, (B) lens, (C) retinal epithelial, and (D) 
CHO cells plated at 20,000 cells/well, exposed to applewood emission extracts with 
different dilution rates. Note that after the cells become confluent, the medium was changed 
only once throughout the rest of the lengthy exposure period. As compared to the control 
cells, the healthy cells, which were exposed to the extracts, could not recover, except at the 
highest dilution rate (1:100). Overall, the applewood emission extract did show a toxic 
effect on ocular cells; however, the same concentrations that were toxic to healthy cells 
accelerated the growth of CHO cells. Values are expressed in mean ± SEM, with each 
condition tested (n = 8). **P < 0.001. 
 
Exposure 
Corneal Lens 
Retinal CHO 
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Discussion 
In short, biomass smoke generated ROS that retarded the growth of healthy ocular cells and 
eventually killed them. Among the non-cancerous healthy cell lines tested, retinal cells 
showed the greatest resistance to bio-induced ROS generation. In fact, the CHO cancer 
cells stood out in their resistance: For both gas and liquid phase exposures, biomass smoke 
promoted their growth. The specifics are discussed below.  
Acute toxicity: Gas phase exposure 
In-vitro studies with biomass and coal smoke can potentially generate toxic products from 
reactions between the smoke components and cell media (Lee et al. 2015, Capistrano et al. 
2017). Nevertheless, for both practical and ethical reasons, evaluating emissions on cells is 
a logical precursor to in-vivo tests. In conformance with strict animal protocols, animals, 
unlike cells, cannot be exposed to biomass and coal emissions for extended periods 
(Capistrano et al. 2017). Furthermore, the specific way a cell reacts to its environment 
varies with the set of receptor proteins on its cell membrane and according to their primary 
role in the body (Epand and Ruysschaert 2017). Cell types have evolved to perform 
different roles, and thus their responses to the same stimuli can be dissimilar (Hanley et al. 
2009). In-vitro models can advantageously provide results for longer exposure periods and 
multiple types of cells. 
In Figure 3A, we compare the viability, amount of apoptotic cells, and the amount of ROS 
generation for the four cells types exposed (gas phase) to emissions from applewood and 
coal combustion. Corneal and lens epithelial cells exposed to the emissions from the two 
fuels showed similar viability results, and the type of fuel did not show a statistically 
significant difference (Figure 3A). On the other hand, both retinal and CHO cells were 
more tolerant of applewood emissions than coal emissions. Surprisingly, when exposed to 
applewood emissions, CHO cells actually grew, their viability was recorded as 109% 
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(Figure 3A). Unlike applewood emissions, coal emissions did adversely affect the CHO 
cells’ viability (89%). The apoptotic cell measurements showed statistically significant 
differences in response to applewood and coal combustion emissions for lens epithelial and 
CHO cells only (Figure 3B). The amount of apoptotic cells was highest among the lens 
epithelial cells, followed by corneal and retinal cells. Simply put, cells succumb to 
environmental stress differently (Reed 2000, Hanley et al. 2009). The concentration of 
applewood and coal smoke that led to apoptosis in corneal and lens epithelial cells did not 
result in the same level of apoptotic response in retinal and CHO cells. Our results also 
showed that retinal pigment epithelial (RPE) cells can cope well with oxidative stress 
(Figure 3C). This result may be attributed to their unique ROS handling capacity, an 
evolutionary mechanism for tolerating light exposure (Qin and Rodrigues 2008). Similar to 
the apoptotic signal results, corneal and lens epithelial cells produced significantly higher 
amounts of ROS (Figure 3C). On the other hand, retinal and CHO cells showed relatively 
less ROS generation as a result of gas phase exposure to biomass and coal emissions. As 
expected, since the ROS generation was higher in corneal and lens epithelial cells, 
apoptosis signal initiation was higher in those cells and evidently was reflected in the 
eventual viability results (Figure 3). Overall, based on viability, apoptosis, and ROS 
generation results, coal appears to show more adverse effects than applewood combustion 
emissions on all cell lines tested.  
Smoke from solid-fuel combustion is a complex mixture of hundreds of organic and 
inorganic chemical species in both gaseous and particulate phases, making it very difficult 
to associate health effects with a single component. More details on smoke constituents and 
their associated health effects can be found in (Zhang and Smith 2007), where the authors 
reviewed relevant studies from 1980 to 2016, with a focus on China. Detailed physical and 
chemical characterizations of the PM emissions from the two fuels tested in this study have 
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been published in our previous studies (Patel et al. 2016, Leavey et al. 2017), and therefore 
are not included here. Emissions from coal combustion exceeded those from applewood on 
almost all characterization metrics, such as mass concentration, number concentration, 
particle size, surface area concentration, organics concentration, and polycyclic aromatic 
hydrocarbons (PAH) concentration (Patel et al. 2016). Therefore, it is not possible to 
comment on the role of any single metric in the trends observed in Figure 3. Systematic and 
controlled laboratory studies are required to associate different specific emission 
components and metrics with their health effects. 
Figure 4A shows real-time cell attachment impedance measurements for all four cell types 
when removed from incubation conditions and exposed to filtered air (negative control). 
For all cell types except retinal cells, impedance levels decline sharply just after exposure to 
filtered air, but eventually recover to their original value. The variations in the initial drop 
in the impedance might be due to the cells’ varied abilities to compensate for and adapt to 
the changes in the extracellular environment (Berg et al. 2002, Brooks et al. 2011). It is 
clear that retinal cells are least affected by changes in, for example, the amount of carbon 
dioxide and the temperature, and therefore their impedance level is least altered (Figure 
4A).  
Figures 4B and 4C show the responses of all cell types to applewood and coal emissions, 
respectively. The initial post-exposure responses of cells were similar to those for the 
control, i.e., a decline in impedance, followed by recovery. Again, this decline may be due 
to the cells’ varied abilities to adapt to the extracellular environment. Unlike the control 
experiments, the impedance dropped for retinal, lens, and corneal epithelial cells, starting at 
the 73rd, 78th, and 81st hours, respectively. However, the impedance level of CHO cells 
continued to rise until the end of the experiment (~120 hours) (Figure 4C). This increase is 
a result of cell proliferation, triggered by the increased amount of intracellular ROS (Figure 
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5C), as reported previously (Liou and Storz 2010, Sullivan and Chandel 2014, Galadari et 
al. 2017). It can, therefore, be concluded that for CHO cells, the increased ROS caused 
more cell proliferation (Zamkova et al. 2013).  
Acute toxicity: Liquid phase exposure 
The retinal cells withstood increased oxidative stress better than the corneal and lens 
epithelial cells (Figures 5A and 5C). ROS production in cells is a double-edged sword 
(Martin and Barrett 2002). ROS are created mainly as host defenses against infectious 
agents; however, when a threshold is exceeded, increased ROS can lead to apoptosis 
(Sullivan and Chandel 2014). We measured both the apoptotic cell amount as well as ROS 
generation and found a direct correlation for healthy ocular cells (Figures 5B and 5C). 
When the amount of ROS production exceeded the cells’ capacity to repair oxidative 
damage, the cells initiated apoptosis, as was also reported in previous studies (Fiers et al. 
1999, Lemarie et al. 2011). On the other hand, cancer cells adapted to oxidative stress. 
Their viability results were significantly higher than for the healthy ocular cells (Figure 
5A). Comparing the apoptosis onset values measured in RLU (Figure 5B) with the ROS 
values in Figure 5C, it can be seen that cancer cells tolerate 1.7-2.7 times greater 
concentration of ROS than healthy ocular cells. This finding is consistent with previous 
studies that reported significantly higher ROS generation in cancer cells than healthy cells 
(Fiers et al. 1999, Sullivan and Chandel 2014). Notably, our apoptosis measurement 
technique is based on Caspase 3/7 activity measurement, which is detectable only during 
apoptosis, not during necrosis (Denecker et al. 2001). Apoptotic cell death is a programmed 
cell death as a result of increased oxidative stress (ROS generation); therefore, there is a 
strong correlation between ROS generation and the apoptotic cell amount (Figure 5).  
Unlike the corneal and lens cells (Figures 6A and 6B), the real-time impedance results for 
retinal epithelial cells did not show a sharp decline following the exposure events (Figure 
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6C). The first exposure did not affect the impedance; however, after the second exposure, 
the impedance decreased slightly. The cells did not crash by the end of the experiment 
because, as explained previously, retinal cells can cope with oxidative stress better than 
other ocular cell types. Interestingly, the impedance measurements of the cancer cells 
revealed an unexpected behavior. The CHO cells which were exposed to cookstove 
emissions extracts grew more than the control cells, displaying the same unexpected 
behavior found with gas phase exposure, which suggests that exposure to biomass exhaust 
can promote tumor growth.  
Although we do not fully understood exactly how inhaling stove emissions causes 
secondary injury to the eye and other organs (Zou et al. 2009, Hawley and Volckens 2013), 
extended exposure to smoke efficiently transfers environmental pollutants to the 
bloodstream (Pappas 2011, Schulze et al. 2017). Due to their high metabolic activity, tumor 
cells need more oxygen and nutrients than normal cells (Amoêdo et al. 2013). It has been 
shown that tumor cells can grow their own blood vessels (Jain 2005), and as a result, 
tumors receive more blood than normal cells (Carmeliet and Jain 2000, Chambers et al. 
2002). Once environmental pollutants enter the bloodstream, their constituents inevitably 
reach tumor cells. Our in-vitro study demonstrates that once tumor cells are in direct 
contact with biomass emissions, their growth is promoted. Based on our findings, it is 
reasonable to hypothesize that daily exposure to biomass smoke from stoves poses a risk 
for cancer patients.  
Conclusions 
Our in-vitro study found a significant disturbance in healthy ocular cells’ attachment, 
indicative of death, as a result of both liquid and gas phase biomass smoke exposure. On 
the other hand, the growth of cancer cells was significantly promoted. The ROS amount 
that led to ocular cell death did not destroy the cancer cells, but instead accelerated their 
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growth. Our in-vitro study connects cellular responses with epidemiological disease 
findings, clearly underscoring the troubling implication that people exposed daily to 
biomass-fueled stove smoke are at risk, especially considering that our findings were for a 
limited exposure time. People who are regularly exposed to biomass combustion smoke are 
more prone to developing eye diseases, either from direct exposure or secondary exposure 
by inhalation. More importantly, everyday activities like cooking and heating using stoves 
with biomass fuels may accelerate the growth of tumors. These findings emphasize that we 
should pay added attention to the environment of the person living with cancer, not only to 
their genetic predisposition.
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Hyaluronic Acid Conjugated Carbon Quantum Dots for Bioimaging and Targeted Drug 
Delivery Applications in Ophthalmology. 
2. 245th American Chemical Society National Meeting, New Orleans, LA, April, 2013. 
The Effect of Competing Anions on Arsenic Removal via Magnetite Nanoparticles. 
3. 4th International Symposium on Energy & Environment: ACESS, Mumbai, India, December, 
2012. The Effect of Competing Anions on Arsenic Removal via Magnetite Nanoparticles. 
 
4. International Water Association, Cities of the Future Xi’an, China, September, 2011.  
An Integrated Approach to Water Management in Kayseri: Rain Water Collection and Use in 
an Amusement Park.  
Poster Conference Presentations 
5. The Association for Research in Vision and Ophthalmology, Seattle, WA, May, 2016. 
Biocompatibility Assessment of End-thiolated Hyaluronate Coated Gold Nanoparticles on 
Retinal Pigment Epithelial (ARPE-19) cells.  
 
6. The Association for Research in Vision and Ophthalmology, Orlando, FL, May, 2014. Effects 
of Nanoparticle Exposure on the Growth of Retinal Pigment Epithelial Cells. 
 
7. 4th International Symposium on Energy&Environment: ACESS, Mumbai, India, December 
2012. Impacts of Fracturing Fluids Chemistry on Trace Element Mobilization from Shales. 
  
311 
 
Teaching Experience 
Teaching Assistant (3)  
1. Engineering Analysis of Chemical Systems (E44.EECE.201, Fall 2015) 
Washington University UG course, Instructors: Drs. Pratim Biswas and Fuzhong Zhang 
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